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Abstrakt /
Časté (více než 20%) předčasné
komorové extrasystoly (KES) mohou
vést k rozvoji dysfunkce levé komory.
Možnou léčbou těchto pacientů je radi-
ofrekvenční ablace (RFA) počátečního
místa (ohniska) ektopické aktivity, která
se provádí během invazivní elektrofyzi-
ologické (EP) studie. Přesná lokalizace
ohniska KES je nejdůležitějším fakto-
rem úspěšnosti RFA. Cílem dizertační
práce je předoperační neinvazivní lo-
kalizace ohniska KES s použitím EKG
mapování z povrchu hrudníku (BSP) a
individualizovaného modelu hrudníku,
vyhodnocení a výběr nejlepších vstup-
ních parametrů inverzního řešení pro
přesnou lokalizaci ohniska KES.
Pacienti s KES podstoupili mapování
BSP, CT skenování a EP studii s RFA.
Pro určení optimálních vstupních dat
byl u každého pacienta zpracován po-
čáteční časový interval 30 ms z 5 KES
komplexů v rámci tohoto intervalu bylo
vypočteno 21 integrálových (IBSPM) a
31 okamžikových BSP map (TIBSPM)
pro každý z pěti komplexů. Individu-
alizovaná TIBSPM byla vybrána na
základě maximální průměrné korelace
mezi TIBSPMs z celého sledovaného
časového intervalu. CT vyšetření byly
použity k získání modelů torza pacienta
s různou úrovní uvažování nehomoge-
nit: homogenní model H, nehomogenní
model V (obsahující plíce a srdeční
komory) a nehomogenní model AV
(obsahující plíce, srdeční komory, atria
a výtokové cesty). Po skončení RFA
byla lékařem vyznačena poloha ablač-
ních lézi pomocí čísla segmentu podle
doporučení AHA pro segmentaci levé
komory, která byla rozšířena také pro
segmentaci pravé komory, nebo pomocí
12-hodinového dělení pro ablační léze v
místě odtokových traktů.
Pro nalezení jediného dipólu repre-
zentujícího ohnisko KES byl vyřešen
inverzní problém pro všech 156 mož-
ných kombinací vstupních parametrů,
pro 5 KES u deseti pacientů. Dipól byl
vybrán na základě kritéria minimální
relativní zbytkové chyby (RRE) mezi
vstupní BSP mapou a mapou genero-
vanou tímto dipólem. Pouze inverzní
řešení s hodnotou RRE menší nebo rov-
nou 0, 3 byla považována za relevantní.
Relevantní výsledek byl považován za
správný (SRV) pokud se jeho umístění
shodovalo se segmentem označeným
lékařem.
Byl vyhodnocen vliv vstupních dat
inverzního řešení na jeho přesnost a
stabilitu. Nejvyšší počet — 61.3% SRV
bylo dosaženo při použití vstupní mapy
IBSPM 0–15 ms bez ohledu na pou-
žitý model hrudníku (p < 0.01); nebo
62.9% SRV když byl jako vstupní data
použít homogenní model hrudníku H
bez ohledu na použitou BSP mapu
(p < 0.01). Když byly jako vstupní
data použity kombinace homogenního
modelu torza H a TIBSPM z 8., 9.
nebo 10. ms byl dosažen nejvyšší počet
SRV — 77, 4% (p < 0, 01). Použití indi-
vidualizovaných vstupních dat nevedlo
k signifikatně vyššímu počtu SRV.
Stabilita inverzního řešení v závislosti
na funkci RRE a fluktuace vstupních dat
ukázala, že funkce RRE je prostorově
stabilní, ale vysoké fluktuace EKG mo-
hou zhoršovat inverzní řešení.
Získané výsledky naznačují, že navr-
žená metoda neinvazivní lokalizace oh-
niska KES může být použita před ope-
rací pro zkrácení EP studie při zásahu
pomocí RFA.
Klíčová slova: mapování potenci-
álu povrchu těla; inverzní problém
elektrokardiografie; ektopická aktivita;
předčasné komorové extrasystoly; mo-
del nehomogenního trupu; neinvazivní
lokalizace.
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Abstract /
Frequent (more than 20%) premature
ventricular complexes (PVCs) can lead
to the development of left ventricular
dysfunction. Possible treatment of
such patients is radiofrequency abla-
tion (RFA) of the initial site (focus)
of the ectopic activity, which is per-
formed during invasive electrophysio-
logical (EP) study. PVC focus accurate
localization is the most important factor
for the RFA success. The aim of the
thesis is preoperative noninvasive local-
ization of the PVC focus using ECG
body surface potential (BSP) mapping
and patient-specific torso geometry,
evaluation and selection of the best
input parameters of the inverse problem
for accurate PVC focus localization.
Patients with PVCs underwent BSP
mapping, CT scanning, and EP study
with RFA. To find optimal input data,
in each patient, initial 30 ms time in-
terval of 5 PVC signals were processed
and within this interval 21 integral BSP
maps (IBSPMs) and 31 time instant
BSP maps (TIBSPMs) were computed
for each of the five beats. Patient-
specific TIBSPM was selected based
on the maximum averaged correlation
between the TIBSPMs from the whole
studied time interval. CT images were
used to obtain patient torso models
with different levels of torso complexity:
homogeneous model H, inhomogeneous
model V (with lungs, and heart ven-
tricles), and inhomogeneous model AV
(with lungs, heart ventricles, atria and
outflow tracts). After successful RFA
the clinician assigned the localization
of the ablation lesions by a segment
number according to AHA recommen-
dations of LV division and its extension
to the RV, or using a 12 segment clock-
like-division for ablation lesions with
outflow tract locations.
The inverse problem was solved for
all 156 possible combinations of the
input data, for 5 PVCs in ten patients
to find a single dipole representing the
PVC focus. It was selected using the
criterion of minimal relative residual
error (RRE) between the input BSP
map and the map generated by the
dipole. Only inverse solutions with
RRE less or equal 0.3 were considered
as relevant. Relevant result was con-
sidered correct (CRR) if its location
matched with the segment assigned by
the clinician.
Impact of the input data on the accu-
racy and stability of the inverse problem
was evaluated. The highest number —
61.3% of CRR was obtained when IB-
SPM from 0–15 ms was used as input
data, regardless of the used torso model
(p < 0.01); or 62.9% of CRR when the
homogeneous torso model H was used as
input data, regardless of the used BSP
map (p < 0.01). In combinations, the
homogeneous torso model H and one of
the TIBSPM computed in 8 ms, 9 ms,
or 10 ms led to the highest number of
CRR — 77.4% (p < 0.01). The use of
patient-specific input data did not yield
significantly higher number of CRRs.
Stability of the inverse solution de-
pending on RRE function and fluctua-
tions in input data showed that the RRE
function is spatially stable but high fluc-
tuations in ECG can hinder the inverse
solution.
The obtained results suggest that the
proposed method for noninvasive local-
ization of the PVC focus can be used
pre-operationally for shortening of the
EP study with the RFA intervention.
Keywords: body surface potential
mapping; inverse problem of electrocar-
diography; ectopic activity; premature
ventricular complexes; inhomogeneous
torso model; noninvasive localization.
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bspm . body surface potential map
D . single dipole
dbspm . body surface potential map, generated by the single dipole
df . degrees of freedom
D(t) . equivalent heart generator
I . examined time interval
LA . left arm electrode
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Chapter1
State of art
1.1 Heart as part of cardiovascular system
Heart is a functional organ, a part of the circulation system, which pumps blood via
blood vessels. In humans, it has four chambers: right (RA) and left atrium (LA),
right (RV) and left ventricle (LV) (Fig. 1.1). RA receives deoxygenated blood from
systematic circulation through inferior and superior vena cava and pumps it to the RV
via the tricuspid valve. From the RV the blood is pumped via the right ventricular out-
flow tract (RVOT) through the pulmonary valve to the pulmonary artery. After passing
through the pulmonary capillary beds, where the blood is oxygenated, the blood is re-
turned via pulmonary veins to the LA and ejected to the LV through the mitral valve.
From the LV the blood is pumped through the left ventricular outflow tract (LVOT) and
is ejected through the aortic valve to the aorta (AO). From AO it is distributed to the
organs of the body. The movement of the blood from the right to the left heart (through
the lungs) is called pulmonary circulation. And the movement to and from the rest of
the body is called systematic circulation.
Figure 1.1: The anatomy of the heart and associated vessels. From [1]
The main function of the heart is to pump the blood through the blood vessels of the
circulatory system and is gained by contractions of the heart. Each heart cycle consists
of two phases: relaxation (diastole) and contraction (systole) of the chambers. During
the diastole, the ventricles are filled with blood, and during the systole, they eject the
blood into the large vessels. The contraction of the heart is controlled by the electrical
activity of the myocardial cells.
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1.2 Electrical activity of the heart
1.2.1 Conduction system of the heart
The conduction system of the heart (Fig. 1.2) consists of cardiac muscle cells and con-
ducting fibers that are specialized for initiating impulses and conducting them rapidly
through the heart. Activation of the heart starts in the pacemaker cells of the sino-
atrial node/sinus node and then impulse is propagated throughout the atria and makes
them contract. As the atria are isolated from the ventricles by the collagen layers of
connective tissue, further propagation of the electrical impulse goes only through the
atrio-ventricular (AV) node and after a delay through the system of His. It consists of
the bundle of His located in the septum which proceeds through the interventricular
septum and divides into right and left bundle branches. Left bundle branch divides
into left anterior fascicles and left posterior fascicles. Electrical activation from the
bundle of His propagates to the bundle branches and disseminate to the conduction
pathways –– Purkinje fibers, located in the inner side of the ventricles. Activation of
the ventricles (Fig.1.3) leads to their contraction.
Figure 1.2: The conduction system of the heart. From [1]
Figure 1.3: Activation sequence of ventricular myocardium. From [2]
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1.2.2 Cellular electrophysiology
Electrical activation of the heart is a result of ionic flows through the phospholipid
bilayer membrane of the cardiac cells and intercellular junctions between them. Ion
channels are protein molecules inserted in the membrane and connected to the cy-
toskeleton [3]. They allow the permeation of ions by generating a water-filled pore or
by providing a path of charged amino acidic residues [4]. Heart regions differ in distri-
bution of ion channels, passive electrical properties (which depend on cell morphology),
type and distribution of gap junctions, arrangement of cells in strands and layers [4].
This causes variation in conduction velocity from 0.05 m/s (found in atrioventricular
node) to 3.5 m/s (found in His-Purkinje system) [5].
Difference between the ions concentrations inside the cell is measured relatively to
the ions concentrations outside the cell. When the cell is at rest, the transmembrane
potential is called resting potential and it is around −90 mV. At this time the concen-
tration of the sodium ions (Na+) outside the cell is about 10 times higher than inside
and concentration of the potassium (K+) ions is about 30 times higher inside the cell
than outside [1]. When the cell is activated and the transmembrane potential reaches
the threshold of −70 mV to −60 mV, the action potential starts (Fig. 1.4).
Figure 1.4: Action potential in cardiac contractile cells. From [6]
Cell activation is evoked by a rapid change of the permeability of the sodium ion
channels in the membrane. Therefore, a rapid influx of the sodium ions occurs thanks
to the concentration gradient, the transmembrane potential reaches +15 mV –– +30 mV
and sodium ion channels close. This phase is called rapid depolarization (phase0) and is
followed by initial repolarization (phase 1) mainly supported by the potassium outward
current. During plateau phase (phase 2) slow calcium channels are open and calcium
is entering the cell, whereas some potassium channels are open allowing potassium to
exit the cell. When the transmembrane potential reaches approximately 0 mV, calcium
ion channels close, potassium ion channels open and potassium is exiting the cell. This
phase is called repolarization (phase 3). At the end of the repolarization phase the cell
returns to the initial resting potential state (phase 4).
Action potential of pacemaker cells differs from the action potential in cardiomyo-
cytes. They do not have stable resting potential thanks to the sodium ion channels, that
evoke slow and normal influx of the sodium ions. This results in a slow change of the
transmembrane potential from −60 mV up to about −40 mV and is called spontaneous
depolarization (Fig. 1.5).
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Figure 1.5: Action potential of the sinus node. From [6]
The next rapid phase depolarization occurs as a result of the calcium ion channels
opening and the influx of the calcium ions continues until transmembrane potential
reaches approximately +5 mV. Then the calcium ion channels close and potassium ion
channels open, resulting in the outflow of potassium ions causing the repolarization.
When the membrane potential reaches around −60 mV, potassium ion channels close
and sodium ion channels open, starting spontaneous depolarization again.
When the action potential starts, another one cannot be initiated for a while. This
interval is called refractory period. It can be divided into two phases: absolute refractory
period when another action potential will not start, and relative refractory period when
another action potential can be started by a stronger stimulus.
1.3 Cardiac arrhythmias
Disorders of the normal heart rhythm are usually referred to as cardiac arrhythmias.
An exception is sinus arrhythmia, which refers to the healthy variation of the sinus
rhythm [7]. Generally, the resting sinus rate in normal individuals is 60–100 beats/min
and in fit individuals it can be low as 40 beats/min. Nevertheless, the rate range in
most average adults is 60–70 beats/min.
There are many ways to classify arrhythmias. First, is whether the arrhythmia
increases (tachycardia) or decreases (bradycardia) the heart rate. Second, they can be
classified by their origin:
. Disturbances from sinus node:
. Sinus bradycardia is a rhythm originating in the sinus node with a rate slower than
60 beats/min.
. Sinus tachycardia is a rhythm originating in the sinus node with a rate greater
than 100 beats/min.
. Sinus arrhythmia is a normal, but extremely minimal increase in the heart rate
during inspiration, and an extremely minimal decrease in the heart rate during
expiration.
. Sick sinus syndrome is characterized by episodes of bradycardia with sinus pauses,
arrest, or exit block associated with poor atrial and junctional escape rhythms.
. Disturbances from atria (also referred as supraventricular):
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. Atrial premature complexes. The term atrial premature beat describes a beat,
which arises from the atrium and occurs before the expected sinus beat. Premature
beats can occur randomly or in a pattern.
. Atrial tachycardias (AT) are sustained rhythms that occur in parts of the atria other
than the sinus node. Atrial tachycardia is characterized by an atrial rate of 150 to
250 beats/min with P wave morphology (see sec. 1.5.2) different from that of the
sinus P wave.
. Multifocal atrial tachycardias. The term multifocal atrial tachycardia is used when
atrial impulses show at least three different P wave morphologies.
. Atrial flutter. Atrial rates in untreated atrial flutter range from 250 to
350 beats/min.
. Atrial fibrillation (AF). This arrhythmia is characterized by the absence of discrete
P waves and irregular ventricular response. Atrial rhythm is chaotic, with rates
that can exceed 400 beats/min when fibrillation waves are identifiable.
. Disturbances from atrioventricular junction:
. Atrioventricular-junctional beats. Isolated premature beats usually originate in
the region of the His bundle rather than the AV node.
. Non-paroxysmal junctional tachycardia. Non-paroxysmal junctional tachycardia
is a junctional tachycardia that occurs primarily in the setting of digitalis toxi-
city. The electrocardiogram shows a narrow QRS complex (see sec. 1.5.2) and the
ventricular rate is between 70 and 130 beats/min. Intermittent AV dissociation is
frequently present. When the rate is less than 100 beats/min, the term accelerated
junctional rhythm is applied.
. Accelerated idioventricular rhythm describes ventricular rates slower than usual
tachycardia rates, but faster than the ventricular escape rhythm. Rates of 75–
100 beats/min are usual.
. Disturbances from ventricles:
. Premature ventricular complexes (PVCs). Ventricular beats may be single or mul-
tiple, early or late in the cardiac cycle and have fixed or variable coupling intervals
relative to the preceding supraventricular beat.
. Ventricular tachycardia (VT) is a fast, regular beating of the ventricles that may
last for only a few seconds or for much longer. The rate ranges from 120 to
250 beats/min.
. Ventricular asystole. It is a state of cardiac standstill with no cardiac output and
no ventricular depolarization.
. Ventricular fibrillation. Ventricular fibrillation occurs if disorganized electrical sig-
nals make the ventricles quiver instead of pump normally. Without the ventricles
pumping blood to the body, sudden cardiac arrest and death can occur within a
few minutes.
The underlying mechanisms of cardiac arrhythmias can be divided into three cate-
gories [8]:
1. Disorders of the electrical impulse formation [9–10], which are provoked by:
. altered automaticity (or spontaneous impulse initiation) is the property of cardiac
cells to undergo spontaneous depolarization (phase 4 depolarization) and initiate
an electrical impulse in the absence of external electrical stimulation. It is caused
by
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. enhanced normal automaticity, which is accelerated generation of an action po-
tential by normal pacemaker tissue. Normal automaticity is found in the si-
nus node and in certain subsidiary or latent pacemakers which can become the
pacemaker if the function of sinus node is compromised. Impulse initiation is a
normal function of these latent pacemakers.
Enhanced automaticity occurs due to excess of catecholamine and electrolyte
deficiencies, which causes cardiac cells to have subthreshold potential for firing
and raising it to the threshold present at basic rhythm of the heart [11].
. abnormal automaticity, whether the result of experimental interventions or
pathology, only occurs in cardiac cells with major abnormalities/changes in
their transmembrane potentials.
. triggered activity which is impulse initiation in cardiac fibers caused by after-
depolarizations (depolarizing oscillations in the membrane potential) that occur
consequent to a preceding impulse or series of impulses. Triggered activity is pos-
sible only if a preceding potential is present. Depending on the time occurrence
of the oscillations there are two types of the afterdepolarizations: early afterdepo-
larizations, which occur early during repolarization phase of the action potential,
and delayed afterdepolarizations, which occur after completion of the repolarization
phase (Fig. 1.6).
Figure 1.6: Types of afterdepolarizations. Afterdepolarizations are indicated by red ar-
rows. Purkinje cell action potentials are shown with (A) phase 2 early afterdepolarizations
and (B) phase 3 early afterdepolarizations, as well as (C) delayed afterdepolarizations, which
occur after full repolarization. From [10]
2. Disorders of the electrical impulse conduction and reentry
. conduction delay. The speed at which impulses propagate in cardiac fibers is
dependent on passive electrical properties, and is governed by “the magnitude
of the inward sodium current flowing through the fast sodium channels in the
sarcolemma during the active potential upstroke and the rapidity with which this
current reaches maximum intensity” [4].. re-entry, which appears when a conduction path is partly slowed down and the
impulse is conducted by the fast and slow pathways. Reentry occurs in presence of
two connected conducting pathways with different refractory periods. The wave-
front from the pathway with slower conduction activates the pathway with faster
conduction thanks to shorter refractory period.
3. Simultaneous abnormalities of impulse formation and conduction.
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Cardiac arrhythmias are more commonly associated with structural heart diseases. The
most important of these diseases in the Western world is myocardial infarction, but there
are also other forms of cardiac dysfunction such as cardiomyopathies, valvular heart
disease, and certain genetically determined disorders. One of the important cause of the
heart rhythm disturbances are infections. Thus, in the Far East is common rheumatic
heart disease, and in the South America –– Chagas disease [7].
1.3.1 Premature ventricular complexes
This study focuses on premature ventricular complexes, which are caused by the spon-
taneous impulse in ventricles. They also can be referred to as premature ventricular
contractions, ventricular ectopic beats or ventricular extrasystoles. It is important to
distinguish between asymptomatic PVCs detected during clinical examination and con-
firmed by the electrocardiogram, and symptomatic PVCs, which can have important
effects on the quality of life. The last ones can cause unpleasant symptoms such as pal-
pitations, sensation of a missed beat, of cardiac arrest or of strong beats [4]. Frequent
PVCs are also associated with dizziness, angina, hypotension or fatigue.
The hemodynamic effects of the PVCs include the following [4, 12]:
. reduction in the LV systolic pressures (prematurity dependent);. postectopic beat tends to produce an increased stroke volume secondary to enhanced
ventricular filling during postextrasystolic compensatory pause;. abnormal valve motion (premature closure, mitral valve prolapse, decreased valve
opening, etc) clearly demonstrated by echocardiography.
PVCs are often induced by physical activity, anxiety, stimulants (tobacco, alcohol,
caffeine, cocaine, amphetamines, etc.), drug administration (tricyclic antidepressants,
digoxin, aminophylline, amitriptyline, pseudoephedrine, fluoxetine, etc.), sleep distur-
bances, hypoxia, physical stress or damage of the heart (cardiomyopathy, myocardial
stretch, cardiac contusion, valvular heart disease, acute myocardial infarction), hor-
monal changes in female patients (menses, pregnancy, menopause) and using isopro-
terenol during electrophysiological study [4]. Premature ventricular complexes can
also be caused by a viral infection of the myocardium, electrolyte disturbances (hy-
pokalemia, hypomagnesemia, hypercalcemia). The underlying mechanisms of the PVC
are enhanced automaticity, triggered activity, and reentry.
PVCs are common and their occurrence increases in general adult population with
age [13]. If PVCs are present in more than 20% of all QRS complexes, they can lead
to the development of left ventricular dysfunction [13–15]. Frequent PVCs can also
lead to a form of tachycardia related cardiomyopathy called PVC-related cardiomyopa-
thy [16–17]. Patients that have combination of frequent PVCs and structural heart
disease are especially at risk of fatal disturbances of the rhythm [18–21].
1.4 Treatment of the cardiac arrhythmias
Treatment of the cardiac arrhythmias aims to achieve two goals:
. to moderate symptoms for improved quality of life;. to prolong survival.
The treatment can be pharmacological (see sec. 1.4.1) or nonpharmacological (see
sec. 1.4.2–1.4.4). Nonpharmacological interventions considered in many clinical settings
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include catheter ablation and implantable cardioverter-defibrillator (for primary and
secondary prevention of sudden cardiac death) [7].
1.4.1 Pharmacotherapy
All cardiac tachyarrhythmias are caused by localized or generalized changes in action
potential regardless of underlying mechanism (abnormal automaticity, reentry or chan-
nelopathies). Therefore, principle of antiarrhythmic drugs (AAD) is based on a change
of the shape of the action potential. This is achieved by the altering of the ionic chan-
nels in the cardiac cell membrane and in this way controlling the ionic fluxes through
it. Modifying the action potential shape, the conductivity and refractory period of the
cardiac cell is changed. As stated in [22], in practice AAD are relatively ineffective in
automatic arrhythmias or channelopathies treatment, but they are highly used in the
treatment of reentrant arrhythmias [22].
According to the latest guidelines on AAD there was no significant improvement in
clinical pharmacology for arrhythmias over the last decades [23]. Because of severe car-
diac and extracardiac adverse effects, the AAD is not a neutral medication and should
be used only when arrhythmias are significantly symptomatic or life-threatening [24].
Studies focused on discovering target-specific AAD try to improve safety and decrease
complex drug-drug interactions. Currently, decision-making when starting AAD fo-
cus on the patient’s clinical condition, structural and functional substrate, arrhythmia
mechanism at the cellular and molecular level. Patient-centered decision making is also
explained by interference of multiple factors (such as race, gender, genetics, tempera-
ture, drug-drug interaction, triggering factors, neurohormonal changes, disease state
and severity, disease-induced substrate remodeling, etc.) with drug effects [23].
1.4.2 Surgical therapy
Because pharmacological therapy may not be adequate and/or may be associated with
significant proarrhythmic effects, the preferred treatment of the arrhythmia is destruc-
tion or removal of the tissue responsible for arrhythmia [25]. Thus, catheter ablation
(see sec. 1.4.4) and surgical procedures are helpful in arrhythmia treatment [24, 26]. For
instance, reentrant circuits can be mapped and disrupted surgically; and arrhythmias
caused by cardiac ischemia often respond to coronary artery bypass.
1.4.3 Device therapy
Permanent artificial pacemakers are used to increase the heart rhythm in patients with
bradyarrhythmias. The pacemaker consists of a source of electrical current that is
connected to the cardiac muscle by a wire (lead) and is controlled by an integrated
circuit. The pacemaker stimulates the heart if it is not generating intrinsic electrical
impulses often enough. If a disorder of conducting system present, pacemakers also can
be used to coordinate contraction of the atria and ventricles or between ventricles.
In patients with malignant ventricular tachyarrhythmias implantable cardioverter de-
fibrillators are used to deliver a large defibrillating current (shock) in order to terminate
the arrhythmia. It is common knowledge that implantable defibrillators have prevented
sudden cardiac death in many patients with lethal ventricular arrhythmias [24].
1.4.4 Catheter ablation
One of the most important advance in the electrophysiology field, which happened over
the past three decades, is that an electrophysiological (EP) study evolved from largely
diagnostic therapy to mainly therapeutic one [24]. Currently, many arrhythmias can
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be treated by means of catheter ablation techniques instead of potentially toxic drugs
or cardiac surgery.
Catheter ablation is an invasive procedure performed during the EP study in a
catheterization laboratory. The basic idea behind is using a catheter to destroy patho-
logical tissue or disrupt the pathways required for pathological tachyarrhythmias, and
create an electrically inert discrete scar. Obviously, to perform successful ablation it is
important to know the precise position of the pathological tissue/pathway, understand
the physiology of the involved electrical pathways, have the technology for precise po-
sitioning of the catheter, and technology to create a lesion of the desired size at critical
location [24].
From the first successful ablation in human in 1982 until 1989, direct current (DC)
shocks were used for ablation [24]. The electrode catheter was connected to a conven-
tional defibrillator and delivered the shocks of 200–300 J [27]. The shock was delivered
between the distal catheter electrode and the surface electrode, which was used as a
sink [26]. DC shocks resulted in several forms of potentially damaging energy –– heat,
light, pressure, and electrical current. Only electrical current energy created desired
damage, whereas all the other forms of energy increased the possibility of complica-
tions [24]. Therefore, low energy DC shocks (up to 40 J) were used [27]. Also, the
DC shocks often created lesions with patchy borders, which were potentially proar-
rhythmic [24, 28]. Hence, ablation using DC shocks had traumatic nature and limited
usage [26]. In the 1990’s it was replaced with radiofrequency ablation (RFA) [24, 26].
Oppositely to ablation using DC shocks, radiofrequency ablation allowed to create
discrete lesions, perform the procedure on conscious patients, terminate lesion forma-
tion in case of complication occurrence [26]. Radiofrequency current has the ability
to heat the tissue and create hyperthermic injury (lesion/scar) without stimulation of
the cardiac and skeletal muscles, avoiding arrhythmia induction and decreasing the
pain for the patient [9]. Radiofrequency generators deliver alternating continuous low
voltage (typically 40 V) [27] current with a frequency between 300–1000 kHz [7, 26],
which causes resistive and conductive heating (Fig. 1.7). Resistive heating damages the
tissues in direct contact with the catheter and the conductive heating –– the deeper
and surrounding tissues. Irreversible damage occurs when myocardial tissue reaches
temperatures around 48–50◦C. It usually takes 5–20 s to achieve a steady state be-
tween current delivery and heat dissipation by tissue and blood [27]. Therefore, the
electrophysiological effect is continuously monitored and proper actions can be taken.
If the observed change in electrocardiogram is desired, the ablation continues for at
least 30 s, otherwise it is disrupted immediately with the hope of avoiding permanent
damage. The radiofrequency current is delivered between the tip of the catheter elec-
trode and a large (surface area 100–250 cm2) dispersive/indifferent electrode applied to
the skin [29].
There are also other kinds of arrhythmia ablation –– microwave energy, laser energy,
and cryoablation. Microwave ablation, similarly to RFA, uses thermal energy to create
damage. In this case, the tissue heating is achieved by the molecular oscillations of
dipoles within polar molecules (such as water) [9, 29]. These oscillations are caused by
the electromagnetic field created with the microwave antenna, which can be designed
with various lengths (915 MHz–2450 MHz) and pattern of delivering energy. Microwave
energy allows performing deeper and more even tissue damage with less surface heating,
but requires closer monitoring of lesions [30]. Light amplification by stimulated emis-
sion of radiation (laser) produces a monochromatic phase-coherent beam at a specific
wavelength [9]. Absorption of the photon energy causes photothermal effect and heats
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Figure 1.7: Thermal injury of myocardium caused by resistive and conductive heating.
From [27]
the tissue. The laser ablation allows creating large and precise lesions but requires
nearly perpendicular delivery angle to the myocardium [29–30]. Cryoablation is carried
out by delivering a pressurized liquid refrigerant to the catheter tip. Freezing of the
cellular and extracellular fluids results in disruption of the intracellular organelles and
membranes causing complete cell death [29]. Reversible changes occur when −20◦C to
−40◦C temperatures are used and irreversible damage is caused by the range of −70◦C
to −80◦C [26, 29]. Thus, cryoablation allows to determine which tissue is a critical
component in the arrhythmia, but it also has high rates of recurrence. Nevertheless,
RFA remains the most commonly used method of cardiac arrhythmias ablation.
Intracardiac positioning of the catheter requires to use the vascular tree, mostly
through the veins, but arteries are also used in some cases (Fig. 1.8). In order to
insert a catheter into a patient’s body a puncture of the femoral vein is made after
local anesthesia and a guidewire (modified Seldinger technique) is introduced [30–31].
The percutaneous approach (access to inner organs or other tissue via needle-puncture
of a skin) has various benefits: fast, relatively painless, rapid healing of the vein and
allowing the prompt exchange of the catheter [25]. A single femoral vein can usually
accommodate up to three standard (6Fr) catheters. In some cases, jugular, subclavian
or median basilic veins are used as alternative routes [27, 30]. The catheter is guided
under X-ray control and optionally by a 3D navigational system.
The catheter consists of the insulated wire with an electrode on the distal tip of
the catheter. The proximal part of the catheter has a plug, which is used to connect
it to the recording system. There are diagnostic catheters, which are used to record
the electrograms and to perform pacing, and ablation catheters, which additionally can
perform ablation. Diagnostic catheters are made in different sizes from 3Fr up to 8Fr
(most commonly used are 5Fr or 6Fr [27]), vary in curve shape and amount of the
electrodes on the distal tip (Fig. 1.9). Multipolar catheters were developed to ease elec-
trode placement in the desired location and to fulfill various recording requirements [9].
Electrodes on the tip are typically 1–2 mm long with 1 to 10 mm (or even more) inter-
electrode distance. Ablation catheters usually have 4 mm or 8 mm tip and in sizes up
to 10 mm in length (Fig. 1.10) [9].
12
State of art . . . . . . . . . . . . . . . . 1.4 Treatment of the cardiac arrhythmias
Figure 1.8: Catheter approach for electrophysiological study [25]
Figure 1.9: Multipolar diagnostic catheters with different electrode amount and curve
shape
Figure 1.10: Ablation catheters with different tip electrode sizes and shapes
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1.4.5 Treatment of the PVCs
For many years wrong assumption existed that anti-arrhythmic drug therapy can im-
prove the risk of sudden death associated with PVCs [22, 32]. However, numerous clini-
cal trials [33–36] examined this question and showed that it is not appropriate to treat
patients with AAD for the purpose of improving the patients’ survival [22, 37]. But, in
symptomatic patients AAD can be used and an appropriate choice of the AAD depends
on the patient’s clinical condition [22]. For example, to reduce symptomatic PVCs in
patients with prior myocardial infarctions or heart failure beta-blockers could be used
(because of the significant improvement in survival they impart to these patients) [22].
In case of high frequency PVCs or if they are symptomatic and do not respond
to pharmacological treatment, they are indicated for catheter radiofrequency ablation
according to the ESC2015 ESC Guidelines for the management of patients with ven-
tricular arrhythmias and the prevention of sudden cardiac death [38–39]. According to
the guidelines, radiofrequency ablation is recommended for three groups of patients:
1. patients with symptomatic PVC;
2. symptomatic or asymptomatic patients with frequent PVC plus left ventricular dys-
function;
3. asymptomatic patients with very frequent extrasystoles (more than 20%), to pre-
vent the development of left ventricular dysfunction. Following successful catheter
ablation, the symptoms of PVC disappear and in patients with decreased ejection
fraction, the function of the left ventricle can normalize [40–42].
Accurate localization of the PVC focus is the most important factor for the success
rate of the ablation that reached 77% in a long-term follow-up [43]. The anatomi-
cal origin of PVCs can be anywhere in the ventricles and adjacent structures with a
predominant location in the right and left outflow tracts. Less common PVC foci lo-
cations include the myocardium around the aortic (Valsalva) sinus, aortic cusps, the
region between the aortic and mitral valves (the aortomitral continuity), and the region
of coronary sinus [44]. Approximately 70% of them are in the RVOT [45]. Several
algorithms have been developed to determine the site of PVC origin using a 12-lead
ECG [46], however, even the best algorithm has only 90% positive predictive value. This
means, that in 10% of patients intracardial mapping procedure is prolonged jointly with
longer fluoroscopy time.
Therefore, noninvasive localization of the position of the ectopic focus would accele-
rate and simplify intracardial mapping.
1.5 Measurement of the cardiac electrical field
Cardiac electrical field can be measured invasively using intracardial catheters or
noninvasively using electrodes placed on the body surface. Signals obtained from
invasive intracardial measurements are referred to as intracardiac electrograms (see
sec. 1.5.1), and signals measured noninvasively on the body surface are called electro-
cardiograms (ECGs) (see sec. 1.5.2, 1.5.3).
1.5.1 Intracardiac electrograms
The electrical activity of the local cardiac tissue recorded by the electrode catheter is
called intracardiac electrogram. As was mentioned before in sec. 1.2.2, the cardiac action
potential reflects cardiac activation and majority of the electrical activity is generated
within individual myocardial cells and some net charge flow in the extracellular space.
14
State of art . . . . . . . . . . . . . 1.5 Measurement of the cardiac electrical field
In general, clinicians are interested in the rapid depolarization phase (phase 0) of the
cardiac tissue [9].
In order to record an electrogram, two electrodes are used. One is positive and one
is negative. Electrogram is derived by subtraction of the information at the negative
electrode from the information at the positive electrode. Intracardiac electrograms can
be divided into unipolar and bipolar recordings.
Unipolar recordings use one electrode in the heart and a reference electrode, distant
from the heart (Fig. 1.11a). One of the ways to create a reference electrode with
zero potential is by using a driving reference. It means that input at one electrode is
summarized with its inverse signal, resulting in a zero potential (Fig. 1.12). Unipolar
recordings provide information about the direction of impulse propagation. The major
disadvantage of unipolar recordings is that they contain substantial far-field signals
generated by depolarization of tissue remote from the recording electrode [9].
(a) Unipolar recording. From the top
schematic, as the wavefront propagates to-
ward the electrode a positive deflection,
an R wave, is inscribed. As the wavefront
propagates past the recording electrode, an
S wave is inscribed and thus an RS complex
occurs (middle schematic). Recording from
the initial site of depolarization (origin at the
left side of the tissue) produces a QS com-
plex as the wavefront moves away from the
recording electrode. Recording at the right
side of the tissue (dead end) produces a
monophasic R wave
(b) Bipolar recording. Electrode 1 is con-
nected to the positive input of the amplifier
and electrode 2 is connected to the negative
input. Electrograms created by a math-
ematical simulation are shown below the
schematic. Compared to the signal from
electrode 1 (Uni–1), the signal from elec-
trode 2 (Uni–2) is slightly delayed (because
the wavefront reaches it later) and is inverted
because it is attached to the negative input
of the recording amplifier. Adding these two
signals together generates the bipolar signal
(Bi 1–2) that removes much of the far-field
signal
Figure 1.11: Generation of the unipolar and bipolar recordings. Horizontal bars that rep-
resent a sheet of myocardium with depolarization propagating from left to right (arrow).
The potential in front of the wavefront is positive and that behind the wavefront is negative,
generating a vector that points toward the positive potential. Electrodes resting on the
tissue are shown as grey circles. Theoretical electrograms are shown in boxes. From [47]
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Figure 1.12: Creating zero potential using driving reference
Bipolar recordings use two electrodes located in the area of interest (Fig. 1.11b). The
bipolar recording is generated as a summation of the potential at the positive electrode
and inverted potential of the negative electrode. Bipolar electrograms obtained from
the catheter with small interelectrode distance are almost unaffected by the far-field.
Unipolar electrograms provide information regarding the local and distant electrical
activity (which are decreasing in proportion to the square of the distance from the
electrode). Bipolar electrodes provide information only about local activity and are
sensitive to the direction of the activation front [48]. Therefore, intracardiac electrogram
provides precise, localized data on the heart’s electrical impulse [24]:
. the time of the activation (local activation time) of the myocardium bordering with
the recording electrode relative to the reference;. direction of the propagation of the electrical impulse;. complexity of the myocardial activation within the field of view of the recording
electrode.
1.5.2 Standard 12-lead electrocardiogram
The method, which is widely used in the clinical practice thanks to its quick, simple,
harmless, noninvasive procedure and diagnostic efficiency is called electrocardiography
and uses 12–lead ECG. Surface ECG represents the electrical activity of the entire heart.
It is the sum of all of the action potentials of all of the cardiac cells. Thus, an ECG
provides information about the sequence of cardiac depolarization and repolarization
across the entire heart [49].
To record standard ECG, the electrodes are placed on the limbs and chest (Fig. 1.13).
Standard leads are denoted I, II, III and are obtained by measuring the difference
between electrodes placed on the arms and left leg (right arm (RA), left arm (LA), left
leg (LL)) in the following combinations:
I = LA−RA (1.1)
II = LL−RA (1.2)
III = LL− LA. (1.3)
Standard leads form a triangle with a heart in its centre. Besides the bipolar leads, the
12–lead ECG method also includes unipolar leads: augmented limb leads and precordial
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(a) Torso model in frontal
view with limb electrodes:
right arm (RA), left arm
(LA), left leg (LL)
(b) Torso model in frontal
view with chest electrodes
(V1–V6)
(c) Torso model in superior
view with chest electrodes
(V1–V6)
Figure 1.13: Placement of the ECG electrodes on the torso
leads. Augmented leads are obtained from the limb electrodes using the Goldberger’s
central terminal for the reference [49]. Using the Goldberger’s central terminal as a
negative pole is a combination of the two voltages from the other two limb electrodes.
Augmented voltages of the right arm (aV R), left arm (aV L) and leg (aV F ) can be
obtained using the following equations [50]:
aV R = RA− LA+ LL2 (1.4)
aV L = LA− RA+ LL2 (1.5)
aV F = LL− RA+ LA2 . (1.6)
In order to represent the electrical activity of the heart in the frontal plane, six
unipolar precordial electrodes are used (Fig. 1.13b, c). The V1–V2 electrodes represent
information in the anteroseptal region of the heart, V3–V4 in the anteroapical and V5–
V6 in the anterolateral accordingly. The precordial electrodes are measured relative to
Wilson’s central terminal (WCT), which is an average of the potentials of the three limb
electrodes:
WCT = RA+ LA+ LL3 . (1.7)
The ECG waveforms represent the depolarization and repolarization of the heart
(Fig. 1.14), where the depolarization of the atria is reflected by the Pwave, depolariza-
tion of the ventricles by the QRS complex, repolarization of the ventricles by the Twave
and sometimes also U wave (Fig. 1.15). Atrial repolarization is obscured by the much
larger QRS complex; thus, it is not typically visible as a discrete event in the ECG.
The duration of the wave is defined by the two time instants at which the wave crosses
the baseline or significantly deviates from it [50].
Since this work will be focusing on the pathological premature ventricular activity,
it is important to mention that generally, the ventricular activity during ectopic firing
is easily distinguished in the ECG by the presence of a premature broad QRS complex,
generally with QRS duration ≥ 120 ms without a preceding P wave (Fig. 1.16).
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Figure 1.14: Electrocardiogram represents the depolarization and repolarization of the
heart
Figure 1.15: The basic pattern of the normal ECG signal. From [51]
Figure 1.16: Simultaneous recording of leads V1 (upper graph) and V2 (lower graph). The
third and sixth beats are unifocal PVCs. Their ventricular origin is not apparent in lead
V1 but is obvious in V2. From [52]
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1.5.3 Multichannel ECG
Besides the clinically widely used standard 12-lead ECG, also systems that contain a
higher number of electrodes distributed on the patient’s torso are used especially for
experimental and research purposes. After the pioneering work of Taccardi [53], many
research centers around the world became interested in the simultaneous recording of
multichannel electrocardiograms that enabled detailed representation of the electrical
potential distribution on the torso using body surface potential (BSP) mapping tech-
niques discussed in more detail in section 1.6.2. The possibilities of the research groups
that used the sequential measurement of few leads and manual map construction were
limited until the late 1960s when the mini computers were invented and could be used
for automated simultaneous multilead ECG recording, fast data processing, and easy
displaying of obtained maps [4]. Almost each research group has developed its own
mapping system, what resulted in wide diversity between the measuring systems, used
numbers of leads, electrodes locations on the torso and the way of their organization
(individual electrodes, strips or vests with electrodes), methods of signal processing,
analysis and interpretation of results and evaluation of errors.
Since little was known on the spatial variability of the surface potentials and, mapping
systems starting from technically feasible 24 electrodes up to 219 electrodes covering
the whole torso were developed and tested in order to obtain as much information on
the potential distribution as possible [54–56]. Some developed lead systems ordered
according to increasing number of electrodes are presented in Fig. 1.17. The number of
leads for each of the lead systems is given in brackets.
Generally, in BSP map the torso surface is displayed as a rectangle representing an
unfolded elliptical cylinder constituting the human torso model. The height of the
rectangle usually extends from the jugular or suprasternal notch to umbilicus [55].
Electrode positions are usually marked by individual points or points in strips or grids.
Their number and placement have a direct influence on data processing. Lead systems
with a large number of electrodes evenly covering the whole surface of the torso are
called full systems and simple bilinear or spline interpolation is usually used to construct
the potential distribution in the map. Lead systems with a small number of electrodes,
usually with irregular electrode placement are called reduced systems. They use mostly
advanced interpolation methods based on analytical functions approximating the poten-
tial changes between the electrodes or a priori information on the correlation between
torso potentials obtained from full lead measurements [55].
The impracticality of the time-consuming electrode application and hardware ex-
penses limited BSP mapping in fact to research purposes and it was not implemented
in clinical daily routine. It is obvious that a higher number of electrodes provides more
detailed information about the distribution of the electrical potential on the torso [57].
Nevertheless, it is important to keep the method convenient in usage and tolerable for
the patients. An ideal number of mapping electrodes should fulfill the demands of clin-
ical practice that requires low cost, minimal time and effort for their application and
maximum of useful diagnostic information of the body surface potential distribution.
That is why some systems used strips or vests (in order to decrease the time of electrode
placement).
Last year a commercial system CardioInsight Noninvasive 3D Mapping System
(Medtronic) [58] received permission in the USA to be used in clinical practice. This
system uses a vest of 252 electrodes, which is presented in Fig. 1.18.
The possible influence of the lead system on the accuracy of the potential field rep-
resentation as well the impact of electrode displacements on the map patterns was
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Figure 1.17: Schematic representation of electrodes placement in 15 lead systems used
for BSP mapping (adopted from [54–56]). Individual electrodes are indicated by dots
or squares, whereas strips are indicated by vertical or horizontal lines along which the
electrodes are placed
Figure 1.18: CardioInsight vest with 252 electrodes [58]
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extensively studied both, in models and experiments, in normal subjects and in pa-
tients.
One of the first studies on the selection of the number of measuring electrodes [59]
showed that 24 properly located electrodes selected out of a grid of 150 (10 × 15) are
enough to describe body surface potential distribution to an acceptable degree of ac-
curacy. However, the authors recommend to extend this number for clinical practice.
It is obvious that due to the specificity of the individual patient torso geometry, heart
position and orientation, the optimal position of electrodes can vary between the pa-
tients and affects the number of required leads. Therefore, mapping systems with a
higher number of measured leads might be recommended to obtain a more precise de-
scription of the individual body surface potential distribution. However, an evaluation
by Lux et al. [60–61] showed some redundancy in the ECG measured by cumbersome
mapping systems with 100–200 electrodes and suggested 32 lead system with optimal
placement of the electrodes for practical clinical diagnostics. Later, the same research
group proposed a sequential algorithm for optimal recording sites selection and con-
firmed that 32 leads are sufficient for diagnostically acceptable reconstruction of the
body surface potential distribution [62]. Nevertheless, the study highlighted that sug-
gested configuration of the lead system was optimized only for capturing of the signal
information and was not considered as best diagnostic information.
Besides the analysis of the impact of the electrode number and position, it was
also shown in a computer model how the electrode displacement can cause substantial
changes in the map patterns [56].
A detailed overview of the most cited works regarding the selection of the number
and positioning of recording leads based on the signal or diagnostic information criteria
is given by Donnelly et al. [63]. A comprehensive description of the research studies
performed by Kornreich during more than 20 years highlighted the complexity of the
issue to define optimal number and placement of the recording leads.
1.6 Mapping of the cardiac electrical field
1.6.1 Intracardial mapping
In order to obtain a general understanding of the activation sequence in the heart or se-
lected chamber, a methodology of cardiac electrical mapping is performed by recording
intracardiac electrograms (see sec. 1.5.1). Initially, this method was used in order to un-
derstand the normal heart activation, but later it was more used to study the underlying
pathophysiological mechanisms of the arrhythmias, their initiation, and sustenance [7].
Conventional cardiac mapping techniques can be divided into [30, 48]:
1. Activation sequence mapping
defines the localization of the earliest electrical activation (the time difference between
the onset of the signal on the mapping catheter and the onset of PVC on a 12-lead
ECG should be the longest). This technique is highly used for ablation of focal
arrhythmias [30]. Usage of the electroanatomical mapping systems allows creating
color-coded activation maps.
2. Pace mapping
compares the morphology of the paced P wave or paced QRS complex (in sinus
rhythm) with the morphology of the complex during tachycardia in all ECG leads.
If they have an exact match, it is presumed that the pacing was performed from the
location of the arrhythmia origin.
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3. Entrainment mapping
is usually used to define the characteristics of the reentrant circuit. Entrainment
mapping continuously resets the reentrant circuit. It is possible if the reentrant
circuit has an excitable gap at each point of the circuit, which is defined by the time
between the recovery from the last depolarization and the time of arrival of the next
excitation wavefront. Shortly, the method checks whether the applied stimulus or
train of extrastimuli are inside or outside of the reentrant circuit.
4. Miscellaneous pacing procedures
In order to determine the mechanism of arrhythmia, a useful maneuver is to perform
atrial or ventricular pacing during the sinus rhythm or tachycardia.
5. Voltage mapping and fractional local electrogram
determine the amplitudes of the local electrocardiograms in the heart cavities. In
order to perform voltage mapping, electroanatomical 3D mapping systems are used
to distinguish the viable regions from the scar in the presumed reentry circuit.
Cardiac mapping is the bedrock of the radiofrequency ablation and intracardiac in-
tervention. Spatial information about anatomical structures combined with electro-
physiological information from the electrograms is crucial for successful ablation. For
this purpose alternative cardiac mapping systems were developed. Long before these
systems were elaborated, an article by Idecker et al. [64] stated four assumptions for
construction and use of the isochronal cardiac maps, which should be fulfilled by cardiac
mapping system in order it to be used for diagnostic purposes. “These assumptions
include the following:
1. the location of the recording electrodes is known with sufficient accuracy to determine
the mechanism of an arrhythmia or to guide therapy;
2. a single, discrete activation time can be assigned to each recording electrode location;
3. the presence or absence of activation at an electrode site can be reliably ascertained,
and when activation is present, the time of activation can be determined with suffi-
cient accuracy to specify the mechanism of an arrhythmia or to guide therapy;
4. the recording electrodes are close enough together that the activation sequence can
be estimated with sufficient accuracy to determine the mechanism of an arrhythmia
or to guide therapy.” [64]
There are two types of the cardiac mapping systems: sequential mapping systems and
continuous mapping systems [7]. The sequential mapping system collects electrophys-
iological information from the tip of the catheter simultaneously with the tip location
point by point. This allows to create a 3D surface geometry, representing the studied
chamber and depict the electrical activation of the heart [65]. Therefore, these sequen-
tial systems CARTO™(Biosense Webster) [66], LocaLisa®(Medtronic) [67], Realtime
Position Management (RPM™, Boston Scientific) [68], and NavX System (Endocardial
Solutions) [69]) are also referred as electroanatomical. Continuous mapping systems use
basket mapping [70] and noncontact catheter mapping [71] with many simultaneously
recording electrodes to obtain the global information about the rhythm from one or
two cardiac beats. These systems are ideally suited for mapping complex and poorly
tolerated arrhythmias (e.g. infarct-related VT).
Electroanatomical mapping systems and noncontact mapping systems provide fol-
lowing advantages [30]:
. global view of the activation;. nonfluoroscopic catheter navigation;
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. precise tagging of the ablation sites and ability to renavigate ablation catheter to the
sites of prior current application or close to it.
Limitations of the sequential mapping lie in the assumption that the impulse spreads
in exactly the same way during each heartbeat. Therefore, it is not applicable in
patients with complex arrhythmias and during rapid electrophysiological changes as
those associated with ischemia and reperfusion [72].
Noncontact mapping systems also have limitations. The multielectrode array might
be difficult to position in the left atrium or in ventricles [30]. For distances greater
than 4 mm virtual electrograms deteriorate and require multielectrode repositioning.
The system has difficulties to delineate borders of activation zones not bordered by
anatomic structures. Noncontact mapping also does not reliably identifies ventricular
scaring. A detailed comparison of the cardiac mapping systems is given in Tab. 1.1 [73].
Over the past few years, the technology has evolved allowing integration with CT and
MRI data sets [65]. CARTO-UNIVU™(Biosense Webster) integrates electroanatomical
mapping and live fluoroscopy into a single view [74]. A comprehensive review of the
electroanatomical mapping systems and their development is given in [74].
1.6.2 Body surface potential mapping
One of the novel noninvasive methods for cardiac diagnostics is body surface potential
mapping. As it was already mentioned in sec. 1.5.3, this method uses multichannel
ECGs records from the torso surface to obtain significant physiologic and prognostic
information [4, 72, 75].
A detailed comparison of ECG and BSP mapping is given in Tab. 1.2 [76]. Among
valuable advantages of the BSP mapping compared with 12-lead ECG are:
. possibility to explore entire chest surface potential distribution and provide all the
information on the cardiac electric field available at the body surface;. higher sensitivity of the local electrical activity (ventricular recovery heterogeneities
or local conduction disturbances);. besides temporal and amplitude values has additional spatial component, whereas
the 12-lead ECG scalar waveforms only present the voltage variation in time at a
given site.
On the other hand, disadvantages of the BSP mapping include [77]:
. Technical aspect: time-consuming application of a large number of electrodes on the
thoracic surface and the collection of large amounts of data for further processing
and analysis.. Clinical aspect: perception by medical staff that other techniques (echocardiography,
radionuclide imagining, CT-scan, SPECT, PET, Doppler, etc.) provide more useful
or more accurate clinical information.. User-friendliness: novel data representation — unfamiliarity of physicians and car-
diologists with the new methodology — map format of body surface potential repre-
sentation.
BSP mapping is a technique with controversial demands. Nevertheless, it allows
receiving more information from body surface potential electrodes, the procedure is
noninvasive and nonfluoroscopic, and can provide highly useful diagnostic information
without substantially loading the patient. In comparison with the invasive intracardiac
electrophysiological study, the BSP mapping does not introduce additional risks for the
patient such as bleeding, damage of the vessel, infection, perforation of the heart etc.
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ECG BSPmapping
Technical data
Availability everywhere in specialized centers
Acquisition time 2–3 min 10–60 min
Processing no necessary only by computer
Display simultaneously after processing
Evaluation by all physicians only by experts
Automatic evaluation + −
Information about the electrical event
Components Mainly dipolar dipolar + multipolar
Modeling the electrical sources − +
Localization + ++
Monitoring + −
Diagnostic value
Myocardial infarction
Acute + −+
old Q wave + ++
old non Q wave − ++
+conduction defect −+ +
Hypertrophies + ++
lntraventricular conduction defects + ++
Supraventricular conduction defects + −
Accessory pathway + ++
Hyperdinam rhythm disturbances + −
Localization of ectopic activity + ++
Measuring the effect of invasive procedure −+ +
Table 1.2: Comparison of ECG and BSP mapping. From [76]
Usually, the body surface potential maps are computed from measured data consid-
ering the WCT (see Eq. (1.7)) as the zero-potential reference. Different ways to analyze
the measured electrical information resulted in various map-types [76]:
. isopotential/instantaneous or time instant BSPmap (TIBSPM) displays a distribution
of the potentials φi on body surface based on measured signals in i = 1,m points at
one particular time instant t
TIBSPM = φi=1,m(t)dt (1.8)
. isoarea or integral BSP maps (IBSPMs) are created by integrating signal over certain
defined time interval I (e.g. QRS, QRST, or ST). Generally, IBSPM is defined as
IBSPM =
∫
I
φi=1,m(t)dt, (1.9)
where
IBSPM — is an integral body surface potential map,
φi(t) — is electrical potential measured in i-th point at time instant t,
i = 1,m — is a point on the body surface, which describes the index number of the
measured lead,
I — is examined time interval,
t — is time instant.. dierence integral maps (DIF ) reveal the changes in patient maps. The difference
map is calculated as a subtraction of corresponding values in one map from another.
Thus, the difference integral map between two IBSPMs can be described using the
following equation:
DIFi=1,m = IBSPM1 − IBSPM2 =
∫
I
φi=1,m;k=1(t)dt−
∫
I
φi=1,m;k=2(t)dt, (1.10)
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where
DIFi=1,m— is difference integral map,
k — is the map number.. departure integral maps (DI) are computed to display the departures of patient’s
integral map (Fig. 1.19) from a selected template (expressed in standard deviations).
Thus they show the departure from the normal or reference and can be used for
direct cardiac diagnostics [76, 78]:
DIi =
Pi −Mi
SDi
, (1.11)
where
DIi –– departure integral map,
Pi –– values in the analyzed patient’s integral map,
Mi –– values in the template map,
SDi –– standard deviation of the template in point i,
i – index number of measurement point (electrode).
Figure 1.19: Body surface potential maps for the Q0J time interval. Top left: Departure
map (DIi). Top right: patient integral map (Pi). Bottom left: standard deviations of the
template map (SDi). Bottom right: Template map (Mi). From [78]
. Departure index map only indicates those parts of the departure map, where the
difference from the map of the control group exceeds the 2 standard deviations [76].. Isochronal map displays activation pattern [79]. An isochrone is a curve of equal
travel time (activation time).. Autocorrelation maps are square matrices of values between −1.0 and 1.0, which
represent the correlation coefficients of every pair of instantaneous potential distri-
butions from a set of successive instants in time [4].
Review of the body surface potential map types (Fig. 1.20) and their patterns for
various cardiac abnormalities is given in [4, 76]. The variety of cardiovascular patholo-
gies that can be identified using noninvasive body surface potential mapping includes
ischemia, WPW, ventricular ectopy and other local sources of arrhythmias [80–84], [J5].
Universal software allowing to analyze multichannel ECG records from intracardiac
and also body surface was described by Potse et al. [85]. The technique of BSP mapping
is used to solve the inverse problem, which will be described in more detail in the
following sections.
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Figure1.20: Presentation of various map-types in a schematic form (old anterior infarction,
using the Montreal configuration). (a) potential values on the sites of the electrodes at the
30th ms after QRS onset; (b) the corresponding isopotential map/instantaneous or time
instant BSP map (TIBSPM); (c) isoarea map or integral BSP map (IBSPM) of the first
30 ms of the QRS from the same patient; (d) averaged isoarea map of the first 30 ms of
the QRS in normal group (24 patients) for computation of departure maps; (e) isoarea
departure map of the first 30 ms of the QRS (c–d); (f) isoarea departure index map of the
first 30 ms of the QRS (like “e”but only those sites are assigned, where the difference is
more than 2 SD of the normal group); (g) isochrone map during the QRS also from the
same patient. In (b–f), the maximum and minimum values are given and their location
is indicated by a + or a − sign on the map. Difference between isopotential lines in
(b): 0.5 mV; the difference between isoarea lines in (c–f): 2.2 mVms. From [76]
1.7 Modelling of the cardiac electrical activity
Living organisms are functioning based on cross-correlating mechanisms and therefore
not all measurements can be performed during the experiment. In order to study de-
pendences, interactions, mechanisms, and behavior in the living organisms, hypotheses
are checked on the simplified mathematical models. Models are adjusted to represent
the experimental measurements and controlled by the basic science laws [1].
Mathematical models of physiological bioelectrical processes are usually constructed
to perform experiments, which are not possible to conduct with living tissues. They
contain some simplifications and assumptions, but they are required to accurately rep-
resent the natural behavior [1, 86].
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The ECG record represents the electrical activity of the internal bioelectrical source,
but does not provide its unique specification as different electrical sources might gen-
erate the same distribution of the electrical potential on the body surface. Forward
(see sec. 1.7.1) and inverse (see sec. 1.7.5) problems help to understand the processes of
cardiac electrical activity more deeply from qualitative and quantitative points of view.
Modelling of the cardiac electrical field in the heart (or on its surface) and on the
body surface and its relation with the sources is known as the forward and inverse
problem of electrocardiography (Fig. 1.21) [1]. The forward problem determines the
electrical field from the known source and conductor. Whereas the inverse problem
determines the source from the known field and conductor.
Figure 1.21: Schematic principle of the forward and inverse problems of electrocardio-
graphy. From [1]
The forward problem has a unique solution whereas the inverse problem mathema-
tically has several solutions [87–88]. Hermann von Helmholtz firstly described this fact
in the theoretical paper in 1853 [89].
In order to solve the forward and inverse problem, several assumptions are accepted.
The electrical activity of the heart is represented by equivalent electrical source (see
sec. 1.7.2) and since the body is a three-dimensional conducting medium, it is referred
to as a volume conductor (see sec. 1.7.3).
1.7.1 Forward problem of electrocardiography
The forward problem has fundamental role as it must grasp and describe the rela-
tionship between the electrical sources and distant cardiac bioelectrical activity [4]. A
complete forward solution would include information from the scale of ion-channel pro-
tein to the complete human thorax, and from nanosecond to minutes or even hours of
time [4]. Thus, the multiscale nature of the problem and constraints of the computa-
tional resources requires a division of the problem into several components [90]:
. cellular electrophysiology (protein membrane biochemistry, genetics, pharmacological
impact, kinetics of membrane ion currents),. tissue level (cell-to-cell coupling, tissue structure modelling, activation sequence),. organ level (heart geometry, tissue types, heart activation sequence),. whole body level (geometry and structure of the thorax, electrical field in volume
conductor).
Generally, the forward problem of electrocardiography can be expressed using a ma-
trix formulation [91]. Discretization of the electric source strength of N generator
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elements at T subsequent time instances, produces a matrix S, which represents the
entire source with elements sn,t, n = 1 . . . N ; t = 1 . . . T . Similarly, effect of the volume
conductor might be represented by a transfer matrix A with al,n elements, where each
element represents the potential in the lead l generated by a unit source element n of
unit strength. Therefore, the computation of the forward problem can be represented
by matrix multiplication:
Φ[L×T ] = A[L×N ] · S[N×T ], (1.12)
where
Φ[L×T ] — represents potentials at L lead positions at T discrete time instants. The ma-
trix formulation of the forward problem can be viewed as a mapping of the information
about the heart sources onto the images on the body surface [91].
Forward problem was solved using various approaches [87, 92] in simulation [93–95],
animal [96–98] and patient studies [93, 99–101]. The latest revision of the conducted
studies is presented in [86, 102–103].
1.7.2 Sourcemodels
There are various source models, which can be used to represent the electrical activi-
ty of the heart: discrete source models (dipole, moving dipole, multiple dipoles and
multipole), epicardial potentials, uniform and equivalent double layer models [1, 4, 92].
A huge advantage of the discrete source models of the heart is the small number of
parameters required for the source description, which results in simplicity of the asso-
ciated forward (and inverse) problems. The biggest disadvantage of the discrete source
models is the absence of clear physiological and physical links between the discrete
sources and true sources (that they represent) or any directly measurable quantities [4].
. Dipole
The simplest and the best-known model of the cardiac electrical generator is a single
dipole [91]. This model is defined by a single dipole moment with fixed location and
variable orientation and magnitude. Therefore, the dipole has three independent
components: in Cartesian coordinates it is Dx;Dy;Dz and in spherical coordinate
system it is the magnitude D and two direction angles θ and φ [1]. This model is
used in vectorcardiography as an equivalent generator during the QRST interval to
analyze the trajectory of the electrical depolarization and repolarization [4, 104]. In
spite of its simplicity, dipole model is widely used in solving forward and inverse
problems.. Moving dipole
Moving dipole model means that the dipole can have variable location at different
time instants. It has three variables defining the location and three variables defining
the dipole moment itself. Therefore, it has six independent variables in total [1, 105].. Multiple dipoles
The heart volume with electrical sources can be divided into smaller regions and each
region can be represented by a dipole. The dipoles are in fixed positions and have
varying magnitude and orientation. Therefore, if the number of dipoles is N , then
3×N independent variables are necessary to characterize the multiple dipole. If the
orientation of the dipoles is fixed, then each dipole can be characterized by only one
independent variable — the magnitude [1, 87].. Multipole
Multipole is an expansion of the dipole model, formed by higher orders of
monopoles [1, 91, 106]. While the dipole is formed from two equal and opposite
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monopoles, the quadrupole is formed by two equal and opposite dipoles. Continuing
adding the source configurations in this way a higher order source can be formed.
The multipole is described by the coefficients as well as the dipole. The dipole, as it
was already mentioned, is characterized by three coefficients; the quadrupole can be
defined using five coefficients, an octopole by seven, and so on [1, 91, 107–108].. Epicardial potentials
The model describing the equivalent cardiac generator as electric potentials on the
surface of the epicardium is based on the theoretical unique one-to-one relationship
between the voltage on the cardiac surface and voltage on the outer body surface [87,
91]. The following preconditions should be met: the internal surface should be closed
and no primary sources should be present between the cardiac and body surfaces,
assuming that all the representing sources are lying within the internal surface [4].
In this model only the outer epicardial surface is taken into account, therefore there
is no need in the exact knowledge of the inner heart geometry or impact of the
intracardiac blood masses [4]. A significant benefit of this model is the possibility
of the experimental validation. The epicardial potentials can be measured during
the open chest surgery or in the studies with animal hearts placed in the electrolytic
tanks [109].. Uniform and equivalent double layermodels
The source model based on the two assumptions of elementary dipoles lined up with
the direction of the wavefront propagation and having uniform strength is known as
the uniform double layer (UDL) [4]. This model is restricted to describing the major
sources during depolarization only [91].
An extended variant of the UDL uses current sources of the double layer type and is
referred as equivalent double layer (EDL) model [4]. It represents the depolarization
wavefronts in the myocardium using surfaces carrying elementary current dipoles and
separating the resting (polarized) and excited (depolarized) regions This model has
the potential of describing the cardiac electrical generator during the depolarization
phase as well as during the repolarization phase of the cardiac cycle, both in the
manner that is related to the underlying electrophysiology [4]. There is a direct
link between the UDL and EDL source model, which is based on the solid angle
formulation of body surface potential description caused by the cardiac electrical
activity [110]. EDL model was highly used to explain the ECG waveforms [91].. Bidomainmodel
Besides abovementioned source models, it is important to mention another technique
used for the description of the cardiac activity — bidomain model. The actual struc-
ture of myocytes connected to each other by gap junctions, forming branching and
intertwining muscle fibers embedded in an interstitial fluid and interspersed with
capillaries and other structures, is abstracted by two continuous domains. There
are the intracellular domain, representing the myocytes and gap junctions, and the
extracellular domain, representing all other tissue components. Each domain is char-
acterized by an electrical conductivity that is greater along than across the fibers and
changes from place to place, to account for the variable fiber orientation in the heart.
The two domains are coupled through the cell membrane [4, 111]. The membrane
includes the ionic channels, which are represented by voltage- and time-dependent
currents, that generate action potential within the cell. The currents flowing from
the extracellular space into extramyocardial volume conductor ultimately form BSP
on the torso [4].
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This enables to investigate not only the effect of the drugs on cellular electrophy-
siology, but on action potential propagation, and arrhythmia. Special notice should
be given to the point that the bidomain model allows simulating the application
of external stimuli and defibrillation currents because it distinguishes intracellular
and extracellular current flows. The bidomain model developed by Potse et al. [112]
consists of 12 million cells and allows to consider not only anisotropy, but also rotating
fiber direction, early activation times of the specialized conduction system.
The bidomain model has benn used in the most biophysically detailed approach
for ECG computation [113]. Despite technological improvements in computers and
modalities of the parallel processing over the last twenty years it is still takes too long
time in order to simulate a single heart beat with such model. This fact complicates
the possibility of the implementation of this method in clinics [100, 113].
A simplified bidomain model, referred as monodomain model, sets extracellular
potentials to zero and was shown to be good enough compared to the bidomain
model for propagation studies and computation of the full cardiac cycle [112].
1.7.3 Modelling of the torso volume conductor
In practice, in order to solve the forward (see sec. 1.7.1) or inverse problem (see
sec. 1.7.5) of electrocardiography usually it is necessary to use numerical methods (see
sec. 1.7.4). Generally, these methods require a discrete description of the torso geo-
metry, which is achieved by segmentation of scans from imaging modalities and results
in mesh generation. Mesh generation usually starts with surface representation based
on triangles or quadrilaterals [4]. Depending on the numerical method, the resulting
mesh will be either a surface or volume mesh [86].
There are two types of the torso models depending on the level of volume conductor
complexity. If the torso model has the same conductivity between the heart and body
surface, then this model is homogeneous. If the torso model includes various regions with
different conductivities, then the volume conductor is described as inhomogeneous. The
electrical conductivity of the selected region in the model can be constant (isotropic)
or can vary with the direction (anisotropic) [1].
The human heart is filled with blood, which has high conductivity, and the myo-
cardium itself has about one-third conductivity of the blood. The heart is located
between the lungs, filled with air, and therefore region with low conductivity. The
lungs are surrounded by the high conductivity skeletal muscle layer, which in turn is
surrounded by the low conductivity subcutaneous fat [1, 114]. It is obvious that the
electrical field of the heart will be modified on the outer body surface after passing the
regions with different conductivities due to the secondary sources, which appear at the
interfaces between these regions [114].
Simulation study of the torso inhomogeneities effect on the body surface potentials
was performed by Gulrajani [115] using realistic heart and torso models. Simulations
were performed for four torso models:
1. homogeneous;
2. with muscle layer;
3. with muscle layer and lungs;
4. with muscle layer, lungs, and blood masses.
They confirmed that inhomogeneities of the torso model does not change the general
pattern of the potential distribution and tend to smooth out the activation details.
Therefore, the effect of the blood masses will override the effect of the muscle layer and
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the equivalent source will appear greater in strength compared to the homogeneous
torso model [115].
Influence of the conductivity uncertainties was presented in [116]. It was shown
that fat conductivity uncertainties do not have significant effect on the inverse solution
whereas uncertainty in conductivity of the lungs and skeletal muscle can alter the results
of the reconstructed potential. This smoothening effect of the volume conductor model
on the BSP maps was consistently observed in several studies according to the editorial
by Rudy [102] to the article by Bear et al. on the forward problem [103].
Also in overall study [117] of the torso inhomogeneities impact on atrial and ventric-
ular ECG signals realistic forward simulations showed that the conductivity of blood in
the main vessels had a high impact on the atrial signals. Unfortunately, the influence
of this conductivity on the inverse solution was not evaluated in the study.
Aforementioned latest in vivo study of the torso inhomogeneities influence on the
forward problem by Bear et al. [103] was performed on pigs. The study compared the
simulated body surface potentials from measured epicardial electrodes for homogeneous
and inhomogeneous (including lungs, anisotropic skeletal muscle, and subcutaneous
fat) torso models with simultaneously measured body surface potentials. It showed a
considerable distinction between the measured BSP maps and BSP maps computed
for the homogeneous torso model. Although adding inhomogeneities to the forward
model improved the results of the computation, they did not remove these differences
completely.
A closer look on the impact of the torso geometry in obese patients was conducted in
a simulation study using modified realistic and torso models of the ECGSim software
and bidomain forward problem solution [118]. It was shown that obesity changes body
surface ECGs compared to the normal torso geometry. The study underlines that the
heart in obese patients is displaced with respect to the normal position and 12-lead
ECG has limitations compared to the BSP mapping, which was also confirmed in [119].
Evaluation of the impact of torso inhomogeneities and geometrical modelling errors
on the BSP maps by solving the forward problem was performed by Kumar et al. [120].
They showed that adding inhomogeneities had an impact only on the magnitude of
the BSP maps, whereas a 5% change in the geometry had a significant impact on the
BSP map pattern. They concluded that patient-specific homogeneous model will serve
better than inhomogeneous nonpatient-specific model.
The possibility to use only partial torso scan, an approximation of the whole patient-
specific torso-heart model or heart-surface model reconstructed from biplane X-ray
images that can be acquired routinely in the electrophysiology laboratory should be
studied [121–122]. Benefits of the patient-specific geometry use for accurate inverse
solution were shown in [123–126], [J4]. That is why there was an effort to create a
semi-automatic approach of the patient-specific volume conductor modeling from MRI
images [127]. The automatic segmentation of CT or MRI images still needs improve-
ment of its accuracy to avoid manual intervention and fasten the procedure [128]. It was
suggested by Gillette et al. [129] to combine torso model geometries reconstructed using
two image modalities with different tissue contrast: CT and MRI. Another approach
suggests to obtain torso surface geometry using a laser scanning device and reconstruct
heart geometry using three-dimensional ultrasound [123].
It was shown by Prakosa in [130] that the precision of the reconstruction of the
patient-specific geometry from CT images is influenced by the selected interpolation
reconstruction method. Nevertheless, it was shown by Rahimi [131] that patient-specific
anatomical models do not require high-level complexity for the accuracy of electrophy-
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siological imaging (see sec. 1.7.6) and main anatomical parameters of the heart (size,
it’s position and orientation) provide feasible results of the inverse solution.
Evaluation of the cardiac phase and torso inhomogeneities impact on the reconstruc-
tion of the body surface potentials was evaluated in [132]. It was shown that car-
diac phase did not have significant affect on the reconstruction performance, whereas
the difference in torso conductivities (homogeneous/inhomogeneous) did. Ramanathan
concluded in [133] that in clinical application it is not necessary to include torso inho-
mogeneities in noninvasive electrophysiological imaging, but Zemzemi showed in [134]
that using inhomogeneities in combination with low noise ECGs improves the accuracy
of the inverse solution. Attempt to define ST-elevated myocardial infarction area using
12-lead ECGs and gender-dependent generalized torso model was performed in [135]. It
was shown, that accurate patient-specific model is required to obtain a correct inverse
solution, which corresponds with [136]. Summarizing, it is fair to say that the problem
of the impact of the torso model complexity on the accuracy of the inverse solution
remains open.
1.7.4 Numerical methods
Most bioelectric field problems can be formulated in terms of either the Poisson or
the Laplace equation for electrical conduction [137]. Numerical methods are used
to solve the governing equations written in the form of ordinary and partial diffe-
rential equations, approximately [4]. These are boundary element method (BEM),
finite dierence method (FDM), finite element method (FEM) and finite volume
method (FVM) [137–138].
BEM assumes that different torso regions have isotropic conductivities and takes
into account only the boundaries between different torso regions. FDM, FEM, FVM
represent numerically the whole torso model in three-dimensional space using usually a
combination of tetrahedral and hexahedral elements. In order to represent incorporation
of the regions with varying conductivity only these methods can be used.
The BEM uses integral equations (boundary integral form) to solve the partial dif-
ferential equations [86]. The surface integrals are computed on the surfaces with homo-
geneous conductivity. As it was mentioned previously, the unknown potential values
are defined only on the surfaces.
The FDM is based on the application of a local Taylor expansion to approximate
the differential equations. The partial derivatives are approximated by the finite dif-
ferences creating sparse diagonal dominant matrix. FDM uses a regular structured
three-dimensional grid to discretize the torso geometry. Since FDM is using topolo-
gically square network of lines, it is hard to represent complex biological geometries
precisely. Therefore, the grid should have a smaller step near the boundaries of the
different conductivities. As the grid should have the regular structure in the whole
torso, the amount of the nodes will increase significantly and slower down the solution
process [138].
FEM divides the torso regions into small subdomains referred to as “finite elements”.
Interpolation function is used to describe each element relatively to its nodes. Finite
elements can have different size resulting in a possibility to use irregular mesh near
the regions with local refinement and keeping a relatively small amount of nodes. It
also allows to represent the torso regions with similar conductivities and little solution
variations by larger finite elements and reduce computing time [4, 138].
FVM is similar to the FEM, but without a priori assumption of the potential variation
within an element, therefore a high level of discretization should be used for higher
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accuracy. This results in a large set of the equations defining potential at the centre of
each volume element and sparse coefficient matrix [4, 138].
The number of nodes involved in computation is smaller for BEM than for FEM.
Nevertheless, the coefficient matrix in BEM characterizing the set of underlying integral
equations has to include coupling of the potential at every element to the potential at
every other element, making the matrix fully populated. In result, the computation
time can be comparable between these two methods. FEM and FVM, as was mentioned
above, use more complex torso models and determine potentials at each point in the
terms of the potentials at its nearest neighbors, resulting in large, but sparse coefficient
matrix [87, 139].
1.7.5 Inverse problem of electrocardiography
Inverse problem of electrocardiography tries to determine the electrical activity of the
heart based on the measurements of electrical potential on the body surface. Inverse
problem does not have a solution that is mathematically unique. Thus, the same
measured BSPs can be caused by more than one source configurations [4, 140]. Since
the inverse problem is ill-posed, it implies that an arbitrary small change in the BSP can
cause an arbitrary large change in the equivalent source solution [4, 140]. A misleading
solution is unacceptable in the clinical practice [104].
To avoid non-unique nature of the inverse problem a priori knowledge on the solu-
tion should be imposed [137, 141–143]. It is usually achieved by various regularization
methods [4, 144–150].
Usually, the Tikhonov regularization method is used. It consists in converting the
original problem into a well-posed one by adding a penalty term to the equation de-
scribing the epicardial potential. This method has practical advantages, but obtained
solution is often oversmoothed, which can hinder precise clinical diagnosis and treat-
ment planning. Studies on numerical factors of the inverse solution using the Tikhonov
regularization were reported in [151] and [152].
A comparison of two regularization approaches (spline method and cardiac isochrone
positioning system) were performed in AF patients with healthy ventricles by solving the
inverse problem in order to determine the paced endocardial site of the ventricles [153].
Due to high variation in the obtained results, the authors did not come to the conclusion
which method performs better. The study had several limitations including the location
of the pacing site, which was determined as a projection of the obtained point from the
electronavigational system CARTO XP®onto the nearest node on the heart. Therefore,
as the authors claim themselves, they added unrealistic errors to the ground truth for
both methods. However, it is important to underline, that the study tried to localize
stimulated position by reconstruction of the electrical activity, which is the main goal
of the new imaging method more described in the following sec. 1.7.6.
Similar attempts to find the focus of ectopic ventricular activity by reconstruction of
the electrical activity of the ventricles by solving the inverse problem were performed on
simulated data [154] and also in animal experiments [155–156]. Few validation studies
on patients were published in [124, 153, 157–159]. In [160–161] inverse solution was
successfully used to guide the ablation procedure of outflow tract VT/PVC.
Nevertheless, in some cases (focal arrhythmias or ischemia) full reconstruction of
the activation sequence might not be necessary, and simpler and more robust inverse
methods can be applied [J3], [122]. Representation of the equivalent cardiac generator
in the form of moving or fixed dipoles was used to solve the inverse problem in various
studies [94, 97, 140, 162]. Thus, evaluation of the local ischemic lesions was performed
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by Tyšler using single dipole generator [163–164] and multiple dipole generator [75].
Inverse solution defining the last activated area in the ventricles was performed in the
simulation study on the ECGSIM heart model using one and two dipole models [165].
Group of Bin He performed several studies in well-controlled intact pigs to localize
the endocardial pacing site using single moving dipole model [96], to obtain single
moving dipole trajectories originated near the pacing site [97] and to localize endocardial
pacing site using current density reconstruction method [166]. Results of the applied
approaches showed that the localization of the pacing sites was in a good agreement
with the actual position of the pacing electrode.
Summarizing, there are various approaches to solve the inverse problem. Since the
inverse solution can be influenced by various factors as torso inhomogeneities, electrode
displacement, method of signal processing, accuracy of the CT/MRI segmentation, best
representing equivalent source model, etc. the selection of the inverse method should
be performed carefully in order to reduce the ambiguity of the obtained results.
1.7.6 Noninvasive electrocardiographic imaging
Available imaging methods as computer tomography and magnetic resonance to-
mography allow combining computing and modelling methods with real patient
measurements. Electrocardiographic imaging (ECGI) represents new noninvasive
imaging modality for cardiac electrophysiology, which allows reconstructing electrical
activity of the heart using information about electrical data recorded on the body
surface together with cardiac CT or MRI imaging that provides accurate electrode
positions and the heart-surface morphology and structure of the patient chest.
ECGI has great perspective benefits and might be helpful in treating cardiac ar-
rhythmias, assessment of the drug effect on the cardiac conduction system, estimate
the arrhythmogenic areas prior to the operation [167]. Formulation of the inverse ap-
proach [168] to define the epicardial potentials from BSP and to reconstruct the activa-
tion sequence has received considerable attention [169]. Numerous studies [98, 170–172]
based on EDL model evaluated epicardial [104, 169, 173] and endocardial [100] activity.
Rudy et al group [174] studied, tested and validated their technique formulated
in [168, 175] experimentally using isolated canine hearts in torso-tank models [176]
and in humans [177]. In particular, studies have successfully provided images of car-
diac activation and repolarization during normal excitation [177–178], during ventri-
cular pacing [176, 179–180], in the presence of conduction disturbances [181], during
atrial fibrillation [179], and ventricular tachycardia [174, 182–183]. It was shown by Co-
chet et al. [128] in patients with VT, WPW, atrial fibrillation, and scar-related ven-
tricular fibrillation that fusion of the BSP mapping and imaging modalities enables
comprehensive noninvasive assessment of cardiac arrhythmias to guide mapping and
ablation. ECGI results have been compared with intraoperative mapping in patients
undergoing cardiac surgery and have demonstrated the spatial accuracy of 6–10 mm in
locating focal activity initiated by pacing [174, 184–185].
Summarizing, ECGI provides the same information (or its close approximation) that
could be obtained invasively with a multi-electrode sock placed over the heart or with
a basket catheter inside the heart, but without the need to open the chest. However,
to date ECGI is not being used as a primary clinical tool for arrhythmia diagnosis
and management [104, 186]. “To enter the clinical arena, the physical validity of the
simulations and robustness of individual methods must be undisputed.” [104].
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Aim and goals of the thesis
Aim:
Proposal of a diagnostic method for noninvasive localization of the ventricular ectopic
beat focus using body surface potential mapping, 3D model of the torso structure from
an imaging method and suitable solution of the inverse problem of electrocardiology.
Goals:
1. Overview of existing noninvasive diagnostic methods for ventricular ectopic beat focus
localization.
2. Suggestion of a diagnostic method based on inverse solution and using appropriate
electrical equivalent source, representing the pathological ventricular ectopic beat.
3. Verification of the proposed method in patients.
4. Experimental study of the selection of the evaluated body surface potential map on
stability and accuracy of the inverse solution.
5. Study of the influence of torso model complexity on stability and accuracy of the
inverse solution.
Practical impact:
The noninvasive method should supply pre-operational information about the lo-
calization of the ectopic focus enabling to decrease the time required for the invasive
electrophysiological study and the ablation therapy.
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Selected processing and evaluationmethods
3.1 Inversemethod
As shown in sections 1.7.5 and 1.7.6, pre-operational noninvasive localization of the
premature ventricular complex focus can be obtained by solving the inverse problem of
electrocardiography. To solve the inverse problem in this particular case, several partial
tasks have to be accomplished:
. proper formulation of the electrical generator that represents the pathological elec-
trical heart activity during the PVC has to be selected and appropriate method for
the inverse solution yielding its parameters has to be proposed,. suitable methods for measurement and processing of the surface ECG have to be
proposed that allow to obtain sufficient data on the cardiac electrical field and extract
the specific information needed for the inverse solution,. appropriate model of the torso volume conductor has to be created that represents
the heart and other organs and tissues within the torso and leads to a sufficiently
accurate and numerically stable inverse solution.
For all that, proper methods have to be proposed that allow evaluation of the success
rate, accuracy and stability of the obtained inverse solution and estimation or identi-
fication of optimal parameters for proposed methods for processing of electrical and
geometrical data.
These partial tasks are discussed in following chapters.
3.1.1 Selection of the electrical generator and the computational
method
Premature ventricular complexes represent early activation of the ventricles, which is
caused by pathological depolarization initiated in a small region of cardiac cells — in
the PVC focus. As the main aim of this work is finding of the focus as the target for
the catheter ablation, we propose not to look for an inverse solution reconstructing the
whole depolarization/repolarization sequence but to concentrate on the beginning of the
depolarization what leads to simpler formulation of the equivalent electrical generator
that will make the inverse solution easier. To represent a small activated region, a single
dipole model can be used as an equivalent cardiac generator. Single dipole model offers
benefits of simplicity, robustness, and quick computation.
Finding of such a single dipole model, commonly known as the “moving dipole” [1,
94, 187–188], requires determination of six parameters: three components of the dipole
moment and three coordinates of its position. However, solving of this task leads to a
nonlinear problem with respect to the dipole coordinates. Moreover, it can happen that
the resultant position of the dipole will not coincide with real region in the ventricular
tissue but can be found only in its vicinity.
To avoid solving of the nonlinear problem and to guarantee the position of the dipole
in the ventricular myocardium, an alternative approach, originally proposed in [189] is
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suggested in this work. This “brute force” approach takes the advantage of today’s fast
computers and calculates only three dipole moment components of “fixed dipoles” [1,
187] in all possible positions within the ventricular myocardium, what is a fast and
linear task. Then a dipole in a position where it generates the distribution of surface
potentials that best resembles the really measured BSP map is selected as the inverse
solution.
3.1.2 Inverse solution with one dipole
To find the inverse solution, possible positions of the dipole are predefined within the
whole ventricular myocardium. A straightforward method of defining these positions is
to place them in a regular rectangular grid. The grid step should be selected depending
on the desired resolution of the inverse solution (see sec. 3.1.4).
Let’s assume that there are n single dipoles in the pre-defined positions in the myo-
cardium. Then the dipole generator D, representing a single point equivalent heart
generator, creates in each time instant t a potential distribution on the body surface
torso, which can be described by the equation:
bspm(t) = B ·D(t), (3.1)
where
bspm[m×t] — is a body surface potential map measured in m leads on the torso, gene-
rated by the heart generator D.
B[m×3] — is a transfer matrix representing the relation between the single dipole D
and potentials on the torso. This matrix is time independent with size [m× 3], where
m is the number of measured points on the torso and 3 is the number of single dipole
moments. Computation of the transfer matrix is performed using boundary element
method [190].
D(t)[3×t] — is the equivalent heart generator in the form of a single dipole with 3 dipolar
moment components each in instant time t.
For each pre-defined position of the single dipole an inverse problem is calculated,
therefore a matrix Bn, corresponding to the n-th position of the single dipole, is com-
puted. If we know the input BSP map, the unknown components of the single dipole D
can be computed using the formula
D = B−1n · bspm, (3.2)
where
B−1n — is a pseudoinverse matrix of the Bn.
D — is a single dipole with three dipole moments, which best represents the input
BSP map.
The inverse of the submatrix Bn can be obtained using singular value decomposi-
tion (SVD) method [191]. Application of the SVD method to Eq. (3.2) will factorize
the matrix Bn into the form:
Bn = U×Σ× VT (3.3)
where
Σ = diag{λi}— is a diagonal matrix with non-negative singular values λi. Columns of
the V and U are singular vectors, that define orthonormal basis of the dipole space and
BSP map space. The singular vectors are unit vectors, therefore, each singular value
λi is a scaling coefficient of the corresponding basis vector (i-th column of V) for the
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dipole D. Since both of the matrices V and U are orthonormal, their inverses can be
computed through the transposition:
U−1 = UT (3.4)
V−1 = VT (3.5)
Hence,
B−1n =
(
U×Σ× VT)−1 = (VT)−1 ×Σ−1 ×U−1 =
=
(
V−1
)−1 ×Σ−1 ×UT = V×Σ−1 ×UT, (3.6)
where
Σ−1 = diag
(
1
λi
)
. Singular values λi in matrix Bn are arranged in decreasing sequence.
For small values of the λi, the inverse value 1/λi causes numerical instability. Therefore,
generally the matrix Bn is inverted through the so-called truncated SVD, using only
singular vectors with large enough singular values [191–192]. In our case of defining
three dipole moments only first 3 singular values are used. Therefore, the inverse B−1n
is numerically stable.
Inverse solution for a single dipole in each pre-defined position results in defining its
dipole moments D for each position n. BSP map generated by this dipole dbspm in m
measuring points on the torso can be computed using:
dbspm = Bn ·D, (3.7)
where the sizes of the matrices are: [m× 1] = [m× 3] · [3× 1]
To select the best single dipole D, a criterion of the relative residual error (RRE)
between the input BSP map (bspm) and map computed from the inversely calculated
dipole (dbspm) is evaluated for each dipole position:
RRE =
√√√√√√√√√
m∑
i=1
(bspmi − dbspmi)2
m∑
i=1
bspm2i
(3.8)
The single dipole D with minimal RRE value is selected as the resulting single dipole
that can represent the small initially activated area of the myocardium during the PVC.
3.1.3 Number of ECG leads for the inverse solution
As it was discussed in sec. 3.1.2, one of the inputs for the inverse solution is the BSP
map. Existing variety of the lead systems (characterized in sec. 1.5.3) raises the
question what is the sufficient number of ECG leads for an accurate inverse solution.
This issue was addressed already by one of the pioneer studies on BSP mapping [59].
It showed that 24 properly placed leads with measuring points located mostly on the
left anterior torso (in close proximity to the heart) and several measuring points scat-
tered widely on the rest of the torso are sufficient for acceptable description of the
body surface potential distribution over time. However, Lux et al. [60, 193] and Pu-
urtinen et al. [194–195] studies indicated necessity to use 32 leads with high electrode
density in precordial region in order to obtain reliable inverse solution.
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Since required number of measuring electrodes can be dependent on the used in-
verse method, studies on sufficient leads number from the inverse solution performance
viewpoint was evaluated in simulation studies [196–197]. More recent study by Ghar-
balchi et al. [197] compares mapping systems consisting of 771, 192, 64 and 32 electrodes.
It confirms that reduced lead systems with optimal placement of electrodes can be used
for the inverse solution.
Our method selected for the inverse solution in sec. 3.1.2 was used in a simulation
study by Tysler et al. [164] that compared the accuracy of the inverse solution depending
on the used lead system for BSP map computation. It showed that localization error
of the inverse solution obtained using 32 leads [61] was twice smaller compared to the
localization error of the inverse solution using 24 leads. And their later study [163]
suggests to increase the number of measuring leads to improve accuracy of the inverse
solution, which is also supported in [55, 198] recommending to use more than 64 leads
for the inverse solution to obtain meaningful results. Use of the reduced lead systems
requires high precision while positioning the electrodes on the body surface because
electrode dislocation leads to unsatisfactory inverse solution with low accuracy of the
source localization [194–195, 199].
Though the question of the sufficient number of the measuring electrodes for accurate
inverse solution was never resolved, many research groups used 62–65 leads in their
patient studies for PVC focus localization [81, 150], optimization of the biventricular
pacing in [200], identification of the heart regions with changed repolarization [75],
and validation of the sinus rhythm reconstruction [201–202]. Worth mentioning, that
the inverse solution aiming to reconstruct the whole activation sequence of the heart
requires high number of about 192 measuring leads [196] (evenly distributed around
torso) and up to 224 and 252 measuring leads placed on the vest, which was intensively
studied by Rudy research group [128, 177, 181].
Summarizing, when selecting desired lead system the following should be considered:
. To obtain reliable results of the inverse solution using single dipole model, the lead
system should include more than 62 electrodes.. To avoid lengthy application of individual electrodes, the lead system should be
organized in stripes (of several electrodes) or should be placed on a vest. Lead
system organized in a vest will require several vest sizes due to vast variability of
the torso geometry among patients. It also can be difficult to use this system in
larger-breasted female patients. So, lead system organized in stripes is preferable
thanks to its flexibility.. Because patient’s torso geometry and heart position within the torso is individual, it
will be challenging to find optimal placement [197] of the electrodes. Thus, electrodes
should have even distribution around the torso (regular grid).. For patient’s convenience the electrodes application should take less than 5 min.
Existing lead systems were described in sec. 1.5.3. Four of them have even dis-
tribution of the electrodes organized in stripes: Bath, 80 Regular, 96 Regular and
Lux − 192. Bath system uses 43 electrodes, which is not enough for reliable inverse
solution. Oppositely, for our purpose Lux − 192 has redundant number of electrodes.
Such a high number of leads is generally used for activation computation or studies in
atria.
As can be seen in Fig. 1.17, 80 Regular has 16 stripes with 5 electrodes each and
96 Regular has 12 stripes with 8 electrodes each. The 96 Regular should be selected
because it has smaller amount of stripes, which will be applied quicker. At the same
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time this lead system has higher amount of electrodes, which will provide more detailed
description of the BSP distribution.
3.1.4 Required resolution of the inverse solution
It is obvious that due to the use of simplified equivalent electrical generator, unavoidable
presence of noise in the ECG measurements, simplification and geometrical uncertain-
ties of the torso model, and imprecision of numeric calculations, the accuracy of the
inverse solution will be affected. As this accuracy is not known in advance, the needed
or desired resolution of the inverse solution may be estimated from the main goal —
successful ablation of the PVC focus. The diameter of the tip of the electrode on the
cardiac catheter used for the destruction of the pathological source is 5–7 Fr (1.67–
2.33 mm, Fig. 1.10); and the diameter of the ablation lesion depends on the applied
power, temperature, orientation of the electrode, irrigation of the electrode [48] and can
be about 10 to 15 mm. As can be seen from the Fig. 3.1, the smallest ablation depth
4.7± 0.6 mm is observed during the constant voltage mode.
Figure 3.1: Diagram of ablation lesions dimensions for different radiofrequency ablation
modes. A indicates maximal lesion depth; B maximal lesion diameter; C depth at maximal
lesion diameter; D lesion surface diameter. Lesion volume was calculated by use of the
formula for an oblate ellipsoid, by substracting the volume of the “missing cap” (hatched
area). From [48]
Therefore, the resolution of the method (i.e. the grid step of possible dipole positions)
should be less than 5 mm to hit the PVC focus safely in all ablation modes. Meanwhile,
because the size of the ablation electrode is around 2 mm, setting the spatial resolution
less than 2 mm is redundant. Summarizing, the selected grid step should be in the
range 2–5 mm.
To select the resolution of the inverse solution it is important to keep in mind that
preoperational localization of the PVC focus is highly important for cases with septal
localization of the focus. Correct discern between right and left ventricle approach
is possible only if the thickness of the septum will be bigger than the grid step of
the possible dipole positions. According to Marcomichelakis et al. [203] interventricular
septum thickness increases with age and according to Am Soc Echocardiography [204] in
normal the thickness of the interventricular septum is 6–10 mm [204–206]. Therefore,
by selecting grid step of the possible dipole positions twice smaller than the normal
interventricular septum results in value of 3 mm.
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3.2 ECGmeasurement and processing
3.2.1 Selection of the processed time interval in ECG
When localizing the focus of the premature activity, we are not interested in the elec-
trical activity of the whole ventricular myocardium but only in its initial part, right
after the onset of the ectopic QRS [189], [J3, C12], and appropriate time interval from
the ECG signal should be selected.
Careful selection of the used time interval of the BSP map used as input data for the
inverse solution is necessary to obtain correct inverse result. When selecting the proper
time interval, we are facing two contradictory requirements:
1. The interval should be taken so that the recorded electrical activity is strong enough
to be clearly distinguishable from the noise present in the ECG signal, what effectively
means that the evaluated interval should be taken “as late as possible” after the PVC
onset.
2. The interval should be taken very early, “as soon as possible” after the PVC onset to
fulfill the condition that the activated area is small enough and can be represented
with a reasonable accuracy by a single dipole – i.e. a point source.
It also means that selection of the interval can depend on the actual position of the
PVC focus in the heart influencing
. the amplitudes of electrical signals projected to different ECG leads and the signal-
to-noise ratio (SNR), and. the possibly asymmetric spread of the activation front due to the anatomy or
anisotropy of the myocardium near the PVC focus.
A closer look on the last condition is provided in example in Fig. 3.2. If the PVC
focus is located in point F, the volume activated during a short time interval T1 will be
still nearly symmetric and the equivalent dipole generator will be located in point D1 at
the gravity center of the activated zone, near the PVC focus. In this case the ablation
electrode placed in position E1 can safely destroy the focus. However, after a longer
time interval T2 the activated volume can be highly asymmetric due to the local tissue
shape or anisotropy. In this case the equivalent dipole generator located at the gravity
center of the activated zone in point D2 is far from the PVC focus and the area ablated
by the electrode placed in position E2 will not “hit” the PVC focus.
Taking into account that the velocity of the activation front in isotropic working
myocardium is about 0.6 to 0.75 m/s [207–208], within the first 15 ms after the PVC
onset the activated area will reach a diameter of 18 to 22.5 mm which in this work will
be supposed to be:
. large enough to generate ECG signals clearly distinguishable from the noise,. small enough to be represented by a single equivalent dipole placed in its center of
gravity and yielding position of the dipole so close to the PVC focus that it will fall
within the ablation lesion of 14.3 ± 1.5 mm diameter caused by application of the
constant voltage RFA via an irrigating catheter (according to Fig. 3.1).
To select the best time interval for accurate PVC focus localization based on the re-
sults of the inverse solution (described in more detail in sec. 3.5.3) several time intervals
will be studied. For this purpose a longer initial time interval (twice longer than 15 ms)
will be considered and several sub-intervals will be tested for IBSPM computations (see
sec. 1.6.2, Eq. (1.9)). The use of too long or late sub-intervals can lead to evaluation
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Figure 3.2: Example of the possible influence of the evaluated time interval after the ac-
tivation onset on the inversely obtained dipole position and its impact on the ablation
success. F — PVC focus position. Red — area activated in time T1 yielding equivalent
dipole in position D1 and enabling successful ablation by electrode placed in position E1.
Blue — area activated in longer time T2 yielding equivalent dipole in position D2 preventing
successful ablation by electrode placed in position E2
of larger activated part of the myocardium which can not be correctly represented by
a dipole. On the other side, the use of too short or early sub-intervals can lead to
evaluation ECG signals with low SNR. In both cases, the inverse solutions obtained
using IBSPM from these sub-intervals may lead to incorrect inverse results. Evaluation
of correct and incorrect inverse solution results will allow to select the optimal time
interval which should be used to represent the PVC focus by a single dipole.
The question still remains if BSP map from a single time instant or some
“smoothed” ECG from a longer time interval should be used to improve the signal-to-
noise ratio. In this work it is suggested to test both, using BSP maps from individual
time instants and integral BSP maps from different sub-intervals within the whole
evaluated ECG interval. Also, in order to study the consistency/stability of the
obtained inverse solution from beat to beat, five PVCs are analyzed in each patient.
This amount is based on practical reasons that the multichannel ECG measurement
should be fast and should not be tiresome for the patient due to “PVC expectation”.
Thus, for each of the five ectopic beats, the BSP maps will be computed within
the initial 30 ms time interval of the PVC. The TIBSPMs will be calculated for each
millisecond within this interval, resulting in 31 TIBSPMs. Then also IBSPMs for
21 sub-intervals of the initial 30 ms interval will be computed.
3.2.2 Correction of the ECG baseline
During the ECG measurement, namely patient’s movements and breathing cause
changes of skin-electrode contacts and electrode polarizing voltages leading to ECG
baseline wandering (Fig. 3.3). Correction of the ECG baseline should be performed
before the PVC onset can be selected and desired time interval in the ECG is evaluated.
The baseline wander is localized in low frequencies and is not limited in a specific
band [209]. The periodic respiration movements (15 respirations/min) generate a cycle
of 4 seconds and fundamental component of 0.25 Hz [210]. The baseline noise spectrum
is usually not higher than 1 Hz but in most cases overlaps with the ST segment spec-
trum. According to [210] interpretation of the ST segment should be performed only
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Figure 3.3: (a) Example of the ECG baseline wander due to sudden body movements. The
amplitude of the baseline wander is considerably larger than that of the QRS complexes.
(b) ECG signal frame (a) magnified (10×), the estimated baseline obtained by fitting a
cubic spline to the series of knots (indicated by dots), and the corrected ECG signal.
From [209]
using high-pass filters with cut-off frequency of 0.05 Hz or lower. AHA recommenda-
tions [211] also state that 0.5–Hz low-frequency cut-off introduces considerable distor-
tion into the ECG, particularly with respect to the level of the ST segment. Therefore,
baseline wander is considered less distorting than the main interference, but more dif-
ficult to be removed or even reduced. The specified requirement of the baseline drift in
the standard of the Association for the Advancement of Medical Instrumentation [212]
is 10µV/s.
In this study small time interval (its selection is described in sec. 3.2.1) of the initial
QRS signal will be processed. As in this case artefacts from sudden body movements are
rare, a linear 2-point baseline correction using points in the electrically still intervals
after the T wave and before the P wave, will be used. It will not affect the small
deviations of the signal, but will enable to correct the baseline sway without the use of
a high-pass filter which can yield phase shift [210, 213].
As a rule, the baseline correction is performed in two steps using 2-point baseline
correction. First, the baseline is roughly corrected along a longer time interval with
two normal beats, that have longer baseline after the preceding T wave. This longer
interval between the beats guarantees unbiased selection of two time markers. One of
them marks the baseline before the normal complex preceding the PVC complex. The
second one marks the baseline after the normal complex following the ectopic beat. The
markers are placed on the time interval with undeniable absence of cardiac activity.
After the first/rough baseline correction, both time markers will be re-defined. The
first one will be set to mark the baseline immediately before the ectopic complex and
the second one right after it. Using this setting, the 2-point baseline correction will be
performed once more.
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3.2.3 Definition of the PVC onset in the ECG
In order to find in the ECG signal the beginning of the premature ventricular activation
(“Zero-time”), a semi-automatic approach will be used after the baseline correction.
Zero-time will be at first defined manually and then re-defined after using the algorithm
estimating the SNR. Because the Zero-time (or PVC onset) represents the premature
activation of the ventricles, initial part of the QRS complex representing activation of
the ventricles will be analyzed.
To define the onset of the QRS more precisely, a derivative (reflecting fast change) of
the reference lead will be used. Multichannel ECG measurement has the advantage of
more dense coverage of the surface potential compared to the 12-lead ECG. To use this
advantage, root mean square (RMS) signal which reflects the “energy” in all measured
signals is calculated using the formula:
RMS =
√√√√√ m∑
i=1
sig2i
m
, (3.9)
where
RMS — root mean square signal,
sigi –– signal of the i-th measured lead,
m — number of measured leads.
Manual definition of the Zero-time will be based on the morphology of three graphs:
the reference lead, it’s derivative and RMS ; so that the Zero-time will be the time
instant of the strict simultaneous change (increase/decrease) in all of them. Manual
selection of the Zero-time can be biased as it does not take into account the overall
noise in the signals. Therefore, an automated approach evaluating the signal-to-noise
ratio will be applied to improve the initial manual definition of the Zero-time.
To estimate the level of the overall noise in the measured signals, the following
assessment might be considered. Two windows of the same duration (their length is
chosen at the end of this sub-chapter) will be selected. The first window, assumingly,
will contain only noise and the second window, will contain useful signal with noise.
Assuming that there is no useful signal between the T (or U) and P waves, the first
window should be considered as pure noise and selected on the isoelectric line between
the end of the T (or U) wave and the onset of the P wave. Its root mean square signal
RMSNoise will be calculated from all measured chest leads.
Then the second window should be selected prior to the manually defined Zero-time
and its RMSSignal value will be computed also from all measured chest leads. To
compare the level of noise in the previously selected RMSNoise signal with RMSSignal,
a ratio is evaluated from these two signals of similar duration:
Ratio =
t∑
i=1
RMSSignal(t)
t
/ t∑
i=1
RMSNoise(t)
t
=
t∑
i=1
RMSSignal(t)
t∑
i=1
RMSNoise(t)
. (3.10)
If the ratio is less or equal to 1, it means that the selected time interval (second
window) does not contain any useful signal. The window of the Signal can be shifted
for 1 ms towards Zero-time and evaluation can be repeated iteratively until the ratio is
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more than 1.5. The middle of this selected time window Signal will be defined as the
Zero-time (PVC onset).
Since the new Zero-time will be placed in the middle of the window, it is assumed that
the signal from this new Zero-time is significantly higher than the noise. Therefore, a
mean from window containing noise and useful signal should be higher than 1. Selecting
relatively low ratio of 1.5 will guarantee not to “miss” early activation.
In order to select the duration of the window (which is identical for the first and
second window), it is important to keep in mind that real measurements often contain
disturbances of various nature (in more detail, see sec. 3.2.4). A mean of the signal,
evaluated from longer time interval, is more precise. At the same time, the suggested
method sets the new Zero-time in the middle of the window and too wide window could
shift results incorrectly. To remove 50 Hz noise caused by power lines, the length of
the window should be some multiple of 20 ms duration, and in this study 20 ms will be
selected.
Because the Manual definition of the Zero-time is influenced by the human judgment,
the algorithm should start evaluation earlier than the actual Zero-time. As the length of
the window is 20 ms, evaluation can be 50 ms prior to the manually defined Zero-time.
3.2.4 Filtering of the ECG
Additional method to improve the signal quality is filtering of the signal. The main
sources of disturbances in ECG (Fig. 3.4), besides baseline wandering, are noise from
the power lines (50 or 60 Hz) and myopotentials (35–45 Hz) [49, 209]. Unfortunately,
both these disturbances are in the spectrum of useful ECG signals (Fig. 3.5), which
is considered 0.05–150 Hz according to recommendations of American Heart Associa-
tion (AHA) [212, 214] and the Association for the Advancement of Medical Instrumen-
tation [215].
Figure 3.4: Examples of artifacts caused by different sources. From [216]
For this reason, filtering of these frequencies will also distort the useful signal and
should be used only if unavoidable, i.e. if the disturbances are present and strong. For
power line interference a notch filter can be used, but it may alter the ECG components
around the power line frequency (50 or 60 Hz). To avoid this issue adaptive filters
can be used, but they are not effective in cases of ectopic beats and arrhythmia in
general because they require an adaptation period after every abrupt change in the ECG
signal [209]. The electromyogram noise is produced by many sources and therefore can
be treated as random. Since it overlaps with the ECG spectrum its filtering in many
cases is not effective [209]. In this work Pipberger filter will be used in cases with signal
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Figure 3.5: Relative power spectra of an QRS complex, P and T waves, muscle noise and
motion artifacts based on an average of 150 beats. From [49]
highly disturbed by the noise. It is a low pass filter with cut-off at 25 Hz and zero
transfer at 50 Hz and its higher harmonics.
3.3 CT data processing
Because the heart and torso geometry varies from patient to patient, a patient-specific
torso model should be created using some imaging method. As it was mentioned in
sec. 1.7.3, accuracy of the torso model is of high importance. And so, CT scanning
providing high-resolution spatial images is used to create 3D torso models. These torso
models are formed by closed surfaces (boundaries) that separate internal regions of the
torso volume conductor with different conductivities, while each considered region is
assumed to be homogeneous. To use BEM for the forward and inverse solution, the
torso models should be described by triangulated surfaces.
The selection of the CT as imaging method is also based on the necessity to know
exact positions of measuring electrodes relatively to the patient’s torso [217–219] for an
accurate inverse solution.
However, the optimal complexity of the torso model used for the inverse solution,
i.e. the inclusion of regions with different conductivities within defined boundaries, is
to date an open question. According to Cuffin et al.[220], impact of the torso inho-
mogeneities on the inverse solution is negligible unless the cardiac cavities are closely
located to the lung tissue. It was shown in [221] that such inhomogeneities as lungs and
intracavitary blood masses cause noticeable effect on the torso potential distribution.
In order to study the impact of the torso model complexity on the inverse solution, in
this work three types of torso models are constructed for each patient. They vary in the
degree of included inhomogeneities. The first model is homogeneous torso without any
considered internal regions with different conductivities (torso model H — Fig. 3.6 a).
The second torso model is inhomogeneous torso with lungs, right and left ventricle
(torso model V — Fig. 3.6 b). The third torso model has the biggest complexity; it
is also inhomogeneous and includes torso, lungs, heart ventricles and atria, aorta, and
pulmonary artery (torso model AV — Fig. 3.6 c).
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(a) torso model H (b) torso model V (c) torso model AV
Figure 3.6: Torso models with different degree of included inhomogeneities
The second torso model (V) includes inhomogeneities in close proximity to the myo-
cardium, which are lungs and ventricular cavities filled with blood. The third torso
model (AV) includes lungs and more detailed heart cavities filled with blood. The
heart cavities of right ventricle, right atrium and pulmonary artery are joined into
one internal region with the same conductivity. Similarly, combined cavities of the
left ventricle, left atrium and aorta form one internal region. Therefore, the V and
AV torso models have the same number of regions with inhomogeneities but in the
AV torso model the heart cavities include also corresponding atrium and outflow tract.
3.4 Correctness of the inverse solution
In order to verify the correctness of the inverse solution, the results of the inverse so-
lution are compared with the results of the clinical invasive electrophysiological study.
During an EP intervention, the origin of the PVC activity is defined by the physi-
cian according to the standard protocol of the EP study using intracardiac mapping
techniques described in sec. 1.6.1. To obtain spatial information about the PVC focus
location, the cardiac mapping is performed by the use of a 3D navigation system.
During the mapping, a 3D model of the endocardial surface of the investigated cham-
ber is constructed by mapping of the catheter electrode tip positions. This model is
merged with the 3D model of the heart constructed from the CT images using a build
in tool of the navigation system and a few reference points (Fig. 3.7). The reference
points are selected by the clinician performing the EP study depending on the studied
heart cavity and patient-specific anatomy. Thus, merge of these two geometries pro-
vides clinician with additional and more reliable knowledge of the patient-specific heart
anatomy enabling precise mapping of the activation and safe radiofrequency ablation
of the PVC focus.
As it was mentioned in sec. 1.4.4, 1.4.5, application of the radiofrequency current to
the myocardium, where the PVC focus is located, destroys the pathological tissue and
creates a lesion. Ablation lesions are marked by the 3D navigation system automatically
on the 3D model of the investigated chamber by vinous markers. Thus, if the ablation
procedure was successful, locations of these ablation lesions in the 3D model are assumed
as real PVC focus location. Then, locations of these ablation lesion markers can be
compared with the PVC focus localization obtained from the inverse solution.
In order to keep the study unbiased, the designation of the heart area with ablation
lesion markers is performed by the clinician without knowledge of the inverse solution
results. After the EP study, the clinician evaluates the positions of the ablation markers
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(a) Merged geometries of the intraoperation
endocardial geometry of the right ventricle
(cyan color) with 3D model of the recon-
structed from CT images right ventricle and
pulmonary artery geometry (moss color).
Left view
(b) 3D reconstruction of the heart showing
the posterior superior course of the RVOT.
Antero-posterior view
Figure 3.7: Heart geometries obtained using 3D navigation system and CT [31]
within the heart regions and assigns them to particular heart segments in agreement
with clinical conventions. Region assignment is performed depending on the location of
the ablation lesion within the right/left myocardium or near the outflow tracts. If the
lesions are located in the LV myocardium, the recommendations of the American Heart
Association [222] are used and the name of the ablation lesion position is given according
the division of the LV myocardium into 17 segments. The recommendations of the AHA
for the LV segmentation are extended to create corresponding segmentation of the RV,
by mirroring the LV segmentation with regard to septum (Fig. 3.8). If the ablation
lesions are near the outflow tract of the RV or LV, the outflow tract in superior view is
divided into 12 segments as on the clock without mirroring for the RVOT (Fig. 3.9).
Figure 3.8: LV division into 17 segments according to the AHA recommendations [222]
(right) and its extension to RV segmentation (left). Apex to base view
Considering the computed results of the inverse solution we use the same segmenta-
tion of the heart as physicians and, similarly to clinicians to stay unbiased, we assign
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Figure 3.9: Example of the superior view of the RV with the RVOT and its division into
12 segments
the appropriate anatomical region to the inverse results without knowing the EP study
findings.
Later, the anatomical region assigned to the inverse solution by us will be compared
to the region assigned by the clinicians. If the anatomical region is the same, the result
of the inverse solution will be marked as CORRECT. If the anatomical region of the
inverse solution is different from the region assigned by physician, the inverse solution
will be marked as INCORRECT.
3.5 Evaluation of the inverse solution results
3.5.1 Used statistical terms and tests
To describe and analyze the measured/evaluated data, commonly known statistical
terms are used: mean, median, deviance, variance/dispersion, standard deviation and
interquartile range (IQR). As it was described in sec. 3.4, the obtained result of the
inverse solution is evaluated as correct or incorrect. Therefore, the evaluation of the
inverse solution result, which has only two possible values, is a categorical data type.
In this work, different types of BSP map and torso model are used as input data
for the inverse solution. In order to study whether different types of these input data
have impact on correctness of the inverse solution the Pearson’s chi-square test will be
used [223]. It will test whether:
. the type of the BSP map has impact on the inverse solution;. the torso model complexity has impact on the inverse solution;. there is the best combination of the input BSP map and torso model in order to
obtain correct inverse solution.
The Pearson’s chi-square tests the null hypothesis that the variables are indepen-
dent. The test compares the observed frequencies in certain categories to the expected
frequencies you might get in those categories by chance. The expectedij frequencies for
each of the categories can be calculated using the equation [223]:
expectedij =
rowtotali × columntotalj
k
, (3.11)
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where
rowtotali — is the sum of the frequencies in the i-th row of the contingency table∑n
i=1 aij ,
columntotalj — is the sum of the frequencies in the j-th column of the contingency
table
∑m
i=1 aij ,
i –– is the number of row in the contingency table,
j –– is the number of column in the contingency table,
k –– is the total number of the observations (
∑
aij).
Pearson’s chi-square test standardizes the deviation for each observation. Sum of
these standardized observations results in Pearson’s chi-square (χ2) [223]:
χ2 =
∑ (observedij − expectedij)2
expectedij
. (3.12)
The obtained Pearson’s chi-square χ2 is checked against a chi-square distribution
with known properties. Degrees of freedom df are calculated as
df = (m− 1) (n− 1) , (3.13)
where
df — degrees of freedom,
m — is the number of rows in the contingency table,
n — is the number of columns in the contingency table.
Then, the observed value of the chi-square distribution χ2 is compared against the
critical value for the chi-square distribution with df and significance value p. If the
observed value of the chi-square distribution χ2 is bigger than the critical value, the null
hypothesis is rejected and the categorical variables are assumed to be dependent [223].
In order to find patient-specific time instant for TIBSPM computation, which repre-
sents the initial part of the ectopic activation and at the same time has high signal-to-
noise ratio, a correlation coefficient r will be used [223]. It can be calculated using the
expression:
r =
∑
(xi − x¯) · (yi − y¯)
(n− 1) · sx · sy , (3.14)
where
r — correlation coefficient;
sx — is the standard deviation of the first variable x;
sy — is the standard deviation of the second variable y;
xi — values of the first variable x;
yi — values of the second variable y;
x¯ — is mean of the first variable x;
y¯ — is mean of the second variable y;
n — number of observations.
The absolute value of the correlation coefficient shows the relationship strength and
can be any value from −1 to +1. The larger the number — the stronger the relationship.
The values of correlation coefficient less than ±0.5 represent a weak relationship, and
values greater than ±0.8 is generally described as strong relationship.
To compare the stability of the inverse solution results obtained when torso models
of different complexity were used, the dispersions of the positions of the inverse results
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are evaluated using the F -test of equality of variances [223–224]. Usually, F -test is
used to test the null hypothesis that the two variables x and y with normal distribution
have the same variance. The F -test can be one-tailed or two-tailed test. If the test is
one-tailed, it checks only in one direction, which means that the variance σ2x of the first
variable x is either greater than or less than the variance σ2y of the second variable y.
If the test is two-tailed, it checks the alternative that the variances are not equal. The
definition of the F hypothesis can be described as [224]:
H0 : σ2x = σ2y
H1 : σ2x < σ2y for a lower one− tailed test;
σ2x > σ
2
y for an upper one− tailed test;
σ2x 6= σ2y for a two− tailed test.
The tested statistics is F = s
2
x
s2y
, where the s2x, s2y are the sample variances, and
the presumption that they have Fisher-Snedecor distribution with degrees of freedom
(n1 − 1, n2 − 1) and significance level α. The more this F ratio deviates from 1, the
stronger is the evidence of the unequal variances of the two variables. The hypothesis
that two variances are equal is rejected if:
F < F1−α, n1−1, n2−1 for a lower one-tailed test;
F > Fα, n1−1, n2−1 for an upper one-tailed test;
F < F1−α2 , n1−1, n2−1 or F > Fα2 , n1−1, n2−1 for a two-tailed test;
where Fα, n1−1, n2−1 is the critical value of the F -distribution with n1−1, n2−1 degrees
of freedom and a significance level of α [224].
3.5.2 Selection of the relevant results using relative residual error
criterion
The main criterion of the relevancy of the inverse solution is the relative residual error,
which is described in more detail in sec. 3.1.2. RRE shows the deviation of the BSP
map computed from the inversely estimated dipole from the input BSP map used for
the inverse solution. The dipole with minimal RRE value is selected as the resulting
single dipole of the inverse solution. If the value of the RRE is higher than a selected
threshold value the result is assumed as not relevant, i.e. the measured BSP map cannot
be satisfactorily represented by a single dipole.
In this study all results of the inverse solution which have RRE value higher than 0.3
are considered not relevant and excluded from the later evaluation. The inverse results
with RRE value less or equal to 0.3 are referred as relevant results.
3.5.3 Evaluation of the input BSPmaps impact on inverse solution
One of the inputs for the inverse solution is body surface potential map. In this work
two types of BSP maps are used – time instant BSP maps (TIBSPMs) and integral
BSP maps (IBSPMs). The difference between these types of maps, as it was already
mentioned in sec. 1.6.2, is that the TIBSPM displays the potential distribution over
the torso at a particular time instant, while the IBSPM displays the distribution of
potential integrated over the defined period of time (interval).
To determine whether the type of the BSP map has an impact on the inverse solu-
tion a Pearson’s chi-square test is used. The test checks the null hypothesis that the
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correctness of inverse solution is independent of the used BSP map. The first category
represents independently used BSP maps (TIBSPMs and IBSPMs) for all five mea-
sured PVCs and the second category represents the correctness of the inverse solution
(correct, incorrect).
If the null hypothesis is rejected, a new Pearson’s chi-square test is performed to
check whether the BSP map, which gave the highest amount of correct results, is
better compared to all the other BSP maps joined into one category. In other words,
compared to the previous test, instead of separate categories of BSP maps (for each
time interval or time instant), we assume that there might be two categories of BSP
maps. The first one is the BSP map, which provided the highest amount of the correct
results, and the second category consists of all the other BSP maps. In this case, the
Pearson’s chi-square test checks the null hypothesis that the highest amount of the
correct inverse results is independent of the used BSP map.
3.5.4 Search of the patient-specific time instant for TIBSPM
computation
Keeping in mind, that PVC may arise in any part of the ventricles and that ectopic
focus position varies from patient to patient, the PVC beat morphology also varies from
patient to patient. It means that there is a high chance that the best time interval for
computing the most proper BSP map for the inverse solution can vary from patient
to patient. That is why an approach to determine patient-specific time instant for the
input BSP map is required. In order to define/find this time instant a study of the
correlations between the TIBSPMs is performed.
The theoretical background behind this test lies in two presumptions:
. The first one is that the TIBSPM, best representing the premature ventricular ac-
tivity, contains only the initial activation of the pathological cardiac tissue.. The second presumption is that the signal-to-noise ratio for this TIBSPM is suffi-
ciently high (typically higher than 3), which is very hard to achieve in the very initial
time instant in real measurements.
Because the TIBSPMs, computed from the nearby time instants depict similar elec-
trical change, they should be highly correlated. The TIBSPMs obtained from the
beginning of the initial time interval represent the very initial part of the activation,
but might be more corrupted by the noise; and the TIBSPMs for the latest part of the
selected time interval are less disrupted by the noise, but represent much larger part
of the activated myocardium, which cannot be correctly represented by single dipole in
the inverse solution. A TIBSPM, which has the highest correlation with the TIBSPMs
obtained from both, the beginning and ending of the selected time interval represents
the compromise between the small area of activation and high signal-to-noise ratio.
In order to find such TIBSPM, correlations between all TIBSPMS within the studied
initial 30 ms are calculated (Fig. 3.10).
After computing the correlations within the whole selected time interval, an average
of the correlations is calculated for each time instant. The time instant with maximal
value of the obtained average correlation is selected as the best “patient-specific” input
TIBSPM (Fig. 3.11).
The inverse results obtained for these 5 best TIBSPMs with the highest average
correlation coefficient are evaluated separately with respect to 3 torso models with
different complexity. Only relevant results with RRE less than or equal to 0.3 are taken
into account.
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Figure 3.11: Average correlation of the TIBSPMs for each time instant of the selected
initial 30 ms time interval. Five lines represent five PVCs from Fig. 3.10
Then the hypothesis whether such TIBSPM can be assumed as the optimal input
map for the selected PVC for the specific patient is tested.
3.5.5 Evaluation of the impact of the torsomodel complexity on
the inverse solution
As it was described in sec. 3.3, three types of torso models are constructed for each
of the patients. The torso models vary in completeness/degree of inclusion of the
inhomogeneities. To evaluate whether the inclusion of torso inhomogeneities has impact
on the inverse solution a Pearson’s chi-square test is used. The first category represents
the degree of inclusion of torso inhomogeneities and the second category describes the
correctness of the inverse solution. In this case the Pearson’s chi-square test checks the
null hypothesis that the correctness of inverse solution is independent of the used torso
model.
If the null hypothesis is rejected, a new Pearson’s chi-square test is performed to
check whether the torso model, which gave the highest amount of the correct result, is
better compared to the other two torso models joined in one category. The Pearson’s
chi-square test checks the null hypothesis that the highest amount of correct results
using selected torso model is independent of the used torso model.
3.5.6 Search of the best combination of input data for the inverse
solution
As it was already discussed in sec. 3.5.3–3.5.5, selection and processing of the input
data for the inverse solution can have impact on the correctness of the inverse results.
In this chapter, we describe the testing whether there is the best combination of the
BSP map and torso model data, which generates the correct inverse results with higher
probability than some other combinations.
In order to do this, we will perform the Pearson’s chi-square test to check the null
hypothesis that the correctness of the inverse results is independent of the used combi-
nation of the input parameters for the inverse solution. As there are various BSP maps
(several IBSPMs and 31 TIBSPMs) and 3 torso models (homogeneous H, inhomoge-
neous V, and inhomogeneous AV), there is a total amount of possible combinations.
These combinations are used to compute the correct or incorrect inverse solution for
each out of five ectopic beats in each patient. Only relevant inverse results are taken
into account.
If the null hypothesis is rejected and the inverse solution is dependent on the used
combination of the input parameters, a further analysis is performed to define the best
combination of input parameters for the inverse solution. The combination with highest
amount of correct inverse results is compared against all the other combinations joined
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together. Here, the Pearson’s chi-square test checks the null hypothesis that the best
combination of input parameters provides the highest amount of correct inverse results
by chance.
3.5.7 Evaluation of the stability of the inverse solution
Two aspects of the stability of the inverse solutions are studied. First, the spatial
stability of the inverse solution obtained according sec. 3.5.6 is computed using the
best combination of the input torso model with one input BSP map based on the
minimal value of the RRE parameter. Second, the stability of results obtained from
slightly different input data is evaluated.
The inverse problem of electrocardiography is ill-posed, therefore small inaccuracy in
the input data can cause significant change of the obtained inverse result. In practical
applications, it is important to know how the result will be affected by the input data
fluctuations/errors, because it can be challenging to reduce them in real measurements.
To evaluate whether the RRE function, which is the main criterion of the selected
inverse method, provides inverse solutions with steady and consistent dipole localization
within the ventricles, the localizations of the first five dipoles with minimal RREs will be
studied. If the positions of these dipoles are located close to each other, we can suppose,
that the minimal RRE value indicates a spatially stable solution. On the other hand, if
the positions of these first five dipoles are located far from each other in different parts
of the ventricular myocardium, the inverse solution found according the minimal RRE
value is spatially unstable and unreliable. In this study the best combination of input
parameters selected in sec. 3.5.6 is used for the inverse computations.
In order to assess the abovementioned spatial stability of the inverse solutions, the
following steps are performed:
1. Instead of one dipole with the smallest RRE value, five dipoles with the smallest
RRE values are evaluated.
2. For these five dipoles a gravity center is computed.
3. Distances between this gravity center and each of the five dipoles are calculated.
4. Mean, standard deviation and quartiles of the obtained distances are determined and
used as measures of the spatial stability of the inverse solution.
Stability of the inverse solution can be also dependent on the fluctuations of the
input data. In our case, the input data for the inverse solution are BSP map and
homogeneous or inhomogeneous torso geometry. Therefore, the stability of the inverse
solution depending on the fluctuations of both of them is analyzed.
The stability of the inverse solution in dependence on the fluctuations of the BSP
map is assessed using the above suggested evaluation method of the stability and the
same combination of input parameters as selected in sec. 3.5.6 but in this case it is used
for all 5 PVCs in each patient. Therefore, results of the inverse solution for each patient
include 25 dipoles from 5 PVCs in total. After estimation of the gravity center of these
25 dipoles, mean and dispersion of the distances to each dipole from this gravity center
is calculated. The smaller the dispersion of the positions of the inverse results, the more
stable is the inverse solution depending on the BSP map fluctuations.
To assess the stability of the inverse solution in dependence on the selected torso
model the same method as for evaluation of the RRE stability is used. Only one
ectopic beat is used for the inverse solution jointly with each of the three torso models.
BSP map computed for this one PVC is selected in sec. 3.5.3. For each of the three
combinations, first five dipoles with minimal RRE value are obtained as the result of
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the inverse solution. For these 5 dipoles a gravity center is computed. Then, mean and
dispersion of the dipole distances from the gravity center are evaluated for each of the
three combinations.
In order to compare the stability of the inverse results when different torso models
are used, obtained dispersions are evaluated using the F -test of equality of variances,
described in sec. 3.5.1. This comparison of dispersions gives an understanding how
consistent are the positions of the inversely obtained dipoles when using each of the
combinations with different degree of inclusion of the torso inhomogeneities. Besides
this, the analysis of the distances between gravity centers, obtained for each of the
combinations, provides information how the inverse results shift when different torso
models are used.
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Experimental evaluation of the proposed
methods
4.1 Selection and description of the patient group
The experimental measurements were performed in cardiologic departments of Univer-
sity Hospital Kralovske Vinohrady (Prague, Czech Republic). Characteristics of the
eighteen measured patients is given in Tab. A.1. The patients with frequent monomor-
phic PVCs were selected by the clinicians of the cardiologic department. The data from
patients were collected after obtaining their informed consent (Appendix B). All used
methods and applied procedures were approved by the Ethic Committee of the Uni-
versity Hospital Kralovske Vinohrady. From the total amount of 18 measured patients,
10 patients were evaluated after excluding patients with less than 5 PVCs during the
ECG recording (3 patients), wrong selection of the ECG sampling frequency (1 pa-
tient), cancelled EP study due to atrial fibrillation (1 patient), or CT data of poor
quality (3 patients).
4.2 Measurement procedures
Patients underwent up to 30 minutes of multichannel ECG recording. Right after
the ECG recording the cables were unplugged from the electrodes and the patients
underwent whole torso CT scanning with electrodes remaining on their chests. This
enabled to obtain precise positions of electrodes respectively to the torso directly from
the CT scan. An intracardiac electrophysiological study with catheter ablation using a
3D navigational system was performed on the same or the next day.
4.2.1 Multichannel ECGmeasurement and processing
ProCardio 8 system [83, 225–226] (Fig. 4.1) was used for multichannel ECG recording.
The system consists of a set of lead cables with active electrode adapters, data ac-
quisition unit powered by a rechargeable Li-ion battery and connected to a personal
computer by an optical USB cable. The system can be configured for simultaneous
recording of limb leads and up to 128 chest leads according to the user requirements.
Driven right leg (DRL) is used and all ECG signals are measured relatively to a com-
monmode sense (CMS) electrode (that can be placed in selected position on the body)
to minimize the unwanted common mode signal. After the measurement all leads are
recomputed relatively to the Wilson’s Central Terminal (see Eq. (1.7)) by the soft-
ware [226–227].
In this work 96 chest electrodes organized in 12 strips of 8 electrodes (Fig. 4.2)
evenly distributed around the patient’s thorax together with four limb electrodes and
a CMS electrode were used for the multichannel ECG measurements. The signals were
recorded using disposable Ag/AgCl electrodes with active adapters and sampled at
58
Experimental evaluation of the proposed methods . . . 4.2 Measurement procedures
Figure 4.1: ProCardio 8 — BSP mapping system
(a) Anterior-posterior (AP) view (b) Posterior-anterior (PA) view
Figure 4.2: Patient Pat006 with 96 electrodes (organized in 12 strips of 8 electrodes) and
the common mode sense (CMS) electrode
1 kHz sampling frequency with 16-bit resolution (except Pat002 where 500 Hz sampling
frequency was used). The length of records was from three up to 30 minutes depending
on the occurrence of the ectopic beats.
For each patient five ectopic beats were selected from the multichannel ECG records
for further processing. The signals were processed using the software of the ProCardio 8
system. The raw ECG signals were stored in international General Data Format for
biomedical signals (GDF) [228].
Pre-processing of the signals started with the following steps: recalculation of unipo-
lar leads relatively to the WCT and computation of standard bipolar leads, offset cor-
rection, filtration of the signal using Pipberger filter for removing excessive 50 Hz inter-
ference and high frequency noise. A reference lead was selected based on the distinct
morphology and biggest amplitude of the ectopic complex. As a rule, one of the stan-
dard limb leads was selected. If a time marker was set in the reference lead, the same
time marker was valid for all leads.
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After selecting the reference lead the baseline correction in all leads was performed
using the method described in section 3.2.2 (in two steps, using 2-point baseline correc-
tion). Example of two manually selected baseline time markers defining the processed
interval in the reference lead is given in Fig. 4.3. After the baseline was set immediately
before and after the selected PVC, the Zero-time defining the PVC onset (Fig. 4.4) was
manually set and precised by the software using the method described in section 3.2.3.
Figure 4.3: Initial manual selection of the processed interval. Orange lines mark selected
baseline time markers IZO1 and IZO2. Upper graph: standard lead II. Middle graph:
Derivative of the lead II. Lower graph: RMS signal computed from all measured chest
leads
Next, the time markers (Fig. 4.5) were set with 5 ms step to define sub-intervals of
the selected initial 30 ms time interval. Using these time markers, sub-intervals were
created for all possible combinations between them, resulting in 20 sub-intervals with
duration of 5, 10, 15, 20 and 25 ms (Tab. 4.1).
Initial time instant
Duration
5 ms 10 ms 15 ms 20 ms 25 ms 30 ms
0 ms 0–5 0–10 0–15 0–20 0–25 0–30
5 ms 5–10 5–15 5–20 5–25 5–30
10 ms 10–15 10–20 10–25 10–30
15 ms 15–20 15–25 15–30
20 ms 20–25 20–30
25 ms 25–30
Table 4.1: Twenty-one sub-intervals of the selected initial time interval 0-–30 ms used to
compute IBSPMs from each PVC
Finally, all of the 21 time intervals were used to compute IBSPMs (Fig. 4.6) for
each out of five PVCs in each patient. As it was described in section 3.2, for the same
selected 0–30 ms time interval TIBSPMs were computed for each time instant (with
one millisecond time step). It resulted in 31 time instant BSP maps for each of the five
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Figure 4.4: Redefinition of baseline times after first baseline correction (orange lines) and
manual setting of the initial estimate of the PVC onset — Zero-time (green line). Red
line with “?” label is a caliper, which is used to set the markers. Upper graph: standard
lead II. Middle graph: Derivative of the lead II. Lower graph: RMS signal computed from
all measured chest leads
Figure 4.5: Allocation of the final PVC onset (green line) set by the algorithm and six
time markers (pink lines) defining sub-intervals of the selected initial 30 ms time interval.
Orange lines mark selected baseline time markers IZO1 and IZO2. Upper graph: standard
lead II. Middle graph: Derivative of the lead II. Lower graph: RMS signal computed from
all measured chest leads
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Figure 4.6: Integral body surface potential map of Pat006 for the 0—20 ms interval
ectopic beats in each patient. Therefore, there were 105 IBSPMs and 155 TIBSPMs
for each patient used as the alternative input data for the inverse solution.
4.2.2 CT data processing
After the multichannel ECG recording the patients with attached ECG electrodes un-
derwent CT scanning of the whole chest (which is described in section 3.3) to obtain the
patient-specific 3D configuration of the torso with its main electrical inhomogeneities as
well as real positions of the measuring ECG electrodes on the torso surface (Fig. 4.7).
Figure4.7: Anterior-posterior projection of the whole torso CT scan. Lighter dots indicate
electrode positions
CT scanning was performed using Siemens Somatom Definition system. Contrast-
enhanced cardiac CT angiography was performed with the slice thickness 0.3 mm. In
order to create patient-specific torso models, the CT processing was performed using
TomoCon PACS® software [229]. The software enables to perform automatic patient
contouring based on the resolution setting. The contouring was performed for the
following torso structures: torso, lungs, heart atria and ventricles (epi- and endocardial
surfaces), aorta and pulmonary artery (Fig. 4.8).
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Figure 4.8: CT image with contours of the torso structures: pink — torso, grape — left
lung, dark green — right lung, green — right ventricle, yellow — left ventricle, violet —
right atrium, magenta — left atrium, blue — pulmonary artery, red — aorta
After obtaining the contours, each of them was manually corrected. In result, 3D vol-
umes of all abovementioned torso structures were created. Example of the processed
torso model with its internal inhomogeneities is given in Fig. 4.9a and the heart struc-
tures are presented in Fig. 4.9b-c. The surfaces of the torso structures were triangulated.
The number of vertices and triangles was optimized to preserve sufficient geometry ac-
curacy and to speed-up the inverse solution.
(a) 3D torso geometries (b) heart structures in AP
projection
(c) heart structures in PA pro-
jection
Figure 4.9: 3D structures of the Pat006 torso model. Colors display the following torso
structures: pink – torso, grape — left lung, dark green — right lung, green — right
ventricle, yellow — left ventricle, violet — right atrium, magenta — left atrium, blue —
pulmonary artery, red — aorta
Three torso models with different level of complexity were created. The assumed
conductivities were the same for the corresponding parts in all torso models. The
conductivity of lungs was assumed four times lower than the conductivity of the torso;
the conductivity of heart cavities, aorta and pulmonary artery structures was assumed
three times higher than the conductivity of the torso [221].
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4.2.3 Electrophysiological study
After ECG measurement and CT scanning, the electrophysiological study and radiofre-
quency catheter ablation were performed on the same, or on the next day. Patients
underwent the procedure under mild conscious sedation with fentanyl. Intravenous iso-
proterenol was infused as was deemed necessary for the induction of ectopy in patients
with infrequent extrasystoles at the beginning of the procedure [J2].
Catheter ablation was performed using 3D electroanatomical mapping system
CARTO® (Biosense Webster Inc). Endocardial bipolar and unipolar electrograms
were recorded with bandpass filters (30–250 Hz for bipolar and 0.1–100 Hz for unipolar
records) using the EP recording system LabSystem PRO™ (Boston Scientific). The
right ventricle was mapped via standard femoral approach, and the left ventricle was
mapped via transseptal or transaortal retrograde approach. Intracardiac echocardio-
graphic system Vivid q™ (General Electric) was used to guide the transseptal puncture
in patients with the PVC origin in the LV. These patients were anticoagulated with
unfractionated heparin for activated clotting time of 250–300 s [J2].
After insertion of the mapping catheter a 3D model of the investigated cavity was cre-
ated using the electroanatomical mapping system CARTO and merged with 3D model
reconstructed from the CT scan, performed before the EP study. These procedures
are described in more detail section 3.4. An example of the reconstructed endocardial
surface of the right ventricle is presented in Fig. 4.10 and an example of the merged
geometries is presented in Fig. 4.11.
(a) AP view (b) PA view
Figure 4.10: Electroanatomic mapping (reconstruction) of the right ventricle of Pat004.
The colors change according to the rainbow from red to blue/purple, where the red color
represents the earliest activation and the blue/purple — the latest. Ablation points are
marked in dark red/vine color
The target site for the radiofrequency ablation was determined by activation mapping
and confirmed by pace mapping (requiring concordance of 11 out of 12 leads between
the paced ECG signals and the clinical ECG during PVCs). After the target site
was located, radiofrequency catheter ablation was performed using an open irrigated
ablation catheter Thermocool Navistar (Biosense Webster Inc.) in the power-control
mode (25–40 W, flow 15–20 ml/min, max. temperature 43◦C). The position of the
radiofrequency ablation was automatically marked on the intraoperative endocardial
3D model by the electroanatomical mapping system CARTO in dark red/vine color
and labeled as ablation.
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(a) AP view (b) Left anterior oblique view
Figure 4.11: Right ventricle endocardium model (rainbow gradient color) in Pat007 ob-
tained from the CARTO® mapping and navigation system by merging the intracardiac
mapping with 3D model of the right ventricle and pulmonary artery geometry recon-
structed from CT scan (moss color)
Patients were monitored for a minimum of 15 minutes with isoproterenol challenge
after the last energy application to ensure complete abatement of the ventricular ec-
topy [J2].
After the EP study experienced clinician evaluated the location(s) of the ablation
markers according to the suggested method described in section 3.4, and assigned it to
the appropriate heart segment.
4.3 Inverse solution setting
In order to find the location of the PVC focus with a good accuracy, equivalent generator
(selected in sec. 3.1.1) was computed for all positions in a dense regular 3 mm grid
(sec. 3.1.4) throughout the modeled ventricular myocardium. The implementation of
the SVD algorithm (described in 3.1.2) was developed in the Institute of Measurement
Science SAS (Bratislava, Slovakia).
In each patient 5 PVCs were processed. For each ectopic beat 31 TIBSPMs and
21 IBSPMs from the initial 30 ms time interval (sec. 3.2.1, 3.2.3) were computed from
multiple chest leads (selected in 3.1.3). Three torso models were modelled in each
patient with different level of complexity (sec. 3.3). The inverse problem was solved for
all possible combinations of the input parameters:
(31 TIBSPMs + 21 IBSPMs)× 3 torso models = 156 combinations. (4.1)
Summarizing, in each patient there were 156 combinations for each of 5 selected PVCs
used as input data to solve the inverse problem using a single dipole model (representing
the cardiac electrical generator) and a torso model (representing the volume conductor).
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Results
5.1 Selection of the relevant results using relative
residual error criterion
As it was described in sec. 3.5.2, to evaluate the correctness/quality of the inverse
solution in terms of single dipole — the relative residual error RRE value (Eq. (3.8))
less or equal to 0.3 is used as the main criterion to select the relevant results. There
were 5309 (68%) relevant results in total for all combinations of the input parameters
for all patients. A contingency table of the correct and incorrect relevant inverse results
in each patient is given in Tab. 5.1. For better understanding the same information
is presented in percentage in Fig. 5.1 and Fig. 5.2 (or in Fig. 5.3 in absolute values).
Results of the inverse solutions for each patient are given in Appendixes D, E, F, G, H,
I, J, K, L, M.
Figure 5.1: Percentage of the relevant inverse solutions with RRE ≤ 0.3 in each patient
Correctness of the inverse solution
Total
Patient Incorrect Correct
Pat004 281 484 765
Pat005 291 240 531
Pat006 314 466 780
Pat007 519 261 780
Pat008 250 514 764
Pat009 121 144 265
Pat010 189 525 714
Pat011 255 0 255
Pat015 252 24 276
Pat016 179 0 179
Table 5.1: Contingency table showing how many correct/incorrect inverse results were
observed among results with RRE ≤ 0.3
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Figure 5.2: Percentage of the correct relevant inverse solutions out of all relevant solutions
with RRE ≤ 0.3 in each patient
Figure 5.3: Correctness of the inverse solutions in each patient with respect to the RRE
value. The first two columns show the results with RRE ≤ 0.3 (relevant results), where
the first column is the total number of relevant results, and the second column is the
number of correct relevant results. Analogically, the next two columns show the results
with RRE > 0.3, where the third column shows the total number of results and the fourth
one the number of correct results
5.2 Evaluation of the input BSPmaps impact on the
inverse solution
The percentages of correct results depending on the used BSP maps are presented in
Fig. 5.4. The evaluation of correct results in each patient is provided in Fig. 5.5 for the
IBSPMs and in Fig. 5.6 for the TIBSPMs.
The contingency table describing the frequencies of correct and incorrect inverse
results by BSP maps is given in Tab. C.1. Using the Eq. (3.11), a model of expected
data can be calculated (Tab. C.2). Using the Eq. (3.12), we calculate the χ2:
χ2 =
∑ (observedij − expectedij)2
expectedij
= 162.101. (5.1)
The observed chi-square value 162.101 is higher than the critical value of the chi-
square for df = 51 (77.373, p < 0.01) and the null hypothesis is rejected. Therefore,
the correctness of the inverse solution is dependent on the used BSP map.
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Figure 5.4: Percentage of correct inverse results for the selected 52 BSP maps. IBSPMs
are presented in red color and TIBSPMs are presented in blue color
Since the null hypothesis is rejected, the second Person’s chi-square test is performed.
This test differs from the first one in comparison of the BSP map, which provided the
highest amount of the correct results versus all the other BSP maps. As can be seen
from the Tab. C.1, the highest amount (in %) of the correct results was obtained for the
IBSPM computed for the time interval 0–15 ms. Therefore, the contingency table has
2× 2 size and is displayed in Tab. 5.2. Using the Eq. (3.11), we calculated the model of
expected data and the results of these calculations are provided in the Tab. 5.3. Using
the Eq. (3.12), we can determine the χ2:
χ2 =
∑ (observedij − expectedij)2
expectedij
= 4.77, (5.2)
The observed chi-square value 4.77 is higher than the critical value of the chi-square for
df = 1 (3.84, p < 0.05) and the null hypothesis is rejected. Therefore, the correctness of
the inverse solution is dependent on the used body surface potential map and usage of
the BSP map, obtained from the time interval 0–15 ms has 95% probability to provide
highest amount of correct results.
Body surface Correctness of the inverse solution
Totalpotential map Incorrect Correct
IBSPM 0-15 ms 36 57 93
All the other
BSP maps
2615 2601 5216
Total 2651 2658 5309
Table 5.2: Contingency table showing how many correct inverse solutions were observed
using IBSPM from 0–15 ms time interval versus all the other BSP maps
Body surface Correctness of the inverse solution
Totalpotential map Incorrect Correct
IBSPM 0-15 ms 46 47 93
All the other
BSP maps
2605 2611 5216
Total 2651 2658 5309
Table 5.3: Contingency table showing how many correct inverse solutions are expected
(assuming independency of the inverse solution correctness from input BSP map) using
IBSPM from 0–15 ms time interval versus all the other BSP maps
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5.3 Search of the patient-specific time instant for
TIBSPM computation
As it was described in sec. 3.5.4, an approach to determine patient-specific time instant
for computation of the TIBSPM was used. It was based on the correlations between
all TIBSPMs, obtained from the selected 30 ms initial PVC time interval, for each of
the 5 ectopic beats for each patient. The average of the correlation was calculated for
each time instant for each beat separately. Results of these averaged correlations are
presented in Fig. 5.7.
TIBSPM, which had the maximum averaged correlation between TIBSPMs from
the selected initial 30 ms time interval, was used for inverse solution as input data in
combination with each out of the three torso models of different complexity. Amount of
the obtained relevant results of the inverse solutions using these TIBSPMs and amount
of the correct relevant inverse results is given in Fig. 5.8 for each out of the three torso
models with different complexity.
Figure 5.8: Number of the total and correct relevant inverse results obtained using TIB-
SPM with maximum averaged correlation between TIBSPMs of the selected initial 30 ms
time interval in each out of five premature ventricular complexes and one of the torso
models: homogeneous H, inhomogeneous V or inhomogeneous AV. Numbers of the total
relevant inverse results are marked as “total”. Number of the correct relevant inverse results
are marked as “correct”
From Fig. 5.8 it implies that the highest percentage of the correct relevant inverse
results was obtained when TIBSPM with maximum averaged correlation was used in
combination with homogeneous torso model H (68.4%), whereas using of the inhomo-
geneous torso models V and AV resulted in 51.4% and 60.6% success rate, respectively.
5.4 Evaluation of the impact of the torsomodel
complexity on the inverse solution
The percentage of the number of correct relevant results depending on the torso model
complexity are presented in Fig. 5.9. The same information regarding the percentage
of the correct inverse results depending on the used torso model complexity in each
patient is presented in Fig. 5.10. The contingency table describing frequencies of the
correct and incorrect inverse results by torso model complexity is given in Tab. 5.4.
Using Eq. (3.11), we build a model of expected data (Tab. 5.5).
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Figure 5.9: Amount of correct relevant inverse solutions (in %) obtained using integral
and time instant BSP maps generated for five PVCs in each patient for three torso models
with different inhomogeneities. H — homogeneous torso model, V — inhomogeneous torso
model, AV — inhomogeneous torso model with highest level of complexity
Figure 5.10: Percentage of obtained correct relevant inverse results for three levels of torso
model complexity for each patient separately
Torso Correctness of the inverse solution
Totalinhomogeneities Incorrect Correct
Torso model H 676 1144 1820
Torso model V 1042 757 1799
Torso model AV 933 757 1690
Total 2651 2658 5309
Table 5.4: Contingency table showing how many correct relevant inverse solutions were
observed using torso model with selected complexity
Using Eq. (3.12) we calculated the χ2:
χ2 =
∑ (observedij − expectedij)2
expectedij
= 183.81, (5.3)
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Torso Correctness of the inverse solution
Totalinhomogeneities Incorrect Correct
Torso model H 909 911 1820
Torso model V 898 901 1799
Torso model AV 844 846 1690
Total 2651 2658 5309
Table5.5: Contingency table showing how many correct inverse solutions are expected (as-
suming independency of the inverse solution correctness from the torso model complexity)
using torso model with selected complexity
The observed chi-square value 183.81 is higher than the critical value of the chi-square
for df = 2 (9.21, p < 0.01) and the null hypothesis is rejected. Therefore, the correctness
of the inverse solution is dependent on the complexity of the used torso model.
Since the null hypothesis is rejected, a new Person’s chi-square test is performed to
check whether the torso model, which gave the highest amount of the correct result, is
better compared to the other two torso models joined in one category. The new con-
tingency table is displayed in Tab. 5.6. The model of the expected data was calculated
using Eq. (3.11) and is provided in Tab. 5.7.
Torso Correctness of the inverse solution
Totalinhomogeneities Incorrect Correct
Torso model H 676 1144 1820
Torso models
V and AV
1975 1514 3489
Total 2651 2658 5309
Table 5.6: Contingency table showing how many correct relevant inverse solutions were
observed using torso model with selected complexity
Torso Correctness of the inverse solution
Totalinhomogeneities Incorrect Correct
Torso model H 909 911 1820
Torso models
V and AV
1742 1747 3489
Total 2651 2658 5309
Table5.7: Contingency table showing how many correct inverse solutions are expected (as-
suming independency of the inverse solution correctness from the torso model complexity)
using torso model with selected complexity
Calculations of the χ2 value using the Eq. (3.12):
χ2 =
∑ (observedij − expectedij)2
expectedij
= 181.25, (5.4)
The observed chi-square value 181.25 is significantly higher than the critical value of the
chi-square for df = 1 (6.63, p < 0.01) and the null hypothesis is rejected. Therefore, the
correctness of the highest amount of the inverse solution is dependent on the complexity
of the used torso model.
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5.5 Search of the best combination of the input data
for the inverse solution
The frequencies of the correct relevant inverse results for the combinations, which had
more than 60% correct inverse results, are displayed in Fig. 5.11. The contingency table
describing frequencies of the correct and incorrect inverse results for all of the 156 com-
binations is given in Tab. C.3. Using the Eq. (3.11), a model of the expected data can
be calculated. The results are presented in the Tab. C.4. Then, using Eq. (3.12) χ2 is
defined:
χ2 =
∑ (observedij − expectedij)2
expectedij
= 369.00, (5.5)
Figure 5.11: Percentage of the correct relevant inverse results for the combinations with
more than 60% success. The first letter represents the used torso model: H –– homogeneous
torso model H. The second abbreviation represents the type of the used body surface
potential map: IBSPM –– integral, TIBSPM –– time instant. The numbers represent the
time interval or time instant
The observed chi-square value 369.00 is higher than the critical value of the chi-
square for df = 155 (198.312, p < 0.01) and the null hypothesis is rejected. Therefore,
the correctness of the inverse solution is dependent on the used combination of the
input parameters of the inverse solution and there is a combination, yielding higher
probability to obtain correct inverse result.
Since the null hypothesis is rejected, the further analysis is performed to define
whether the combination of the input parameters for the inverse solution, which gave
the highest amount of the correct result, is better compared to the other combinations
joined in one category. According to the Tab. C.3, there are 3 combinations with highest
amount of the correct inverse results. All combinations use the homogeneous torso
model and a time instant map for the 8th, 9th or 10th ms. Therefore, the contingency
table for the Person’s chi-square test contains three best combinations and the remaining
153, joined into one category. The resulting table has 4 × 2 size and is displayed in
Tab .5.8.
A model of the expected data is calculated using Eq. (3.11) and the results are
provided in Tab. 5.9. The chi-square value χ2 is defined using Eq. (3.12):
χ2 =
∑ (observedij − expectedij)2
expectedij
= 28.33, (5.6)
The observed chi-square value 28.33 is higher than the critical value of the chi-square for
df = 3 (11.34, p < 0.01) and the null hypothesis is rejected. Therefore, there are three
74
Results . . . . . . . . . . . . 5.6 Evaluation of the stability of the inverse solution
Combinations of the
Correctness of the inverse solution Totalinput parameters
for the inverse solution Incorrect Correct
H TIBSPM 8 ms 7 24 31
H TIBSPM 9 ms 7 24 31
H TIBSPM 10 ms 7 24 31
All other 2630 2586 5216
Total 2651 2658 5309
Table 5.8: Contingency table showing how many correct relevant inverse solutions were
observed using the selected combination of the used body surface potential map and torso
model with selected level of complexity
best combinations of the input parameters, using which there is a higher probability to
obtain correct inverse result:
1) homogeneous torso model H and TIBSPM computed for 8 ms;
2) homogeneous torso model H and TIBSPM computed for 9 ms;
3) homogeneous torso model H and TIBSPM computed for 10 ms.
Combinations of the
Correctness of the inverse solution Totalinput parameters
for the inverse solution Incorrect Correct
H TIBSPM 8 ms 15.48 15.52 31
H TIBSPM 9 ms 15.48 15.52 31
H TIBSPM 10 ms 15.48 15.52 31
All other 15.48 15.52 5216
Total 2651 2658 5309
Table5.9: Contingency table showing how many correct inverse solutions are expected (as-
suming independency of the inverse solution correctness from the used input combination)
using the selected combination of the used body surface potential map and torso model
with selected level of complexity
5.6 Evaluation of the stability of the inverse solution
For each input BSP map the inverse dipole is computed in each predefined position
in the heart model and the position with the smallest RRE value is assumed as the
best representative of the PVC origin. As it was described in sec. 3.5.7, two aspects
of the stability of the inverse solution were assessed. First, analysis of the inverse
solution spatial stability based on the minimal RRE value and best combination of
input parameters is performed in sec. 5.6.1. Second, the spatial stability of the inverse
solution in dependence on the input data variability was assessed for both input data —
the BSP map (sec. 5.6.2) and the torso model (sec. 5.6.3).
5.6.1 Stability of the inverse solution using the best combination
of input parameters based on theminimal RRE value
The best combination of input parameters (selected in sec. 5.5) consists of homogeneous
torso model H and TIBSPM computed for the time instant 8 ms. The positions of
the five dipoles of the inverse solution with the first five minimal, ascendingly sorted
RRE values obtained from one input TIBSPM were examined. The assessment of the
spatial stability of the inverse solution was based on calculations of the mean, standard
deviation and quartiles of the distances between the positions of these five dipoles and
their gravity center.
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The mean and standard deviation of the distances between the positions of the dipoles
and their gravity center for each of the patients were evaluated. Data range of the
determined distances between the five dipoles and their gravity center for each patient
is shown in box-and-whisker plot in Fig. 5.12. The smallest values were observed in
Pat010 (2.4± 0.43 mm) and the highest values were in Pat011 (5.1± 2.37 mm). The
results of the inverse solution for these two patients are depicted also in Fig. 5.13.
Figure 5.12: Box-and-whisker plot of the distances between the positions of the first five
dipoles of the inverse solution with minimal RRE and their gravity center in each patient.
Inverse solution was solved using the combination of the homogeneous torso model H and
TIBSPM computed for time instant 8 ms. Five dipoles (instead of one) with minimal RRE
were selected as the inverse solutions for one PVC
(a) Pat010 has the smallest values of the
mean and SD of the distances between the
dipole positions and their gravity center
(2.4± 0.43 mm)
(b) Pat011 has the highest values of the
mean and SD of the distances between the
dipole positions and their gravity center
(5.1± 2.37 mm)
Figure 5.13: Positions of the five dipoles of the inverse solutions with minimal RREs ob-
tained for single PVC using TIBSPM in time instant 8 ms and homogeneous torso model H.
Superior view
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5.6.2 Stability of the inverse solution in dependence on the BSP
map variability
For evaluation of the spatial stability of the inverse solution in dependence on the BSP
map variability, TIBSPMs in time instant 8 ms from five PVCs were used as input
data of the inverse solution. For each of these 5 PVCs, five dipoles with minimal RRE
were selected. Assessment of the distances between the positions of these twenty-five
dipoles and their gravity center was performed for each patient. Data range of the
determined distances between the twenty-five dipoles and their gravity center for each
patient is shown in box-and-whisker plot in Fig. 5.14. The smallest values were obtained
in Pat009 (3.9± 1.71 mm) and the highest values were in Pat011 (18.2± 14.17 mm).
Results of the inverse solutions for these two patients are presented in Fig. 5.15.
Figure5.14: Box-and-whisker plot of the distances between the positions of the twenty-five
dipoles of the inverse solutions and their gravity center in each patient. Inverse solution
was solved using the combination of homogeneous torso model H and TIBSPM computed
for time instant 8 ms. Five dipoles (instead of one) with minimal RRE were selected for
each inverse solution for 5 PVCs
5.6.3 Stability of the inverse solution in dependence on the torso
model complexity
The spatial stability of the inverse solution in dependence on the torso model complexity
was estimated using one of the BSP maps (IBSPM for the 0–15 ms time interval, which
was selected in sec. 5.2) in combination with each of the three torso models (described
in sec. 4.2.2). For each combination first five dipoles with minimal RRE values were
selected. Evaluation of the distances between the positions of these five dipoles and
their gravity center was performed for each combination in each of the ten patients.
Mean and standard deviation of these distances in each patient are given in Fig. 5.16
and summarized for all patients –– in Fig. 5.17.
In order to evaluate the dispersions of the obtained inverse results when the torso
models of different complexity level are used, the F-test of equality of variances is used.
As can be seen in Fig. 5.17, the smallest dispersion of the positions of the inverse results
was gained when homogeneous torso model was used as input data for the inverse
solution. The highest dispersion of the positions of the inverse results was obtained
for the inhomogeneous torso model V, which was significantly higher (p < 0.01) than
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(a) Pat009 has smallest values of the mean
and SD of the distances between the
dipole positions and their gravity center
(3.9± 1.71 mm)
(b) Pat011 has highest values of the mean
and SD of the distances between the
dipole positions and their gravity center
(18.2± 14.7 mm)
Figure 5.15: Positions of the twenty-five dipoles of the inverse solutions with minimal
RRE. Inverse solutions for 5 PVCs were solved using the combination of homogeneous
torso model H and TIBSPMs computed for time instant 8 ms. Five dipoles (instead of
one) with minimal RRE were selected for each inverse solution. Superior view
Figure 5.16: Mean and standard deviation of the positions of the five dipoles from their
gravity center obtained for the inverse solutions with minimal RRE values computed for
individual patients. Three combinations of the input data consisted of one BSP map (IB-
SPM for 0–15 ms time interval) and three torso models with different levels of complexity
(torso model H — homogeneous, torso model V — inhomogeneous, torso model AV —
refined inhomogeneous)
the dispersion of the positions of the inverse results obtained using torso models AV
and H. The dispersion of the inverse results positions obtained using homogenous torso
model H was significantly smaller (p < 0.01) than the dispersion obtained using the
inhomogeneous torso model AV.
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Figure 5.17: Mean and standard deviation of the positions of the five dipoles from their
gravity center obtained for the inverse solutions with minimal RRE values computed for
all 10 patients. Three combinations of the input data consisted of one BSP map (IBSPM
for 0–15 ms time interval) and three torso models with different levels of complexity (torso
model H — homogeneous, torso model V — inhomogeneous, torso model AV — refined
inhomogeneous)
For detailed understanding of the variability of the evaluated distances between the
inverse results positions and their gravity center when torso models with different level
of complexity were used for the inverse solution, the box-and-whisker plots for all torso
models are shown in Fig. 5.18 to Fig. 5.20.
Figure5.18: Box-and-whisker plot of the distances between the positions of the five dipoles
of the inverse solution and their gravity center in each patient. Homogeneous torso model H
and IBSPM 0–15 ms were used as input data for the inverse solution
When homogeneous torso model H was used as input data of the inverse solution,
the smallest dispersion of the derived distances between the first five dipoles and their
gravity center was observed in Pat008 and Pat010 (2.4± 0.43 mm), and the highest
dispersion was observed in Pat006 (5.6± 4.04 mm). Obtained inverse results for these
three patients are shown in Fig. 5.21.
When inhomogeneous torso model V was used as input data of the inverse solution,
the smallest dispersion of the derived distances between the first five dipoles and their
gravity center was observed in Pat015 (2.5± 0.96 mm), and the highest dispersion was
observed in Pat009 (8.8± 7.03 mm). Obtained inverse results for these two patients
are shown in Fig. 5.22.
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Figure5.19: Box-and-whisker plot of the distances between the positions of the five dipoles
of the inverse solution and their gravity center in each patient. Inhomogeneous torso
model V and IBSPM 0–15 ms were used as input data for the inverse solution
Figure5.20: Box-and-whisker plot of the distances between the positions of the five dipoles
of the inverse solution and their gravity center in each patient. Inhomogeneous torso
model AV and IBSPM 0–15 ms were used as input data for the inverse solution
(a) Pat008. Superior view (b) Pat010. Superior view (c) Pat006. PA view
Figure 5.21: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H
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(a) Pat015. Superior view (b) Pat009. Superior view
Figure 5.22: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V
When inhomogeneous torso model AV was used as input data of the inverse solution,
the smallest dispersion of the derived distances between the first five dipoles and their
gravity center was observed in Pat015 (2.5± 0.96 mm), and the highest dispersion was
observed in Pat004 (12.6± 3.51 mm). Obtained inverse results for these two patients
are shown in Fig. 5.23.
(a) Pat015. Superior view (b) Pat004. Superior view
Figure 5.23: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV
In order to evaluate whether the gravity center of the determined inverse results shifts
when torso model of different complexity is used, a distance between these three gravity
centers was calculated (Fig. 5.24). The highest shift was observed in Pat007 between
the gravity centers obtained from positions of the inverse solution with input data of
homogeneous torso model H and inhomogeneous torso model V (21.4 mm), which is
shown in Fig. 5.25. The smallest shift was observed in Pat016 between the gravity
centers obtained from positions of the inverse solution with input data of homogeneous
torso model H and inhomogeneous torso model AV (0.85 mm), which is shown in
Fig. 5.26. Generally, the distances were higher between the homogeneous torso model H
and the inhomogeneous torso model V or inhomogeneous torso model AV than between
the two inhomogeneous torso models V and AV.
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Figure 5.24: Distances betweeen gravity centers of the five inverse solution positions ob-
tained for IBSPM 0–15 ms and torso models of different complexity. Torso model H ––
homogeneous torso model, torso model V –– inhomogeneous torso model, torso model AV –
– refined inhomogeneous torso model
Figure 5.25: Biggest distances between the gravity centers of the five dipole positions
obtained for inverse solutions with IBSPM 0–15 ms amd one of three input torso models in
the ventricular myocardium of the Pat007. Superior view. Blue –– torso model H, Green
–– torso model V, Red –– torso model AV
(a) Superior view (b) Base to apex view
Figure 5.26: The smallest distances between the gravity centers of the five dipole positions
obtained for inverse solutions with IBSPM 0–15 ms and each of three input torso models
in the ventricular myocardium of the Pat016. Blue –– torso model H, Green –– torso
model V, Red –– torso model AV
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Chapter6
Discussion
6.1 Measurement-related issues
An accurate localization of the PVC focus before the invasive EP study and RFA can
improve the success rate of the RFA and decrease the risks associated with the invasive
EP procedure. Noninvasive localization of the PVC focus using BSP mapping and
imaging modality (CT/MRI) can be achieved by solving the inverse problem.
A pilot study [J3] was performed in cooperation with the State Establishment “Na-
tional M. Amosov Institute of Cardiovascular Surgery of the Academy of Medical Sci-
ences of Ukraine” (Kyiv, Ukraine). The patient study group consisted of two male
patients of 17 and 57 y.o.
The patients were measured using Amsterdam lead system with an irregular grid
of 62 electrodes (Fig. 6.1). Therefore, each electrode had to be applied separately on
the patient’s thorax. The procedure was very time consuming, impractical for the
clinical use, and hard for the patients. That is why this lead system in this study was
replaced by the 96 lead system with evenly distributed electrodes. It allowed using
electrodes grouped in stripes. Currently, 12 stripes of the electrodes are placed in less
than 5 minutes.
(a) AP view (b) PA view
Figure 6.1: Patient P2 from a pilot study with Amsterdam lead system with an irregular
grid of 62 electrodes. From [J3]
In this study, the patient group included male and female patients of different age
varying 33–77 y.o. and torso geometry with body mass index 17.9–43.4. This variability
in the group (from underweight to obese patients) resulted in a variability of the thorax
structure models. In some female patients, the application of the stripes with electrodes
was troublesome. The stripes had to be cut, in order to be placed on the upper part of
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the torso and lower part of the torso under the breasts. It was a significant decision-
making issue in older and obese female patients because in some cases the breasts were
covering the whole front part of the torso. The position of the electrodes was evaluated
using CT scans. So, in cases when the electrodes were applied in the sitting or standing
position, when an obese female patient with big breasts lied down for the ECG recording
and CT scanning, the electrodes stripes had slight displacement (Fig. 6.2).
Figure 6.2: Example of electrode displacement in female patient Pat008
The multichannel ECG measurement was performed in the lying position, similarly
as the CT scanning. Therefore, it was assumed that the position of the electrode
was the same during these procedures. Nevertheless, it is obvious that this issue adds
imprecision to the performed study. Another issue with electrodes location in obese
female patients was in cases when the electrode was squeezed between the breasts and
torso in a lying position (Fig. 6.3). In most cases of similar electrode location, the
electrode was excluded from analysis and the BSP maps computation. For correct
computations, the electrodes should be located on the surface of the torso and not
inside of the torso model. Thus, the position of the electrode had to be projected on
the body surface. As in this example, in many cases of obese female patients, the
projection of the electrode on the body surface was arguable. Therefore, the electrode
had to be excluded in order to avoid adding of the error.
Figure 6.3: Rendering of the CT scan for Pat005. An arrow points on the electrode with
arguable location
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The quality of the ECG signal has a significant influence on the result of the inverse
solution. The semi-automatic approach of the Zero-point definition evaluated the ave-
rage noise of the signal and shifted the manually defined Zero-point in most of the cases
further in the timeline. Because the PVC activity representing time interval should be
covering as small as reasonably possible activated heart area, high level of noise at the
beginning of the QRS complex distorts obtained BSP maps, which can lead to incorrect
inverse solution. Therefore, special attention should be given during the multichannel
ECG measurement and the clinical personnel should emphasize the necessity for the
patient to be relaxed during the measurement in order not to add additional noise by
the muscular activity. An impact of the exclusion of individual noisy ECG signals on
the inverse solution accuracy was evaluated in half of the patients in [C3]. The results
showed that the exclusion of noisy leads in the heart region can worsen the inverse
solution, whereas the exclusion of noisy leads from the back can improve the inverse
solution. In the future, we plan to evaluate remaining patients.
Another evaluation of the noise in the signals can be based on the denominator of
Eq. (3.10). This value was computed from the signal which was considered as pure noise
and shows the level of the overall noise in signals. Box-and-whisker plot of these values
for each of the five evaluated beats in each patient is given in Fig. 6.4. The graph shows
that there was a high variability of the overall noise level between the patients. Note
that, patient Pat011 with very noisy ECGs did not have any correct inverse results.
Thus, the overall noise in ECG signals plays very important role in the proposed inverse
solution and its levels disqualifying the ECG record from using the method should be
studied in more detail in the future.
Figure 6.4: Box-and-whisker plot of the overall noise level for five beats in each patient
Possible limitation of using the method in some patients can be found when it comes
to the CT scanning. To minimize myopotential artefacts, ECG signals are recorded in
patients in horizontal position with hands lying next to their body. However, several
obese patients could not fit into the CT gentry with hands lying next to their body and
they were scanned with raised hands above their head, which caused change of torso
geometry and skin stretching with displacement of electrodes. The most challenging
measurement was in Pat018, when during the attempt of CT scanning we got to know,
that the patient torso geometry could not be measured completely as it was outside the
boundaries, defined by the CT scanner.
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6.2 Golden truth of the PVC location and precision of
the inverse solution
The correctness of the inverse solution was determined using agreement between the
location of the inversely found equivalent dipole heart generator and assignment of area
treated by the RFA to one of pre-defined segments of the heart by experienced clinician.
Obviously, the ideal way to evaluate the correctness and precision of the results would
be the precise merging of the torso and heart models obtained from CT and during the
EP study and measuring the distance between the location of the inverse result and
location of the ablation point. Unfortunately, this was not possible in this work due to
the following reasons:
. The software of the 3D navigational CARTO® system does not allow to import
3D models, created by another software. It means, that the heart model used for
the inverse solution could not be imported to the 3D navigational CARTO® system
to be used during the EP study and ablation. But, the CARTO® system allows to
create 3D models from CT or MRI data using build-in tool. As it was already men-
tioned in sections 3.4 and 4.2.3, this/these 3D models are later merged/superposed
with intracardial cavity model to provide clinician with additional and more reliable
knowledge of the patient-specific heart anatomy.. 3D models created by the 3D navigational CARTO® system from CT images are
often distorted by the papillary muscles and are not smooth enough. Therefore, in
spite of that these 3D models can be created long before the operation procedure and
can be easily exported, they can not be used for the inverse problem computation as
they will add numerical uncertainties and can hinder correct result.
The only way in this situation would be to create two similar 3D models of the heart
cavities from the same CT data using both software: the 3D navigational CARTO® sys-
tem, and software used for CT images processing for the inverse problem — Tomo-
Con PACS. This similar models of the heart cavities will be easily superposed thanks
to the presence of reliable reference points (such as outflow tracts or coronary sinus) in
both of them.
Since the ablation points are fixed only on the intracardial cavity model (Fig. 6.5a),
this model should be merged with 3D heart model obtained from processed CT data
using build-in tool of the CARTO® system. CARTO® system merging means that three
reference points selected on the intracardial model are superposed with three reference
points selected on the heart model from CT data. Thus, merging of the geometries
implies not combination of two models into one, but alignment, resizing and rotation
of the models to achieve minimal volume difference (Fig. 6.5b). In Fig. 6.6 is given an
example of the merged geometries with used reference points, where can be seen how
challenging it is to select the reliable reference points on the intracardial cavity model.
Because intracardial cavity model has less reliable reference points the merging process
should be performed during the EP study and its correctness should be checked by
clinician invasively. It is also the reason why the intracardial cavity model can not be
merged/superposed with the heart model used for the inverse solution straightaway.
Therefore, as it was already mentioned above, the heart cavity 3D model obtained
from CT data using the build-in tool of the CARTO® navigation system should be
merged/superposed with heart cavity 3D model obtained from the same CT data using
the software for CT data processing for the inverse problem. Since both of the models
will be created using the same CT images, there should be no significant difference be-
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(a) Intraoperational endocardial geometry of
the left atrium and left ventricle with abla-
tion markers
(b) merged/superposed geometries of the in-
traoperational endocardial geometries of the
left cavities (pink) with 3D model of the left
atrium and left ventricle reconstructed from
CT images (cyan). Ablation markers are vi-
sible on intracardial model in vinous color
Figure 6.5: Geometries of the left cavities for Pat006 in PA projection
(a) view on 3D navigational CARTO® sys-
tem. Reference points are marked with flags
(b) view in Matlab. Endocardial right ven-
tricle model (pink color) reference points are
marked by red squares and 3D model of right
ventricle reconstructed from CT (green color)
reference points are marked by black squares
Figure 6.6: Merged geometries of the intraoperational endocardial right ventricle with
3D model of the right ventricle reconstructed from CT of the Pat008. AP view
tween them. The result of this merging procedure is given in Fig. 6.7. These two merg-
ing procedures (intracardial cavity with heart cavity reconstructed using CARTO® sys-
tem, heart cavity reconstructed using CARTO® system with heart cavity reconstructed
using TomoCon PACS) allows to depict the ablation points from intracardial model in
the heart cavity 3D model used for the inverse solution (Fig. 6.8).
This approach will be used in further studies after improvement of the merging
algorithm. As can be seen in Fig. 6.7 there is a slight difference in the size of the
3D models heart cavities created using different software. The error is caused by the
incorrect resizing value during the merging. When this issue will be solved, it would be
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Figure 6.7: Right ventricle + right atrium + pulmonary artery 3D models of the Pat008.
AP view. Grey color – 3D model reconstructed using CT data processing software (Tomo-
Con PACS). Red color – 3D model reconstructed using build-in tool of the CARTO® system
for CT data processing
(a) Intraoperative endocardial 3D model of
the right ventricle (pink) with pulmonary
artery (blue) with ablation points
(b) Joint 3D model of the right atrium, right
ventricle and pulmonary artery used for the
inverse solution with ablation points super-
posed after merging procedure
Figure 6.8: 3D models of the right ventricle with ablation points. AP view
possible to calculate the difference between the ablation lesion positions and location
of the equivalent inverse dipole.
6.3 Analysis of the patients with small number of
relevant results
All results were evaluated based on the RRE criterion (see sec. 3.5.2, Eq. (3.8)). In four
patients, the percentage of relevant results was less than 40% (Fig. 5.1). As can be seen
from Fig. 5.2, patients Pat011 and Pat016 did not have any correct relevant inverse
results. This can be explained by the small amount of electrodes located in the heart
region (Fig. 6.9). These examples prove that variability of the torso geometries and the
location of the heart between the patients urges to make the protocol of the electrodes
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(a) Pat009 torso
model with leads,
AP view
(b) Pat011 torso
model with leads,
AP view
(c) Pat015 torso
model with leads,
AP view
(d) Pat016 torso
model with leads,
AP view
(e) Pat009 torso
model AV, AP
view
(f) Pat011 torso
model AV, AP
view
(g) Pat015 torso
model AV, AP
view
(h) Pat016 torso
model AV, AP
view
Figure 6.9: Torso models of the patients with RRE less than 40%
application more sophisticated. Currently, the procedure was based on placing the 28th
electrode (it is forth electrode on the fourth stripe) on V2 position.
In Pat015 patient the torso geometry ends exactly under the lungs but for numerical
computations also lower part of the torso model should be present. In addition, as
can be seen from the Fig.L.3 many incorrect dipoles were located in the neighboring
segment. If they were considered as correct, the number of correct inverse results would
drastically increase from 8.7% up to 100%.
In spite of the low percentage of the relevant inverse results in Pat009 patient, 73%
of irrelevant inverse results were correct. High percentage of correct irrelevant inverse
results was also observed in other two overweight female patients (Pat005 — 56.2%,
Pat010 — 66.7%), which might signify/indicate of the need to increase the threshold for
RRE in overweight and obese female patients. Fig. 6.10 represents mean and standard
deviation of the RRE of the inverse solutions obtained using one of three torso models in
combination with TIBSPM for male patient Pat006 and female patient Pat009, which
were 0.15 ± 0.0242 (Pat006) and 0.32 ± 0.0411 (Pat009) for all combinations of the
torso models and TIBSPMs.
There were variations of the RRE values when torso models with different level of
complexity were taken into account (Fig. 6.10). Also, a tendency of the RRE decrease
with increasing time was observed at the beginning of the observed interval in all
patients. It was shown in [230] that RRE was higher and inverse solution results were
not stable when the PVC focus was located in septum center, left ventricular apex or
right ventricular posterior wall.
Thus, a thorough simulation study with confirmation in patients should be performed
in order to evaluate the impact of the multiple factors on the RRE value: ECG noise
presence, electrodes exclusion, position of the PVC focus, gender, overweight.
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(a) Pat006 RRE = 0.17± 0.0180 (b) Pat009 RRE = 0.32± 0.0449
(c) Pat006 RRE = 0.15± 0.0237 (d) Pat009 RRE = 0.31± 0.0416
(e) Pat006 RRE = 0.15± 0.0236 (f) Pat009 RRE = 0.33± 0.0351
Figure 6.10: Mean and standard deviation of the relative residual error of the inverse solu-
tions. The first letter represents the used torso model: H — homogeneous torso model H,
V — inhomogeneous torso model V, AV — inhomogeneous torso model AV. The second
abbreviation represents the time instant body surface potential map. Pat006 — male
patient. Pat009 — female patient
6.4 Input parameters for the inverse solution
Obtained results of the thesis showed that selection of the patient-specific time instant
(sec. 3.5.4) for computation of the BSP map improved the results of the inverse solution
only in combinations with torso model AV (Fig. 6.11), but not significantly. So the
patient-specific approach to selection of the input BSP data (selected in sec. 5.3) did
not improve the results of the inverse solution compared to the best combination of the
input parameters (selected in sec. 5.5).
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Figure 6.11: Percentage of correct relevant inverse results for one of the torso models (ho-
mogeneous H, inhomogeneous V, inhomogeneous AV) in combination with patient-specific
TIBSPM or best map (IBSPM 0–15 ms, selected in sec. 5.3), and best combination of the
input parameters (selected in sec. 5.5) — homogenous torso model H and TIBSPM 8 ms
Figure 6.12: Percentage of obtained relevant inverse results for one of the torso models
(homogeneous H, inhomogeneous V, inhomogeneous AV) in combination with patient-
specific TIBSPM or best map (IBSPM 0–15 ms, selected in sec. 5.3), and best combination
of input parameters (homogeneous torso model H and TIBSPM 8ms, selected in sec. 5.5)
for each patient separately
6.5 Stability of the inverse solution
As it was mentioned before, the correctness of the results was not measured quantita-
tively, but qualitatively. Spatial stability of the inverse solution based on the minimal
RRE criterion was merely estimated comparing the position of the “best” dipole with
positions of the dipoles giving second to fifth best result and its dependency on fluctua-
tion of input data was estimated using results from different beats or from using different
torso models. Assessment of the spatial stability of the inverse solution depending on
the torso model complexity showed that dispersion of the positions of the inverse re-
sults was smaller for homogeneous torso model H (p < 0.01) and is comparable with
the 3 mm grid that determines the spatial resolution of the method. However, presence
of high fluctuations in input BSP maps (e.g. in Pat011) can impair the stability.
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Conclusions
Noninvasive method for PVC focus localization was proposed using body surface po-
tential mapping, and 3D model of the torso structure from a CT scan. The inverse
solution was solved using a single dipole model (representing the heart generator), time
instant/integral body surface potential map and a torso model.
Ten patients with frequent monomorphic PVCs underwent BSP mapping, a CT scan-
ning and EP study with RFA. For each patient 5 PVCs were selected from ECG re-
cordings from 96 chest leads. Semi-automatic method considering overall SNR was used
to define the PVCs onset. For each PVC, 21 IBSPMs and 31 TIBSPMs were computed
from initial 30 ms time interval.
Three torso models of different torso complexity were created from the CT scans:
homogeneous torso model H (torso surface), inhomogeneous torso model V (torso, lungs,
RV, LV); inhomogeneous torso model AV (torso, lungs, RA + RV + pulmonary artery,
LA + LV + AO).
RFA was performed during an EP study to ablate the PVC focus. After successful
RFA the clinician assigned the locations of the ablation lesion to one (or two in some
cases) of predefined heart segments using a segment number according to AHA rec-
ommendations for the left ventricle division and its extension to the right ventricle, or
using a 12-segment clock-like division for ablation lesions located in outflow tracts.
Inverse problem was solved for each of 5 PVCs for all 156 possible combinations of
the input data: 21 IBSPMs and 31 TIBSPMs together with three levels of torso model
complexity. Possible positions of the dipoles were specified in a 3 mm rectangular grid
within the ventricular myocardium. The single dipole representing the PVC focus was
selected based on the criterion of the relative residual error between the input BSP
map and the map generated by the dipole. Only inverse solutions with RRE less or
equal 0.3 were considered as relevant. Positions of the relevant inverse solution were
compared with the locations of the ablation lesions obtained during EP study. If the
segment assigned by clinician matched with the segment assigned to the position of the
inverse solution, the solution was considered as correct.
Assessment of the inverse solution in terms of single dipole was based on the amount
of correct inverse solutions. Evaluation of the obtained results can be summarized in
the following points:
. The single dipole model representing the PVC focus can be used for the inverse
solution for PVC focus localization.. For all combinations of selected input parameters for all ten patients relevant results
(with RRE < 0.3 suggesting that the real heart generator might be approximated by
a dipole) were obtained in 68% cases.. Threshold of the RRE criterion should be analyzed and specified more precisely in
additional simulation study with confirmation in patients in order to evaluate the
RRE dependence on multiple factors: ECG noise presence, electrodes exclusion,
position of the PVC focus, gender, overweight.
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Dependence of the inverse solution correctness on input data was assessed us-
ing various combinations of input data (three levels of torso model complexity and
31 TIBSPM/21 IBSPM):
. When different IBSPM were tested as input ECG data regardless of the used torso
model, the highest number (61.3%) of correct relevant results was obtained when
IBSPM from time interval 0–15 ms was used as input data (p < 0.05).. When patient-specific TIBSPMs were used for the inverse solution as input data in
combination with one of 3 torso models of different complexity, the highest success
rate (68.4%) of relevant results was observed in combination with homogeneous torso
model H.. When different torso models were tested as input data regardless of the used BSP
map, the highest number (62.9%) of correct relevant results was obtained when ho-
mogeneous torso model H was used (p < 0.01).. The best combination of input data with highest number (77.4%) of correct rele-
vant results was the combination of the TIBSPMs from 8th, 9th, or 10th ms with
homogeneous torso model H (p < 0.01).
Two aspects of the stability of the inverse solutions were studied. First, the spatial
stability of the solution based on the minimal value of the RRE parameter within
computation from one input BSP map. Second, the stability of the obtained results
computed from slightly different input parameters:
. Evaluation of the RRE function stability (evaluating also results with second to
fifth best RRE) resulted in distances from the gravity center with Med=2.9 mm,
IQR=1.58 mm.. Evaluation of the inverse solution stability depending on BSP map fluctuations re-
sulted in distances from the gravity center with Med=5.5 mm, IQR=4.58 mm.. Evaluation of the inverse solution stability depending on the torso level comple-
xity resulted in distances from gravity center with Med=2.8 mm, IQR=1.66 mm
(torso model H); Med=3.8 mm, IQR=2.94 mm (torso model V); Med=3.55 mm,
IQR=2.8 mm (torso model AV).. The shift of the gravity center was higher between the homogeneous torso model H
and inhomogeneous torso models V and AV.. The suggested approach of the inverse solution in terms of single dipole based on the
RRE criterion is spatially stable, but high fluctuations in input BSP map can hinder
the stability of the inverse solution.
Summarizing, BSP mapping combined with the patient-specific CT model can be
used for noninvasive PVC focus localization using single dipole model for the inverse
solution of electrocardiography. However, high importance should be given to the qual-
ity of the recorded ECG and its proper processing as well as to creation of accurate
torso model.
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Summary of achieved results and fulfillment
of the goals
A noninvasive method for PVC focus localization was proposed using body surface po-
tential mapping and 3D model of the torso structure obtained from a CT scan. The
method is based on inverse solution using single dipole model as equivalent represen-
tation of the heat generator. The method was experimentally tested on a group of
patients and influence of the selection and processing of input data on the correctness
of obtained results and stability of the solution were analyzed.
Fulfillment of the goals of the thesis:
1. Overview of existing noninvasive diagnostic methods for ventricular ectopic beat
focus localization
State of the art overview starts with presentation of medical fundamentals neces-
sary for understanding of the thesis, which covers the heart anatomy (sec. 1.1), its
electrical activity (sec. 1.2), types of cardiac arrhythmias (sec. 1.3) and their treat-
ment treatment (sec. 1.4). Chapter 1 describes also existing approaches to measure-
ment (sec. 1.5), mapping (sec. 1.6) and modelling (sec. 1.7) of the cardiac electrical
activity.
The existing noninvasive diagnostic methods based on solution of the inverse prob-
lem of electrocardiography and ECG imaging and their use for finding the patholo-
gical cardiac electrical generator models in ischemia, arrhythmias and particularly
for the PVC focus localization are presented in the sec. 1.7.5, 1.7.6. ECG (sec. 1.5.2)
remains to be the golden standard for the cardiac arrhythmia diagnostics. Neverthe-
less, ECG imaging shows promising results.
2. Suggestion of a diagnostic method based on inverse solution and using appropriate
electrical equivalent source, representing the pathological ventricular ectopic beat
Proposal of the inverse method for PVC focus localization and its requirements
were described in sec. 3.1. Single dipole model was selected to represent the small
initially activated cardiac area during the pathological premature ventricular beat
(sec. 3.1.1, 3.1.2).
Multichannel measuring system and ECG processing methods were suggested
for obtaining the required distribution of the potential on the patient’s torso in
time (sec. 3.1.3, 3.2). CT scanning was selected to obtain the patient-specific torso
geometry and structure as well as actual positions of the ECG electrodes (sec. 3.3).
To verify the inverse solution correctness it was suggested to compare the with posi-
tions of the RFA lesions (sec. 3.4).
3. Verification of the proposed method in patients
Description of the measured patient group is presented (sec. 4.1). The patients
with PVCs underwent BSP mapping (sec. 4.2.1), CT scanning (sec. 4.2.2), and EP
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study with RFA (sec. 4.2.3). The inverse solution was computed using time integral
or time instant BSP maps and patient-specific torso models with different levels of
complexity. Behavior of the suggested method in patients with PVCs was tested by
using different modifications of the input ECG and geometry data (156 combinations
were used for evaluation of 5 selected PVCs in each patient 4.3). Results are presented
in Chapter 5.
4. Experimental study of the selection of the evaluated body surface potential map on
stability and accuracy of the inverse solution
The method proposed to study the BSP map interval impact on the inverse solution
is described in sec. 3.5.3. Obtained results of the study are presented in sec. 5.2 and
show that integral BSP map computed from the time interval 0–15 ms should be
used as input for the inverse problem solution as it provides the highest amount of
correct results (p < 0.01).
Patient-specific approach to selection of the input BSP data based on TIBSPM
with the maximum correlation between the TIBSPMs from the whole studied 30 ms
time interval was suggested (sec. 3.5.4). The use of patient-specific TIBSPM did not
provide a significantly higher amount of correct inverse results 5.3.
Stability of the inverse solution and its dependence on the BSP fluctuations was
assessed using the methods suggested in sec. 3.5.7 and evaluated in sec. 5.6.2.
5. Study of the influence of torso model complexity on stability and accuracy of the
inverse solution
The proposed method for the study of the torso model complexity impact on
the accuracy of the inverse solution was described in sec. 3.5.5 and the results are
presented in sec. 5.4. It was shown that usage of the homogeneous torso model H
provides the highest number of correct inverse solutions (p < 0.01).
Stability of the inverse solution in dependence of the selected torso model was
analyzed using the approach suggested in sec. 3.5.7 and assessed in sec. 5.6.3.
In addition to goals 4 and 5,a method for finding the best combination of input
parameters for the inverse solution (input BSP map and torso model) was suggested
in sec. 3.5.6. Obtained results presented in sec. 5.5 show that homogeneous torso
model H and TIBSPM computed for the time instant 8, 9 or 10 ms yield the highest
probability to obtain correct results. Spatial stability of the inverse solution using this
best combination was also assessed (sec. 5.6.1).
Based on the obtained results it can be stated, that after careful processing of the
input ECG and CT data and evaluation of their quality, the proposed method for
noninvasive localization of the PVC focus is able to supply pre-operative information
identifying with high probability the proper heart segment with the PVC focus. Prac-
tical impact of using the method can be decreased time of the invasive EP study, higher
safety, and reliability of the ablation therapy.
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Patient group description
Patient Gender
Age, Height, Weight,
BMI CommentsYrs cm kg
Pat001 Female 68 159 89 35.2 excluded: CT — bad quality
Pat002 Male 53 170 90 31.1 excluded: ECG — 500 Hz
Pat003 Female 64 165 70 25.7 excluded: no PVC
Pat004 Male 77 183 74 22.1
Pat005 Female 43 158 74 29.6
Pat006 Male 51 186 97 28
Pat007 Female 54 159 54 21.4
Pat008 Female 33 165 105 38.6
Pat009 Female 74 170 78 27
Pat010 Female 57 157 70 28.4
Pat011 Female 71 173 85 28.4
Pat012 Female 39 167 50 17.9 excluded: 3 PVCs
Pat013 Male 66 176 120 38.7 excluded: cancelled EP study
Pat014 Female 65 168 81 28.7 excluded: 3 PVCs
Pat015 Male 61 167 94 33.7
Pat016 Female 47 165 95 34.9
Pat017 Male 67 195 133 35 excluded: CT — bad quality
Pat018 Female 61 173 130 43.4 excluded: CT — did not fit into
Table A.1: Patient group description
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Patient’s informed consent protocol
Informace pro pacienta – informovaný souhlas 
 
Vážená paní, vážený pane 
rádi bychom Vám nabídli účast v klinické studii „Stanovení lokalizace fokusu frekventních 
komorových extrasystol pomocí neinvazivního multipolárního povrchového EKG 
mapování“. 
Na základě kardiologického vyšetření Vám bylo doporučeno elektrofyziologické 
vyšetřené spojené s radiofrekvenční ablací z důvodu přítomnosti komorových extrasystol. 
Informace o průběhu elektrofyziologického vyšetření jsou uvedeny v informovaném souhlasu 
s tímto výkonem. Komorové extrasystoly představují předčasný srdeční stah komor.  Nalezení 
místa vzniku komorové extrasystoly není vždy nejjednodušší a v praxi se k tomu využívá 
trojrozměrného (3D) elektroanatomického mapování srdce. Spočívá to v tom, že pomocí 
elektrody zavedené do srdce cévou z třísla mapujeme postupně obě komory srdeční a jejich 
okolí (oblast aorty, oblast velkých srdečních žil) a hledáme místo vzniku komorových 
extrasystol. Po jeho nalezení toto místo zničíme aplikací radiofrekvenční energie, což vede 
k úplnému odstranění těchto pro Vás nepříjemných extrasystol. Tato metoda je sice velice 
účinná (účinnější než léky), ale může být časově dosti náročná  tím, že je třeba zmapovat více 
srdečních oddílů. Proto bychom chtěli využívat neinvazivního multipolárního měření EKG, 
které by mohlo ještě před samotným výkonem pomoci k přesnější lokalizaci vzniku 
komorových extrasystol a tím snížit dobu výkonu a výkon by mohl být zacílen na daný oddíl 
a tím taktéž zkrácen.  
V rámci naší studie bychom rádi zjistili, zda multipolární měření povrchového EKG 
může pomoci k přesnější lokalizaci komorových extrasystol. V současné době se z běžně 
dostupného 12 svodového povrchového EKG nedá přesně určit místo vzniku komorových 
extrasystol, lze jen podle určitých pravidel přibližně odhadnout oblast, odkud by signál mohl 
vycházet. 
V případě vašeho souhlasu se zařazením do studie byste navíc absolvovala před 
elektrofyziologickým vyšetřením neinvazivní měření povrchového EKG multipolárním 
systémem spojeným s CT vyšetřením srdce. Na tělo pacienta se připevní stanovený počet 
elektrod (96-144) a provede se CT vyšetření za účelem zjistit přesné rozměry hrudníku 
a srdce. Z naměřeného EKG je poté získána integrační mapa, která se dále vyhodnocuje. Toto 
vyšetřené trvá asi 45 min. Možná komplikace při tomto vyšetření je alergie na kontrastní 
látku, pokud jste alergický na jodovou kontrastní látku, tak vyšetření provedeno být nemůže. 
Dále je CT vyšetření spojeno s vystavením se radiační zátěži, která je 1-2 mSv a zhruba 
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odpovídá dávce, kterou byste obdržel(a) při diagnostické koronarografii bez provedení 
angioplastiky. Elektrofyziologické vyšetření a radiofrekvenční ablace by proběhly zcela 
zvyklým standardním způsobem, jak se na našem pracovišti provádí, v místním umrtvení, bez 
celkové anestezie, pod rentgenovou kontrolou. Taktéž doba hospitalizace a celková péče o 
Vás by zůstala stejná. 
 
Alternativy 
Alternativou pro Vás je se studie nezúčastnit, což nijak neohrozí Vaše zdraví či náš vztah 
k Vám. Účast ve studii nemusí mít pro Vás přímý dopad na zlepšení zdravotního stavu, 
výsledky studie mohou ale pomoci v dalším zlepšování techniky přesné lokalizace 
komorových extrasystol. 
 
Komplikace 
Rizika spojená se samotným elektrofyziologickým vyšetřením s následnou radiofrekvenční 
ablací zůstávají stejná.  
 
Vaše účast ve studii je ovšem zcela dobrovolná, pokud se studie zúčastnit nechcete 
(z jakéhokoliv důvodu), vyšetření Vám samozřejmě bude provedeno a naše péče o Vás se 
nezmění. Data získaná ze studie budou anonymní, výsledky studie budou použity jen 
k vědeckým účelům. 
Pokud máte jakékoliv dotazy, tak je dříve než podepíšete informovaný souhlas, všechny 
vyslovte, abyste byl(a) před jeho podepsáním dostatečně informován (a). 
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Informovaný souhlas 
Já, ……………………………………………………souhlasím se zařazením do projektu 
„Zjištění lokalizace komorových extrasystol pomocí neinvazivního multipolárního 
měření povrchového EKG“. Informovaný souhlas jsem přečetl(a), plně mu porozuměl(a), 
měl(a) jsem možnost klást otázky, které mi byly veškeré zodpovězeny. 
 
Podpis……………………………………………datum……………………………. 
 
Jméno lékaře informujícího pacienta ……………………………….datum….……… 
 
Podpis………………………………………………………………………. 
Kontakt na vedoucího projektu: MUDr. Pavel Osmančík, email: pavel.osmancik@volny.cz, 
tel.: 721544447 
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Contingency tables
Body surface Correctness of the inverse solution
Totalpotential map Incorrect Correct
IBSPM 0–5 ms 37 39 76
IBSPM 0–10 ms 40 49 89
IBSPM 0–15 ms 36 57 93
IBSPM 0–20 ms 42 59 101
IBSPM 0–25 ms 49 61 110
IBSPM 0–30 ms 59 52 111
IBSPM 5–10 ms 38 53 91
IBSPM 0–15 ms 40 57 97
IBSPM 0–20 ms 42 66 108
IBSPM 0–25 ms 51 60 111
IBSPM 0–30 ms 63 49 112
IBSPM 10–15 ms 45 59 104
IBSPM 10–20 ms 49 64 113
IBSPM 10–25 ms 54 58 112
IBSPM 10–30 ms 65 48 113
IBSPM 15–20 ms 49 63 112
IBSPM 15–25 ms 61 52 113
IBSPM 15–30 ms 65 47 112
IBSPM 20–25 ms 66 47 113
IBSPM 20–30 ms 67 42 109
IBSPM 25–30 ms 74 37 111
TIBSPM 0 ms 30 37 67
TIBSPM 1 ms 31 36 67
TIBSPM 2 ms 34 40 74
TIBSPM 3 ms 37 39 76
TIBSPM 4 ms 39 46 85
TIBSPM 5 ms 39 49 88
TIBSPM 6 ms 40 49 89
TIBSPM 7 ms 41 49 90
TIBSPM 8 ms 38 53 91
TIBSPM 9 ms 38 53 91
TIBSPM 10 ms 36 55 91
TIBSPM 11 ms 40 57 97
TIBSPM 12 ms 41 60 101
TIBSPM 13 ms 45 59 104
TIBSPM 14 ms 44 63 107
TIBSPM 15 ms 49 62 111
TIBSPM 16 ms 47 64 111
TIBSPM 17 ms 47 65 112
TIBSPM 18 ms 49 63 112
TIBSPM 19 ms 52 60 112
TIBSPM 20 ms 57 55 112
TIBSPM 21 ms 61 52 113
TIBSPM 22 ms 64 50 114
TIBSPM 23 ms 65 47 112
TIBSPM 24 ms 64 44 108
Continued on the next page
TableC.1: Contingency table showing how many correct inverse solutions were observed
using BSP map generated for the selected time interval or time instant
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Table C.1 — Continued from previous page
Body surface Correctness of the inverse solution
Totalpotential map Incorrect Correct
TIBSPM 25 ms 65 42 107
TIBSPM 26 ms 69 40 109
TIBSPM 27 ms 72 39 111
TIBSPM 28 ms 74 38 112
TIBSPM 29 ms 76 36 112
TIBSPM 30 ms 75 37 112
Total 2651 2658 5309
Table C.1 Contingency table showing how many correct inverse solutions were observed
using BSP map generated for the selected time interval or time instant
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Body surface Correctness of the inverse solution
Totalpotential map (ms) Incorrect Correct
IBSPM 0–5 ms 38 38 76
IBSPM 0–10 ms 44 45 89
IBSPM 0–15 ms 46 47 93
IBSPM 0–20 ms 50 51 101
IBSPM 0–25 ms 55 55 110
IBSPM 0–30 ms 55 56 111
IBSPM 5–10 ms 45 46 91
IBSPM 0–15 ms 48 49 97
IBSPM 0–20 ms 54 54 108
IBSPM 0–25 ms 55 56 111
IBSPM 0–30 ms 56 56 112
IBSPM 10–15 ms 52 52 104
IBSPM 10–20 ms 56 57 113
IBSPM 10–25 ms 56 56 112
IBSPM 10–30 ms 56 57 113
IBSPM 15–20 ms 56 56 112
IBSPM 15–25 ms 56 57 113
IBSPM 15–30 ms 56 56 112
IBSPM 20–25 ms 56 57 113
IBSPM 20–30 ms 54 55 109
IBSPM 25–30 ms 55 56 111
TIBSPM 0 ms 33 34 67
TIBSPM 1 ms 33 34 67
TIBSPM 2 ms 37 37 74
TIBSPM 3 ms 38 38 76
TIBSPM 4 ms 42 43 85
TIBSPM 5 ms 44 44 88
TIBSPM 6 ms 44 45 89
TIBSPM 7 ms 45 45 90
TIBSPM 8 ms 45 46 91
TIBSPM 9 ms 45 46 91
TIBSPM 10 ms 45 46 91
TIBSPM 11 ms 48 49 97
TIBSPM 12 ms 50 51 101
TIBSPM 13 ms 52 52 104
TIBSPM 14 ms 53 54 107
TIBSPM 15 ms 55 56 111
TIBSPM 16 ms 55 56 111
TIBSPM 17 ms 56 56 112
TIBSPM 18 ms 56 56 112
TIBSPM 19 ms 56 56 112
TIBSPM 20 ms 56 56 112
TIBSPM 21 ms 56 57 113
TIBSPM 22 ms 57 57 114
TIBSPM 23 ms 56 56 112
TIBSPM 24 ms 54 54 108
TIBSPM 25 ms 53 54 107
TIBSPM 26 ms 54 55 109
TIBSPM 27 ms 55 56 111
TIBSPM 28 ms 56 56 112
TIBSPM 29 ms 56 56 112
TIBSPM 30 ms 56 56 112
Total 2651 2658 5309
Table C.2: Contingency table showing how many correct inverse solutions are expected
(assuming independency of the inverse solution correctness from input BSP map) using
body surface potential map generated for the selected time interval or time instant
123
Contingency tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Combinations of the input Correctness of the inverse solution
Totalparameters for the inverse solution Incorrect Correct
H IBSPM 0–5 ms 8 18 26
H IBSPM 0–10 ms 9 22 31
H IBSPM 0–15 ms 8 24 32
H IBSPM 0–20 ms 11 24 35
H IBSPM 0–25 ms 13 25 38
H IBSPM 0–30 ms 16 21 37
H IBSPM 5–10 ms 8 23 31
H IBSPM 5–15 ms 10 24 34
H IBSPM 5–20 ms 11 26 37
H IBSPM 5–25 ms 13 25 38
H IBSPM 5–30 ms 18 19 37
H IBSPM 10–15 ms 12 24 36
H IBSPM 10–20 ms 12 26 38
H IBSPM 10–25 ms 15 23 38
H IBSPM 10–30 ms 19 19 38
H IBSPM 15–20 ms 13 26 39
H IBSPM 15–25 ms 18 21 39
H IBSPM 15–30 ms 17 21 38
H IBSPM 20–25 ms 18 21 39
H IBSPM 20–30 ms 18 20 38
H IBSPM 25–30 ms 19 19 38
V IBSPM 0–5 ms 14 11 25
V IBSPM 0–10 ms 15 14 29
V IBSPM 0–15 ms 14 16 30
V IBSPM 0–20 ms 18 16 34
V IBSPM 0–25 ms 20 18 38
V IBSPM 0–30 ms 22 17 39
V IBSPM 5–10 ms 15 15 30
V IBSPM 5–15 ms 17 15 32
V IBSPM 5–20 ms 16 20 36
V IBSPM 5–25 ms 22 17 39
V IBSPM 5–30 ms 24 15 39
V IBSPM 10–15 ms 19 16 35
V IBSPM 10–20 ms 20 19 39
V IBSPM 10–25 ms 21 18 39
V IBSPM 10–30 ms 26 13 39
V IBSPM 15–20 ms 19 19 38
V IBSPM 15–25 ms 23 15 38
V IBSPM 15–30 ms 26 13 39
V IBSPM 20–25 ms 25 13 38
V IBSPM 20–30 ms 25 12 37
V IBSPM 25–30 ms 28 11 39
AV IBSPM 0–5 ms 15 10 25
AV IBSPM 0–10 ms 16 13 29
AV IBSPM 0–15 ms 14 17 31
AV IBSPM 0–20 ms 13 19 32
AV IBSPM 0–25 ms 16 18 34
AV IBSPM 0–30 ms 21 14 35
AV IBSPM 5–10 ms 15 15 30
AV IBSPM 5–15 ms 13 18 31
AV IBSPM 5–20 ms 15 20 35
AV IBSPM 5–25 ms 16 18 34
AV IBSPM 5–30 ms 21 15 36
AV IBSPM 10–15 ms 14 19 33
AV IBSPM 10–20 ms 17 19 36
Continued on the next page
Table C.3: Contingency table showing how many correct relevant inverse solutions were
observed using selected combination of the input parameters (torso model and time
interval or time instant for BSP map)
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Table C.3 — Continued from previous page
Combinations of the input Correctness of the inverse solution
Totalparameters for the inverse solution Incorrect Correct
AV IBSPM 10–25 ms 18 17 35
AV IBSPM 10–30 ms 20 16 36
AV IBSPM 15–20 ms 17 18 35
AV IBSPM 15–25 ms 20 16 36
AV IBSPM 15–30 ms 22 13 35
AV IBSPM 20–25 ms 23 13 36
AV IBSPM 20–30 ms 24 10 34
AV IBSPM 25–30 ms 27 7 34
H TIBSPM 0 ms 6 17 23
H TIBSPM 1 ms 6 17 23
H TIBSPM 2 ms 7 18 25
H TIBSPM 3 ms 8 18 26
H TIBSPM 4 ms 8 21 29
H TIBSPM 5 ms 8 23 31
H TIBSPM 6 ms 9 22 31
H TIBSPM 7 ms 8 23 31
H TIBSPM 8 ms 7 24 31
H TIBSPM 9 ms 7 24 31
H TIBSPM 10 ms 7 24 31
H TIBSPM 11 ms 9 24 33
H TIBSPM 12 ms 10 25 35
H TIBSPM 13 ms 12 24 36
H TIBSPM 14 ms 12 25 37
H TIBSPM 15 ms 13 25 38
H TIBSPM 16 ms 13 25 38
H TIBSPM 17 ms 12 27 39
H TIBSPM 18 ms 14 25 39
H TIBSPM 19 ms 15 24 39
H TIBSPM 20 ms 18 21 39
H TIBSPM 21 ms 17 23 40
H TIBSPM 22 ms 16 22 38
H TIBSPM 23 ms 17 21 38
H TIBSPM 24 ms 16 20 36
H TIBSPM 25 ms 17 19 36
H TIBSPM 26 ms 18 19 37
H TIBSPM 27 ms 18 19 37
H TIBSPM 28 ms 19 19 38
H TIBSPM 29 ms 21 18 39
H TIBSPM 30 ms 22 17 39
V TIBSPM 0 ms 13 9 22
V TIBSPM 1 ms 13 9 22
V TIBSPM 2 ms 14 11 25
V TIBSPM 3 ms 14 11 25
V TIBSPM 4 ms 16 13 29
V TIBSPM 5 ms 16 13 29
V TIBSPM 6 ms 15 14 29
V TIBSPM 7 ms 17 13 30
V TIBSPM 8 ms 15 15 30
V TIBSPM 9 ms 16 14 30
V TIBSPM 10 ms 16 15 31
V TIBSPM 11 ms 17 16 33
V TIBSPM 12 ms 18 16 34
V TIBSPM 13 ms 19 16 35
V TIBSPM 14 ms 17 18 35
Continued on the next page
Table C.3 Contingency table showing how many correct relevant inverse solutions were observed
using selected combination of the input parameters (torso model and time interval or time
instant for BSP map)
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Table C.3 — Continued from previous page
Combinations of the input Correctness of the inverse solution
Totalparameters for the inverse solution Incorrect Correct
V TIBSPM 15 ms 19 18 37
V TIBSPM 16 ms 19 19 38
V TIBSPM 17 ms 18 20 38
V TIBSPM 18 ms 19 19 38
V TIBSPM 19 ms 20 18 38
V TIBSPM 20 ms 21 16 37
V TIBSPM 21 ms 22 15 37
V TIBSPM 22 ms 24 15 39
V TIBSPM 23 ms 25 13 38
V TIBSPM 24 ms 24 13 37
V TIBSPM 25 ms 25 12 37
V TIBSPM 26 ms 27 11 38
V TIBSPM 27 ms 28 11 39
V TIBSPM 28 ms 28 11 39
V TIBSPM 29 ms 29 10 39
V TIBSPM 30 ms 29 10 39
AV TIBSPM 0 ms 11 11 22
AV TIBSPM 1 ms 12 10 22
AV TIBSPM 2 ms 13 11 24
AV TIBSPM 3 ms 15 10 25
AV TIBSPM 4 ms 15 12 27
AV TIBSPM 5 ms 15 13 28
AV TIBSPM 6 ms 16 13 29
AV TIBSPM 7 ms 16 13 29
AV TIBSPM 8 ms 16 14 30
AV TIBSPM 9 ms 15 15 30
AV TIBSPM 10 ms 13 16 29
AV TIBSPM 11 ms 14 17 31
AV TIBSPM 12 ms 13 19 32
AV TIBSPM 13 ms 14 19 33
AV TIBSPM 14 ms 15 20 35
AV TIBSPM 15 ms 17 19 36
AV TIBSPM 16 ms 15 20 35
AV TIBSPM 17 ms 17 18 35
AV TIBSPM 18 ms 16 19 35
AV TIBSPM 19 ms 17 18 35
AV TIBSPM 20 ms 18 18 36
AV TIBSPM 21 ms 22 14 36
AV TIBSPM 22 ms 24 13 37
AV TIBSPM 23 ms 23 13 36
AV TIBSPM 24 ms 24 11 35
AV TIBSPM 25 ms 23 11 34
AV TIBSPM 26 ms 24 10 34
AV TIBSPM 27 ms 26 9 35
AV TIBSPM 28 ms 27 8 35
AV TIBSPM 29 ms 26 8 34
AV TIBSPM 30 ms 24 10 34
Total 2651 2658 5309
Table C.3 Contingency table showing how many correct relevant inverse solutions were
observed using selected combination of the input parameters (torso model and time
interval or time instant for BSP map)
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Combinations of the input Correctness of the inverse solution
Totalparameters for the inverse solution Incorrect Correct
H IBSPM 0–5 ms 13 13 26
H IBSPM 0–10 ms 15 16 31
H IBSPM 0–15 ms 16 16 32
H IBSPM 0–20 ms 17 18 35
H IBSPM 0–25 ms 19 19 38
H IBSPM 0–30 ms 18 19 37
H IBSPM 5–10 ms 15 16 31
H IBSPM 5–15 ms 17 17 34
H IBSPM 5–20 ms 18 19 37
H IBSPM 5–25 ms 19 19 38
H IBSPM 5–30 ms 18 19 37
H IBSPM 10–15 ms 18 18 36
H IBSPM 10–20 ms 19 19 38
H IBSPM 10–25 ms 19 19 38
H IBSPM 10–30 ms 19 19 38
H IBSPM 15–20 ms 19 20 39
H IBSPM 15–25 ms 19 20 39
H IBSPM 15–30 ms 19 19 38
H IBSPM 20–25 ms 19 20 39
H IBSPM 20–30 ms 19 19 38
H IBSPM 25–30 ms 19 19 38
V IBSPM 0–5 ms 12 13 25
V IBSPM 0–10 ms 14 15 29
V IBSPM 0–15 ms 15 15 30
V IBSPM 0–20 ms 17 17 34
V IBSPM 0–25 ms 19 19 38
V IBSPM 0–30 ms 19 20 39
V IBSPM 5–10 ms 15 15 30
V IBSPM 5–15 ms 16 16 32
V IBSPM 5–20 ms 18 18 36
V IBSPM 5–25 ms 19 20 39
V IBSPM 5–30 ms 19 20 39
V IBSPM 10–15 ms 17 18 35
V IBSPM 10–20 ms 19 20 39
V IBSPM 10–25 ms 19 20 39
V IBSPM 10–30 ms 19 20 39
V IBSPM 15–20 ms 19 19 38
V IBSPM 15–25 ms 19 19 38
V IBSPM 15–30 ms 19 20 39
V IBSPM 20–25 ms 19 19 38
V IBSPM 20–30 ms 18 19 37
V IBSPM 25–30 ms 19 20 39
AV IBSPM 0–5 ms 12 13 25
AV IBSPM 0–10 ms 14 15 29
AV IBSPM 0–15 ms 15 16 31
AV IBSPM 0–20 ms 16 16 32
AV IBSPM 0–25 ms 17 17 34
AV IBSPM 0–30 ms 17 18 35
AV IBSPM 5–10 ms 15 15 30
AV IBSPM 5–15 ms 15 16 31
AV IBSPM 5–20 ms 17 18 35
AV IBSPM 5–25 ms 17 17 34
AV IBSPM 5–30 ms 18 18 36
AV IBSPM 10–15 ms 16 17 33
AV IBSPM 10–20 ms 18 18 36
AV IBSPM 10–25 ms 17 18 35
Continued on the next page
Table C.4: Contingency table showing how many correct inverse solutions are expected
(assuming independency of the inverse solution correctness from the used input com-
bination) using combination of selected body surface potential map and torso model
with selected level of complexity
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Table C.4 — Continued from previous page
Combinations of the input Correctness of the inverse solution
Totalparameters for the inverse solution Incorrect Correct
AV IBSPM 10–30 ms 18 18 36
AV IBSPM 15–20 ms 17 18 35
AV IBSPM 15–25 ms 18 18 36
AV IBSPM 15–30 ms 17 18 35
AV IBSPM 20–25 ms 18 18 36
AV IBSPM 20–30 ms 17 17 34
AV IBSPM 25–30 ms 17 17 34
H TIBSPM 0 ms 11 12 23
H TIBSPM 1 ms 11 12 23
H TIBSPM 2 ms 12 13 25
H TIBSPM 3 ms 13 13 26
H TIBSPM 4 ms 14 15 29
H TIBSPM 5 ms 15 16 31
H TIBSPM 6 ms 15 16 31
H TIBSPM 7 ms 15 16 31
H TIBSPM 8 ms 15 16 31
H TIBSPM 9 ms 15 16 31
H TIBSPM 10 ms 15 16 31
H TIBSPM 11 ms 16 17 33
H TIBSPM 12 ms 17 18 35
H TIBSPM 13 ms 18 18 36
H TIBSPM 14 ms 18 19 37
H TIBSPM 15 ms 19 19 38
H TIBSPM 16 ms 19 19 38
H TIBSPM 17 ms 19 20 39
H TIBSPM 18 ms 19 20 39
H TIBSPM 19 ms 19 20 39
H TIBSPM 20 ms 19 20 39
H TIBSPM 21 ms 20 20 40
H TIBSPM 22 ms 19 19 38
H TIBSPM 23 ms 19 19 38
H TIBSPM 24 ms 18 18 36
H TIBSPM 25 ms 18 18 36
H TIBSPM 26 ms 18 19 37
H TIBSPM 27 ms 18 19 37
H TIBSPM 28 ms 19 19 38
H TIBSPM 29 ms 19 20 39
H TIBSPM 30 ms 19 20 39
V TIBSPM 0 ms 11 11 22
V TIBSPM 1 ms 11 11 22
V TIBSPM 2 ms 12 13 25
V TIBSPM 3 ms 12 13 25
V TIBSPM 4 ms 14 15 29
V TIBSPM 5 ms 14 15 29
V TIBSPM 6 ms 14 15 29
V TIBSPM 7 ms 15 15 30
V TIBSPM 8 ms 15 15 30
V TIBSPM 9 ms 15 15 30
V TIBSPM 10 ms 15 16 31
V TIBSPM 11 ms 16 17 33
V TIBSPM 12 ms 17 17 34
V TIBSPM 13 ms 17 18 35
V TIBSPM 14 ms 17 18 35
V TIBSPM 15 ms 18 19 37
Continued on the next page
Table C.4 Contingency table showing how many correct inverse solutions are expected
(assuming independency of the inverse solution correctness from the used input com-
bination) using combination of selected body surface potential map and torso model
with selected level of complexity
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Table C.4 — Continued from previous page
Combinations of the input Correctness of the inverse solution
Totalparameters for the inverse solution Incorrect Correct
V TIBSPM 16 ms 19 19 38
V TIBSPM 17 ms 19 19 38
V TIBSPM 18 ms 19 19 38
V TIBSPM 19 ms 19 19 38
V TIBSPM 20 ms 18 19 37
V TIBSPM 21 ms 18 19 37
V TIBSPM 22 ms 19 20 39
V TIBSPM 23 ms 19 19 38
V TIBSPM 24 ms 18 19 37
V TIBSPM 25 ms 18 19 37
V TIBSPM 26 ms 19 19 38
V TIBSPM 27 ms 19 20 39
V TIBSPM 28 ms 19 20 39
V TIBSPM 29 ms 19 20 39
V TIBSPM 30 ms 19 20 39
AV TIBSPM 0 ms 11 11 22
AV TIBSPM 1 ms 11 11 22
AV TIBSPM 2 ms 12 12 24
AV TIBSPM 3 ms 12 13 25
AV TIBSPM 4 ms 13 14 27
AV TIBSPM 5 ms 14 14 28
AV TIBSPM 6 ms 14 15 29
AV TIBSPM 7 ms 14 15 29
AV TIBSPM 8 ms 15 15 30
AV TIBSPM 9 ms 15 15 30
AV TIBSPM 10 ms 14 15 29
AV TIBSPM 11 ms 15 16 31
AV TIBSPM 12 ms 16 16 32
AV TIBSPM 13 ms 16 17 33
AV TIBSPM 14 ms 17 18 35
AV TIBSPM 15 ms 18 18 36
AV TIBSPM 16 ms 17 18 35
AV TIBSPM 17 ms 17 18 35
AV TIBSPM 18 ms 17 18 35
AV TIBSPM 19 ms 17 18 35
AV TIBSPM 20 ms 18 18 36
AV TIBSPM 21 ms 18 18 36
AV TIBSPM 22 ms 18 19 37
AV TIBSPM 23 ms 18 18 36
AV TIBSPM 24 ms 17 18 35
AV TIBSPM 25 ms 17 17 34
AV TIBSPM 26 ms 17 17 34
AV TIBSPM 27 ms 17 18 35
AV TIBSPM 28 ms 17 18 35
AV TIBSPM 29 ms 17 17 34
AV TIBSPM 30 ms 17 17 34
Total 2651 2658 5309
Table C.4 Contingency table showing how many correct inverse solutions are expected
(assuming independency of the inverse solution correctness from the used input com-
bination) using combination of selected body surface potential map and torso model
with selected level of complexity
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AppendixD
Pat004
(a) Pat004 torso
model AV, AP view
(b) Pat004 torso
model AV, PA view
(c) Pat004 torso
model H with elec-
trode positions, AP
view
(d) Pat004 torso
model H with elec-
trode positions, PA
view
Figure D.1: Pat004. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 14 ms
Figure D.2: BSP maps of patient Pat004
(a) Ablation points from the
EP study. PA view
(b) Superior view (c) Base to apex view
Figure D.3: Results of RFA and positions of all 780 inverse solutions for Pat004.
Blue –– correct results, Red –– incorrect results
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Pat004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure D.4: Pat004. Positions of the inverse solutions for IBSPM 0–15 ms in combina-
tion with one of the torso models: homogeneous torso model H, or inhomogeneous torso
model V, or inhomogenous torso model AV (see sec. 3.5.3 and 5.2). Blue –– correct results,
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure D.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat004: PVC1 — TIBSPM 14 ms; PVC2 — TIBSPM 8 ms;
PVC3 — TIBSPM 13 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 14 ms. Blue ––
correct results
(a) Superior view (b) Base to apex view
Figure D.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat004: PVC1 — TIBSPM 14 ms; PVC2 — TIBSPM 8 ms;
PVC3 — TIBSPM 13 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 14 ms. Blue ––
correct results, Red –– incorrect results
(a) Superior view (b) Base to apex view
FigureD.7: Positions of the inverse solutions for torso model AV and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat004: PVC1 — TIBSPM 14 ms; PVC2 — TIBSPM 8 ms;
PVC3 — TIBSPM 13 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 14 ms. Blue ––
correct results, Red –– incorrect results
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Pat004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure D.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat004: TIBSPM or IBSPM. Blue –– correct
results
(a) Superior view (b) Base to apex view
Figure D.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat004. Blue –– correct results
(a) Superior view (b) Base to apex view
Figure D.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat004
(a) Superior view (b) Base to apex view
FigureD.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat004
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Pat004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure D.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat004
(a) Superior view (b) Base to apex view
Figure D.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat004
(a) Superior view (b) Base to apex view
Figure D.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat004
(a) Superior view (b) Base to apex view
Figure D.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat004. Blue — torso model H, Green — torso model V,
Red — torso model AV
133
AppendixE
Pat005
(a) Pat005 torso
model AV, AP view
(b) Pat005 torso
model AV, PA view
(c) Pat005 torso
model H with elec-
trode positions, AP
view
(d) Pat005 torso
model H with elec-
trode positions, PA
view
Figure E.1: Pat005. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 10 ms
Figure E.2: BSP maps of patient Pat005
(a) Ablation points from the
EP study. PA view
(b) Superior view (c) Base to apex view
Figure E.3: Results of RFA and positions of all 780 inverse solutions for Pat005.
Black — irrelevant results, Blue –– correct results, Red –– incorrect results
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Pat005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure E.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat005. Blue –– correct results,
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure E.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat005: PVC1 — TIBSPM 14 ms; PVC2 — TIB-
SPM 21 ms; PVC3 — TIBSPM 10 ms; PVC4 — TIBSPM 18 ms; PVC5 — TIBSPM 16 ms.
Blue –– correct results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure E.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat005: PVC1 — TIBSPM 14 ms; PVC2 — TIB-
SPM 21 ms; PVC3 — TIBSPM 10 ms; PVC4 — TIBSPM 18 ms; PVC5 — TIBSPM 16 ms.
Blue –– correct results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure E.7: Positions of the inverse solutions for torso model AV and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat005: PVC1 — TIBSPM 14 ms; PVC2 — TIB-
SPM 21 ms; PVC3 — TIBSPM 10 ms; PVC4 — TIBSPM 18 ms; PVC5 — TIBSPM 16 ms.
Blue –– correct results, Red –– incorrect results
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Pat005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure E.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat005: TIBSPM or IBSPM. Blue –– correct
results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure E.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat005. Black — irrelevant results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure E.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat005
(a) Superior view (b) Base to apex view
Figure E.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat005
136
Pat005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure E.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat005
(a) Superior view (b) Base to apex view
Figure E.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat005
(a) Superior view (b) Base to apex view
Figure E.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat005
(a) Superior view (b) Base to apex view
Figure E.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat005. Blue — torso model H, Green — torso model V,
Red — torso model AV
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AppendixF
Pat006
(a) Pat006 torso
model AV, AP view
(b) Pat006 torso
model AV, PA view
(c) Pat006 torso
model H with elec-
trode positions, AP
view
(d) Pat006 torso
model H with elec-
trode positions, PA
view
Figure F.1: Pat006. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 14 ms
Figure F.2: BSP maps of patient Pat006
(a) Ablation points from the
EP study. PA view
(b) Superior view (c) Base to apex view
Figure F.3: Results of RFA and positions of all 780 inverse solutions for Pat006.
Blue –– correct results, Red –– incorrect results
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Pat006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure F.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat006. Blue –– correct results
(a) Superior view (b) Base to apex view
Figure F.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat006: PVC1 — TIBSPM 13 ms; PVC2 — TIB-
SPM 14 ms; PVC3 — TIBSPM 14 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 14 ms.
Blue –– correct results
(a) Superior view (b) Base to apex view
Figure F.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat006: PVC1 — TIBSPM 13 ms; PVC2 — TIB-
SPM 14 ms; PVC3 — TIBSPM 14 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 14 ms.
Blue –– correct results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure F.7: Positions of the inverse solutions for torso model AV and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat006: PVC1 — TIBSPM 13 ms; PVC2 — TIB-
SPM 14 ms; PVC3 — TIBSPM 14 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 14 ms.
Blue –– correct results
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Pat006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure F.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat006: TIBSPM or IBSPM. Blue –– correct
results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure F.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat006. Blue –– correct results
(a) Superior view (b) Base to apex view
Figure F.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat006
(a) Superior view (b) Base to apex view
Figure F.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat006
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Pat006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure F.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat006
(a) Superior view (b) Base to apex view
Figure F.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat006
(a) Superior view (b) Base to apex view
Figure F.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat006
(a) Superior view (b) Base to apex view
Figure F.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat006. Blue — torso model H, Green — torso model V,
Red — torso model AV
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Pat007
(a) Pat007 torso
model AV, AP view
(b) Pat007 torso
model AV, PA view
(c) Pat007 torso
model H with elec-
trode positions, AP
view
(d) Pat007 torso
model H with elec-
trode positions, PA
view
Figure G.1: Pat007. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 16 ms
Figure G.2: BSP maps of patient Pat007
(a) Ablation points from the
EP study. PA view
(b) Superior view (c) Base to apex view
Figure G.3: Results of RFA and positions of all 780 inverse solutions for Pat007.
Blue –– correct results, Red –– incorrect results
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Pat007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure G.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat007. Blue –– correct results,
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure G.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat007: PVC1 — TIBSPM 15 ms; PVC2 — TIB-
SPM 18 ms; PVC3 — TIBSPM 16 ms; PVC4 — TIBSPM 15 ms; PVC5 — TIBSPM 16 ms.
Blue –– correct results
(a) Superior view (b) Base to apex view
Figure G.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat007: PVC1 — TIBSPM 15 ms; PVC2 — TIB-
SPM 18 ms; PVC3 — TIBSPM 16 ms; PVC4 — TIBSPM 15 ms; PVC5 — TIBSPM 16 ms.
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure G.7: Positions of the inverse solutions for torso model AV and patient-specific
TIBSPM (see sec. 3.5.4 and 5.3) for Pat007: PVC1 — TIBSPM 15 ms; PVC2 — TIB-
SPM 18 ms; PVC3 — TIBSPM 16 ms; PVC4 — TIBSPM 15 ms; PVC5 — TIBSPM 16 ms.
Blue –– correct results, Red –– incorrect results
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Pat007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure G.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat007: TIBSPM or IBSPM. Blue –– correct
results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure G.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat007. Blue –– correct results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure G.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat007
(a) Superior view (b) Base to apex view
FigureG.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat007
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Pat007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure G.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat007
(a) Superior view (b) Base to apex view
Figure G.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat007
(a) Superior view (b) Base to apex view
Figure G.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat007
(a) Superior view (b) Base to apex view
Figure G.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat007. Blue — torso model H, Green — torso model V,
Red — torso model AV
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Pat008
(a) Pat008 torso
model AV, AP view
(b) Pat008 torso
model AV, PA view
(c) Pat008 torso
model H with elec-
trode positions, AP
view
(d) Pat008 torso
model H with elec-
trode positions, PA
view
Figure H.1: Pat008. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 16 ms
Figure H.2: BSP maps of patient Pat008
(a) Ablation points from the
EP study. Superior view
(b) Superior view (c) Base to apex view
Figure H.3: Results of RFA and positions of all 780 inverse solutions for Pat008.
Black — irrelevant results, Blue –– correct results, Red –– incorrect results
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Pat008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
FigureH.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat008. Blue –– correct results
(a) Superior view (b) Base to apex view
Figure H.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat008: PVC1 — TIBSPM 15 ms; PVC2 — TIB-
SPM 16 ms; PVC3 — TIBSPM 15 ms; PVC4 — TIBSPM 15 ms; PVC5 — TIBSPM 15 ms.
Blue –– correct results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure H.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat008: PVC1 — TIBSPM 15 ms; PVC2 — TIB-
SPM 16 ms; PVC3 — TIBSPM 15 ms; PVC4 — TIBSPM 15 ms; PVC5 — TIBSPM 15 ms.
Blue –– correct results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure H.7: Positions of the inverse solutions for torso model AV and patient-specific
TIBSPM (see sec. 3.5.4 and 5.3) for Pat008: PVC1 — TIBSPM 15 ms; PVC2 — TIB-
SPM 16 ms; PVC3 — TIBSPM 15 ms; PVC4 — TIBSPM 15 ms; PVC5 — TIBSPM 15 ms.
Blue –– correct results
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Pat008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure H.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat008: TIBSPM or IBSPM. Blue –– correct
results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure H.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat008. Blue –– correct results
(a) Superior view (b) Base to apex view
Figure H.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat008
(a) Superior view (b) Base to apex view
FigureH.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat008
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Pat008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure H.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat008
(a) Superior view (b) Base to apex view
Figure H.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat008
(a) Superior view (b) Base to apex view
Figure H.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat008
(a) Superior view (b) Base to apex view
Figure H.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat008. Blue — torso model H, Green — torso model V,
Red — torso model AV
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Pat009
(a) Pat009 torso
model AV, AP view
(b) Pat009 torso
model AV, PA view
(c) Pat009 torso
model H with elec-
trode positions, AP
view
(d) Pat009 torso
model H with elec-
trode positions, PA
view
Figure I.1: Pat009. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 15 ms
Figure I.2: BSP maps of patient Pat009
(a) Ablation points from the
EP study. PA view
(b) Superior view (c) Base to apex view
Figure I.3: Results of RFA and positions of all 780 inverse solutions for Pat009.
Black — irrelevant results, Blue –– correct results, Red –– incorrect results
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Pat009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure I.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat009. Blue –– correct results
(a) Superior view (b) Base to apex view
Figure I.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat009: PVC1 — TIBSPM 13 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 9 ms; PVC4 — TIBSPM 18 ms; PVC5 — TIBSPM 10 ms.
Blue –– correct results
(a) Superior view (b) Base to apex view
Figure I.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat009: PVC1 — TIBSPM 13 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 9 ms; PVC4 — TIBSPM 18 ms; PVC5 — TIBSPM 10 ms.
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure I.7: Positions of the inverse solutions for torso model AV and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat009: PVC1 — TIBSPM 13 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 9 ms; PVC4 — TIBSPM 18 ms; PVC5 — TIBSPM 10 ms.
Blue –– correct results
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Pat009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure I.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat009: TIBSPM or IBSPM. Blue –– correct
results
(a) Superior view (b) Base to apex view
Figure I.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat009. Black — irrelevant results, Blue –– correct results
(a) Superior view (b) Base to apex view
Figure I.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat009
(a) Superior view (b) Base to apex view
Figure I.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat009
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Pat009 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure I.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat009
(a) Superior view (b) Base to apex view
Figure I.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat009
(a) Superior view (b) Base to apex view
Figure I.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat009
(a) Superior view (b) Base to apex view
Figure I.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat009. Blue — torso model H, Green — torso model V,
Red — torso model AV
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Pat010
(a) Pat010 torso
model AV, AP view
(b) Pat010 torso
model AV, PA view
(c) Pat010 torso
model H with elec-
trode positions, AP
view
(d) Pat010 torso
model H with elec-
trode positions, PA
view
Figure J.1: Pat010. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 15 ms
Figure J.2: BSP maps of patient Pat010
(a) Ablation points from the
EP study. AP view
(b) Superior view (c) Base to apex view
Figure J.3: Results of RFA and positions of all 780 inverse solutions for Pat010.
Black — irrelevant results, Blue –– correct results, Red –– incorrect results
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Pat010 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure J.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat010. Blue –– correct results,
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure J.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat010: PVC1 — TIBSPM 19 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 19 ms; PVC4 — TIBSPM 10 ms; PVC5 — TIBSPM 15 ms.
Blue –– correct results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure J.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat010: PVC1 — TIBSPM 19 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 19 ms; PVC4 — TIBSPM 10 ms; PVC5 — TIBSPM 15 ms.
Blue –– correct results
(a) Superior view (b) Base to apex view
Figure J.7: Positions of the inverse solutions for torso model AV and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat010: PVC1 — TIBSPM 19 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 19 ms; PVC4 — TIBSPM 10 ms; PVC5 — TIBSPM 15 ms.
Blue –– correct results
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Pat010 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure J.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat010: TIBSPM or IBSPM. Blue –– correct
results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure J.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat010. Black — irrelevant results, Blue –– correct results, Red ––
incorrect results
(a) Superior view (b) Base to apex view
Figure J.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat010
(a) Superior view (b) Base to apex view
Figure J.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat010
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Pat010 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure J.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat010
(a) Superior view (b) Base to apex view
Figure J.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat010
(a) Superior view (b) Base to apex view
Figure J.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat010
(a) Superior view (b) Base to apex view
Figure J.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat010. Blue — torso model H, Green — torso model V,
Red — torso model AV
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Pat011
(a) Pat011 torso
model AV, AP view
(b) Pat011 torso
model AV, PA view
(c) Pat011 torso
model H with elec-
trode positions, AP
view
(d) Pat011 torso
model H with elec-
trode positions, PA
view
Figure K.1: Pat011. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 12 ms
Figure K.2: BSP maps of patient Pat011
(a) Ablation points from the
EP study. AP view
(b) Superior view (c) Base to apex view
Figure K.3: Results of RFA and positions of all 780 inverse solutions for Pat011.
Black — irrelevant results, Red –– incorrect results
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Pat011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure K.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat011. Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure K.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat011: PVC1 — TIBSPM 12 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 17 ms; PVC4 — TIBSPM 12 ms; PVC5 — TIBSPM 14 ms.
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure K.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat011: PVC1 — TIBSPM 12 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 17 ms; PVC4 — TIBSPM 12 ms; PVC5 — TIBSPM 14 ms.
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure K.7: Positions of the inverse solutions for torso model AV and patient-specific
TIBSPM (see sec. 3.5.4 and 5.3) for Pat011: PVC1 — TIBSPM 12 ms; PVC2 — TIB-
SPM 15 ms; PVC3 — TIBSPM 17 ms; PVC4 — TIBSPM 12 ms; PVC5 — TIBSPM 14 ms.
Red –– incorrect results
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Pat011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure K.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat011: TIBSPM or IBSPM. Red –– incorrect
results
(a) Superior view (b) Base to apex view
Figure K.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat011. Black — irrelevant results
(a) Superior view (b) Base to apex view
Figure K.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat011
(a) Superior view (b) Base to apex view
FigureK.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat011
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Pat011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure K.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat011
(a) Superior view (b) Base to apex view
Figure K.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat011
(a) Superior view (b) Base to apex view
Figure K.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat011
(a) Superior view (b) Base to apex view
Figure K.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat011. Blue — torso model H, Green — torso model V,
Red — torso model AV
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Pat015
(a) Pat015 torso
model AV, AP view
(b) Pat015 torso
model AV, PA view
(c) Pat015 torso
model H with elec-
trode positions, AP
view
(d) Pat015 torso
model H with elec-
trode positions, PA
view
Figure L.1: Pat015. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 16 ms
Figure L.2: BSP maps of patient Pat015
(a) Ablation points from the
EP study. Superior view
(b) Superior view (c) Base to apex view
Figure L.3: Results of RFA and positions of all 780 inverse solutions for Pat015.
Black — irrelevant results, Blue –– correct results, Red –– incorrect results
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Pat015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure L.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat015. Blue –– correct results,
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure L.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat015: PVC1 — TIBSPM 17 ms; PVC2 — TIB-
SPM 17 ms; PVC3 — TIBSPM 12 ms; PVC4 — TIBSPM 16 ms; PVC5 — TIBSPM 17 ms.
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure L.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat015: PVC1 — TIBSPM 17 ms; PVC2 — TIB-
SPM 17 ms; PVC3 — TIBSPM 12 ms; PVC4 — TIBSPM 16 ms; PVC5 — TIBSPM 17 ms.
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure L.7: Positions of the inverse solutions for torso model AV and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat015: PVC1 — TIBSPM 17 ms; PVC2 — TIB-
SPM 17 ms; PVC3 — TIBSPM 12 ms; PVC4 — TIBSPM 16 ms; PVC5 — TIBSPM 17 ms.
Red –– incorrect results
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Pat015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure L.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat015: TIBSPM or IBSPM. Blue –– correct
results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure L.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat015. Black — irrelevant results, Blue –– correct results
(a) Superior view (b) Base to apex view
Figure L.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat015
(a) Superior view (b) Base to apex view
Figure L.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat015
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Pat015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure L.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat015
(a) Superior view (b) Base to apex view
Figure L.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat015
(a) Superior view (b) Base to apex view
Figure L.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat015
(a) Superior view (b) Base to apex view
Figure L.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat015. Blue — torso model H, Green — torso model V,
Red — torso model AV
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Pat016
(a) Pat016 torso
model AV, AP view
(b) Pat016 torso
model AV, PA view
(c) Pat016 torso
model H with elec-
trode positions, AP
view
(d) Pat016 torso
model H with elec-
trode positions, PA
view
FigureM.1: Pat016. Torso model AV and torso model H with electrode positions
(a) IBSPM 0–15 ms (b) TIBSPM 8 ms (c) patient-specific TIBSPM 12 ms
FigureM.2: BSP maps of patient Pat016
(a) Ablation points from the
EP study. Superior view
(b) Superior view (c) Base to apex view
FigureM.3: Results of RFA and positions of all 780 inverse solutions for Pat016.
Black — irrelevant results, Blue –– correct results, Red –– incorrect results
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Pat016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
FigureM.4: Positions of the inverse solutions for IBSPM 0–15 ms in combination with one
of the torso models: homogeneous torso model H, or inhomogeneous torso model V, or
inhomogenous torso model AV (see sec. 3.5.3 and 5.2) for Pat016. Red –– incorrect results
(a) Superior view (b) Base to apex view
FigureM.5: Positions of the inverse solutions for torso model H and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat016: PVC1 — TIBSPM 14 ms; PVC2 — TIB-
SPM 12 ms; PVC3 — TIBSPM 13 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 12 ms.
Red –– incorrect results
(a) Superior view (b) Base to apex view
FigureM.6: Positions of the inverse solutions for torso model V and patient-specific TIB-
SPM (see sec. 3.5.4 and 5.3) for Pat016: PVC1 — TIBSPM 14 ms; PVC2 — TIB-
SPM 12 ms; PVC3 — TIBSPM 13 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 12 ms.
Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure M.7: Positions of the inverse solutions for torso model AV and patient-specific
TIBSPM (see sec. 3.5.4 and 5.3) for Pat016: PVC1 — TIBSPM 14 ms; PVC2 — TIB-
SPM 12 ms; PVC3 — TIBSPM 13 ms; PVC4 — TIBSPM 13 ms; PVC5 — TIBSPM 12 ms.
Red –– incorrect results
167
Pat016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
Figure M.8: Positions of the inverse solutions for torso model H in combination with one
of 52 BSP maps (see sec. 3.5.5 and 5.4) for Pat016: TIBSPM or IBSPM. Red –– incorrect
results
(a) Superior view (b) Base to apex view
Figure M.9: Positions of the inverse solutions for torso model H and TIBSPM 8 ms (see
sec. 3.5.6 and 5.5) for Pat016. Black — irrelevant results, Red –– incorrect results
(a) Superior view (b) Base to apex view
Figure M.10: Positions of the first five dipoles of the inverse solution with minimal RRE
obtained for one TIBSPM 8 ms and homogeneous torso model H. Five dipoles (instead
one) with minimal RRE were selected for the inverse solution for one PVC (see sec. 3.5.7
and 5.6.1). Pat016
(a) Superior view (b) Base to apex view
FigureM.11: Positions of the twenty-five dipoles of the inverse solution with minimal RRE.
Inverse solution was solved using the combination of homogeneous torso model H and
TIBSPMs computed for 8 ms. Five dipoles (instead one) with minimal RRE were selected
for each inverse solution for 5 PVCs (see sec. 3.5.7 and 5.6.2) for Pat016
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Pat016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) Superior view (b) Base to apex view
FigureM.12: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and homogeneous torso model H (see sec. 3.5.7 and
5.6.3) for Pat016
(a) Superior view (b) Base to apex view
FigureM.13: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model V (see sec. 3.5.7 and
5.6.3) for Pat016
(a) Superior view (b) Base to apex view
FigureM.14: Positions of first five dipoles with minimal RRE value of the inverse solution
for one BSP map (IBSPM 0–15 ms) and inhomogeneous torso model AV (see sec. 3.5.7
and 5.6.3) for Pat016
(a) Superior view (b) Base to apex view
FigureM.15: Gravity centers (see sec. 3.5.7 and 5.6.3)of the five dipoles positions derived
for inverse solution for IBSPM 0–15 ms and each of the three input torso models in the
ventricular myocardium of the Pat016. Blue — torso model H, Green — torso model V,
Red — torso model AV
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